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Section 1: ABOUT THIS CURRICULUM GUIDE
This curriculum guide, o r course o f study, is designed to  meet the training and education 
needs o f public safety workers and emergency medical workers who may be exposed on the 
job  to  human immunodeficiency virus (H IV ) and hepatitis B virus (H B V ). This curriculum 
guide is based on federal guidelines fo r preventing occupational transmission, o r spread, o f 
HTV and H B V  among worker groups. These include public-safety workers (fire  service, law 
enforcement, and correctional facility personnel) and emergency-medical workers (emer­
gency-medical technicians and paramedics).
The Centers fo r Disease C ontrol (C D C ) wrote the guidelines w ith  input from  representatives 
o f  each public safety group. The guidelines, called "Guidelines fo r Prevention o f Transmis­
sion o f Human Immunodeficiency V irus and Hepatitis B V irus to  Health-Care and Public- 
Safety Workers,” are included in this guide.
W h a t does the c u rr ic u lu m  cover?
The curriculum is a model that you can adapt to f it  the needs o f  your organization. As such, 
i t  covers how H IV  and H B V  are spread; personal prevention practices; universal precau­
tions; protective equipment; specific workplace prevention practices, including decon­
tamination; and management o f  exposures.
W ho  can benefit fro m  th is  c u rricu lu m  guide?
W hether you tra in public-safety worker managers o r line staff, this guide was w ritten  fo r you. 
Y ou  may be a fu lltim e tra iner o r someone whose parttime responsibilities include providing 
training. This tra iner group includes administrators, public health officials, and policy 
makers.
W h a t w il l  a pub lic-safe ty w o rke r who completes the c u rr ic u lu m  be able to  do?
•  Recognize the definitions o f  H IV , H B V  and A ID S
•  Identify how H IV  and H B V  are transmitted
•  Recognize who is at risk o f infection
•  Iden tify  personal behaviors and practices that protect people from  risk o f HTV and H B V  
infection
•  Identify workplace situations in  which people may encounter H IV  and H B V
•  Iden tify  situations in which wearing masks, gloves, eyewear, and gowns is recommended
•  Iden tify  recommended protective equipment and devices and methods o f disinfecting and 
sterilizing them
•  State correct procedures fo r needle disposal; handwashing; handling specimens, spills, and 
soiled laundry; resuscitation; cleaning surfaces; conducting searches; and collecting 
evidence
A b ou t This C urricu lum  G uide
•  Recognize local laws and department policies regarding testing, confidentiality, and report- 
ing procedures
Added benefits o f learner involvement include reducing on-the-job stress related to  H IV  and 
H B V  transmission and identifying personal values and opinions about A ID S  and the ir e f­
fects on jo b  performance.
H ow  long  w il l  I t  take to  complete the cu rricu lu m ?
A bout four hours. However, length w ill vary according to  the previous training and ex­
perience o f  the participants, and the number o f  case studies you choose to  cover. Section 4, 
"Case Studies," includes a range o f case studies.
Effective training is tim ely and frequent Schedule regular, ongoing sessions to  fo llow  the 
in itia l course. Y ou  may incorporate these in to  existing department training schedules, struc­
tures, and programs. See Section 2, T ip s  fo r Trainers," fo r suggestions on conducting in itia l 
and fo llow-up sessions.
H ow  is  the gpide organized?
The guide is organized in  eight sections.
Section 1, "About This Curriculum Guide," introduces the form  and content o f  the curriculum 
guide.
Section 2, "Ups fo r Trainers," describes some ways to  plan, deliver, and evaluate training.
Section 3, "Preventing Transmission o f  H IV  and H B V  fo r Public-Safety W orkers and Emer­
gency-Medical Workers," is a lecture outline that you may want to  use in your training ses­
sion. I t  covers basic inform ation on the defin ition and transmission o f H IV  and H B V , 
precautionary measures and protective equipment, decontamination, and management o f 
exposure.
Section 4, "Case Studies," includes realistic descriptions o f incidents that m ight occur during 
the performance o f duty. They provide opportunities fo r learners to  practice making 
decisions about appropriate responses.
Section 5, "Resources," lists sources o f  inform ation related to  each public safety worker 
group, including p rin t and audiovisual materials, organizations and clearinghouses.
Section 6, "Glossary," defines H IV - and HBV-related terms.
Section 7, "Guidelines fo r Prevention o f  Transmission o f  Hepatitis B  V irus and Human Im ­
munodeficiency V irus to  Health-Care and Public-Safety Workers," provides the C DC 
guidelines.
Section 8 contains the overheads fo r the lecture outline.
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A bou t This C urricu lum  G uide
H ow  should you use th is  guide?
To increase your knowledge about the subject. Study the lecture outline in  Section 3. Then use 
some o f the resource materials listed in  Section 5 to develop the fullest possible under­
standing o f the subject
To plan and present your training program. See Section 2, "Tips fo r Trainers," fo r some ap­
proaches, including a checklist and evaluation materials. Use the resource lists in Section 5 
to  order audiovisual aids and handout materials.
This guide is only a starting p o in t Use, modify, and customize the curriculum to accom­
modate local situations, resources, and needs. Supplement it  w ith  references to  your state 
and local laws, guidelines, policies, and procedures. Adapt, sequence, and schedule training 
to  f it  your organization’s special circumstances, issues, and problems. T ry  to get all points 
across in  your own words and in the language o f the learners.
The subject o f this curriculum is dynamic; fo r example, although inform ation about transmis­
sion o f H IV  and H B V  has been well established; the numbers o f infected people do change. 
Therefore, consider this curriculum as a general introduction to  the subject. To update the 
curriculum w ith  new inform ation as it  becomes available, consult the organizations and 
clearinghouses listed in  Section 5, ’'Resources," as well as other sources.
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Section 2: TIPS FOR TRAINERS
Schedule tra in in g  to  be tim e ly  and frequent
To  address serious concerns and to  clear up any misunderstandings about virus transmission 
and A ID S , training should begin as soon as possible and occur regularly. Fo r new staff 
recruits, training should be a part o f the ir orientation on o r before the first day on the job. 
F o r all staff, provide frequent, periodic training to  review the facts, practice perform ing spe­
cial procedures, and introduce new inform ation as i t  becomes available.
In  follow-up sessions, you may ask learners to  bring in  the ir own examples o f cases they would 
like  to  discuss, o r you may choose to  discuss an incident in your d is tric t
Invo lve others in  the tra in in g  process
Seek the help o f  peer workers, public health officials, health and safety committees, union 
and management representatives, and others in  planning the agenda, preparing materials, 
and teaching the curriculum. The ir involvement w ill help make the curriculum appropriate 
and practical as well as accurate.
Peer worker participation, in  particular, often lends credibility to  the training. Their first­
hand experience can ensure a strong lin k  between the training session and the workplace.
Y ou can use experienced workers and other specialists to  give b rie f lectures, present case 
studies and conduct follow-up discussions, fie ld question-and-answer sessions, demonstrate 
how to  use protective equipment, and so on.
Prepare yo u rse lf
Be sure that you and your cooperating trainers know the subjects you present, and are sen­
sitive to  the issues that can be raised. Use Section 5 to  acquire resource materials. Study 
them well, together w ith  inform ation that relates to  your own local area.
Have discussions about the topic w ith  some o f your fellow workers o r o ther people who are 
concerned about the topic. Those talks w ill bring out many o f the questions and issues that 
you w ill encounter later in  the training sessions.
Id e n tify  le a rn ing  objectives
Base the tra in ing on the skills the learners must use on the ir jobs. Training should also ad­
dress learners* concerns, perceptions, and knowledge gaps.
C larify what learners w ill be able to  do as a result o f  training so that you can explain what you 
w ill cover in  the curriculum and what follow-up sessions w ill address. Y ou  might want to 
begin by reviewing the objectives in  Section 1, "About This Curriculum Guide." Pick the 
most appropriate options that are listed under the section heading, "W hat w ill a public safety 
worker who completes the curriculum be able to  do?"
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D eterm ine the  c u rr ic u lu m
The curriculum you teach should be related specifically to  workplace situations and concerns. 
Y ou  should supplement the basic inform ation presented in  Section 3, the lecture outline, o f  
this guide w ith  subjects o f  specific concern to  the learners. For example, subjects relating to  
law enforcement officers include search and arrest procedures.
Throughout the presentation o f  material in  the lecture, you, the trainer, w ill be asked to 
present inform ation that pertains to  your local jurisdiction. For example, you w ill need to 
explain standard operating procedures that apply to  specific tasks in  your jurisd iction and 
you may need to  explain state o r local laws (fo r example, laws that govern whether o r not 
you can test a suspected carrier o f  H IV  o f H B V ). Y ou  need to  make sure you know these 
procedures and laws.
C reate a good c lim a te  fo r  lea rn ing
During training, the atmosphere should encourage openness. Success depends on people 
feeling free to  actively participate, to  comment, to  question, and to  give feedback. Actively 
listening is as im portant as actively participating.
T h ink about the training sessions you’ve enjoyed attending most. I f  there was a team o f 
trainers, how did the members relate to  one another? Was there a chance fo r you to  ask 
questions? W ere you talked at the whole time o r d id you get a chance to  speak too?
Here are some ways to  set a positive, supportive tone.
Introduce yourself and other trainers
Clarify your roles and responsibilities.
Describe the course
Explain what skills the participants w ill be able to  use on the jo b  as a result o f  successful learn­
ing. Describe the activities and time involved.
Encourage questions
Find out what learners want to  know. Reserve tim e fo r a question-and-answer period. A c­
knowledge learners* comments, questions, and concerns, and provide immediate response 
o r o ffe r suggestions fo r appropriate sources o f information.
Be alert to learner attitudes
Note body language and tone o f voice. There may be apprehension, reserve, skepticism, 
even hostility about some o f  these topics. T ry  to  acknowledge and deal w ith  these attitudes 
w ithout putting any one person on the spo t
Listen
Y ou r tra in ing needs to  be in  touch w ith what the learners know and believe. M eaningful 
learning wül occur when the ir feelings, concerns, and issues are addressed.
W o rk  w e ll w ith  o th e r tra in e rs
Successful team tra in ing requires planning. D o  some team building w ith  the others who w ill 
participate before training begins. D on’t  wait un til the training session to  discover d iffe ren­
ces o f  opinion-
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Before the training begins, take time to  discuss your own and each other’s attitudes about 
the subject and the issues that you w ill cover. Share expectations and personal lim itations. 
Discuss how each person w ill handle sensitive issues. Explore the areas in  which you feel 
confident and those in  which you need support. Enlist the help o f others who have strengths 
in  your weak areas.
Rehearse what you are going to  do. Each team member should have a clear place and pur­
pose on the program. D uring the training session, avoid interrupting each other. The trainer 
who has the floor should not hesitate to  call on another to help clarify o r expand on points.
E valuate  lea rn ing  
Pre~ and Posttests
Several o f  the objectives in  this training session w ill involve learning factual inform ation (fo r 
example, how H IV  is transmitted). That type o f learning can be tested by giving a b rie f quiz 
at the end o f the session. (Sample Form 1 is an example o f a possible pre/posttest. I t  can be 
found at the end o f this section.)
Y ou  might also give the same quiz as a pretest at the beginning o f the session. N ot only w ill 
that give you an idea o f how much was actually learned during the session, but it  w ill also set 
the participants’ minds toward learning those answers they did not know.
On-the-job evaluations
The primary aim o f the curriculum is to tra in learners to use infection control principles in 
the performance o f  the ir jobs so that they w ill minimize the ir risk o f  coming in to  contact w ith 
H IV  and H BV.
Y ou  may want to request reports o f supervisors indicating the carry over o f training onto the 
job. The more precisely you define the outcomes to  observe, the more you can structure the 
curriculum to  produce those outcomes. Ask these kinds o f questions: "Can the worker 
demonstrate how to  remove contaminated protective gloves?" O r, "Can the worker name 
the protective equipment and devices that must be on an emergency transport vehicle?"
Ask learners to report-verba lly  in  an interview o r in w riting  on a fo rm -c ritica l incidents in 
which the curriculum affected the ir performance. This approach to evaluation reinforces 
learning by encouraging learners to  apply what they have learned from  the curriculum to 
the ir experiences on the job. Sample Form 3 provided at the end o f  this section may Se used 
to  gather inform ation from learners who have participated in the curriculum.
E valuate  the tra in in g  session
Both trainers and learners should be given the opportunity to  comment on the success o f the 
training session. Future sessions can be refined and strengthened by inform ation gathered 
during past evaluations.
Evaluation by trainers
A fte r the session, get the training team together fo r an evaluation session. Use all the in fo r­
mation you have—your observations and reactions, learner reactions and recommendations, 
comments o f observers o r consultants, opinions o f supervisors, and so on. Focus on what 
happened during the training and how the training compared w ith  your original plan.
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Ask yourselves these questions:
•  D o  the learning objectives s till seem clear and realistic? D id  you achieve them? W hat was 
especially helpfu l in  achieving them and what hindered achievement?
•  D id  the course design w ork out the way you expected? W here did the training not fo llow  
the design? Why?
•  Was there enough tim e to  introduce the material, address learners’ questions, and sum­
marize the content?
•  W ould you change the course design? What would you include o r omit?
•  Was there resistance to  any o f  the training topics? W ere there points on which someone 
was reluctant to  speak o r even listen?
•  W ere you uncomfortable w ith  any parts o f the course, o r in  answering any o f  the learners’ 
questions? I f  so, what can be done to  overcome this discomfort?
Sample Form 2 provided at the end o f this section may be useful when gathering inform a­
tion  from  other trainers.
Evaluation by learners
The use o f training evaluation forms is common. Two sample forms are included at the end 
o f  this section. Sample Form 3 can be distributed to  learners at the end o f each training ses­
sion. I t  w ill provide the learner’s immediate reaction to  the session. Sample Form 4 is an ex­
ample o f  a long-term evaluation. I t  can be sent to  learners after they return to  the ir jobs, 
and w ill provide inform ation about how learners are using the skills and knowledge acquired 
as a result o f  the curriculum. Y ou  may wish to  adapt these forms fo r your own use.
T iy  to  gather specific data that w ill be useful in  planning future sessions. For example, you 
get more inform ation out o f answers to "W hat could be changed to  make the training session 
better fo r you?" than "The training session was ( )good ( )fa ir (  )poor."
As a general rule, try  to  get the participants to  te ll you: 1) what they found most positive 
about the session; 2) what d id not w ork fo r them; and 3) what seemed to  be missing.
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C heck lis t fo r  p lann ing  a tra in in g  session
Place
____  Consider location, availability, and comfortable environments fo r small groups.
____  I f  advance notice is required to  reserve space, w ith  whom should you check? I f  the
room must be unlocked, who has the key?
____  H ow  w ill the room be set up? Chairs only, o r chairs at tables? Chair toward front or
in  a circle? W ho w ill set it  up?
____ I t  may be helpfu l to  draw a sketch indicating how you would like  the room to  be set up.
M ateria ls  and supplies
____  Prepare learner handouts such as local laws/guidelines/policies/procedures/reporting
forms, brochures.
____ Gather name tags, markers, pens, pencils, and flip  charts.
____  I f  refreshments w ill be offered, check supplies.
____  I f  you use audiovisual materials, have you o r a consultant previewed them fo r
suitability?
____  Pre- and posttests. Train ing evaluation forms.
Equipm ent
____  Reserve the slide projector, screen, audio- o r videocassette player, and other equip­
m e n t W ho w ill make sure they are working and set up? W ill everyone be able to  see 
the visuals?
____  I f  you are showing slides, are they arranged in order, right side up?
____  W ill someone who knows how to  run the equipment be there?
O ther tra iners
____Arrange and coordinate the participation o f all training staff and consultants.
____  Remind others o f the ir participation in  the session.
____  C larify what they w ill do and how it  fits in to  the overall training.




(m ay be used as a p re tes t a lso)
1. The viruses that cause A ID S  and hepatitis B  can only live in blood o r in  certain body fluids.
______ True ______ False
2. The follow ing behaviors o r situations w ill put you at risk o f being exposed to  human 
immunodeficiency virus (H IV ) which is the virus that causes A ID S
(check as many as are true):
______ Anal sex
______ Sex w ith one partner who has been tested and shown HIV-negative
______ Sharing drug needles
______ Sharing living o r working space and cooking utensils w ith  an infected person.
3. M ore  people have been infected w ith  the virus that causes hepatitis B  during the per­
formance o f work-related duties than w ith  the virus that causes A ID S.
______ True ____________________________________________________________ Fake
4. I f  you cannot determine what body fluids are present in emergency situation, you should 
wear gloves.
______ True ____________________________________________________________ False
5. Protective equipment (gloves, eyewear, masks, and gowns) should be present on all 
emergency response vehicles.
______ True ____________________________________________________________ False
6. There are documented cases o f  the virus that causes A ID S  being transmitted to health care 
workers who gave mouth-to-mouth resuscitation.
______ True ____________________________________________________________ False




8. Needles used at the emergency care site should be recapped before carrying them back to 
the emergency response vehicle to  be put in to  a puncture-resistant container.
______ True ____________________________________________________________ False
9. A  bleach solution (1:100) is adequate to  k ill the viruses that cause A ID S  and hepatitis B on 
equipment and environmental surfaces.
______ True ____________________________________________________________ False
10. The most effective way for H IV  o r H B V  to  be transmitted in  an occupational setting is 
through a needlestick.
______ True ____________________________________________________________ False
(To the trainer: Y ou  may want to  add questions that pertain to  your standard operating pro­
cedures to  this questionnaire.)
Answers:
1. True









S a m p l e  F o r m  2
Trainer Evaluation of Session
T itle  o f Session _______________________________________  Date ________________
Departm ent _______________________________________
Trainer _______________________________________
O ther trainers and consultants ( i f  any) _______________________________________
1. D id  all learners achieve the instructional objectives?
Z  W hich objectives were many learners unable to achieve?
3. (a) W hich sections o f the course did learners enjoy most? Why?
(b) W hich sections o f the course did learners enjoy least? Why?
(c) W hich sections o f the course were most successful at making a d ifficu lt task easy to 
learn? (This would be shown by observation o f learners* grasp o f knowledge during 
the case studies and by the ir comments on the usefulness o f these sections.)
4. (a) W ith  which sections o f the curriculum did learners have the most trouble?
(b) W hy were these sections d ifficu lt (e.g., were they unclear, too long, unnecessary, etc.)?
5. W hat improvement could be made to  solve o r minimize those problems?
6. H ow  could this course be made more cost-effective?
7. W hat follow-up support is needed?
Date:__________________  Y ou r name (optional):______________________________
Instructions: Please complete this form  and return it  to  the tra iner after the session. Use the 
back o f  this page i f  you need more space fo r any item. Thank you fo r helping improve the 
curriculum.
1. W hat is the single most im portant inform ation, skill, o r  procedure that you learned in 
the session?
2. D id  you feel comfortable asking questions? I f  not, why not?
3. W hat could be changed to  make the curriculum better fo r you?
4. W hat special issues, concerns, o r questions would you have like to  have raised?
5. D o  you have any comments/suggestions/questions/etc. that you would like  to  raise? 
Please w rite  them in the space below.
S a m p l e  F o r m  3
Learner Evaluation of Session
To the Learner:
On _________________  you took part in  a training curriculum. We want to  find out
whether that session was helpful. Please complete the sentences below and return the form 
w ith in  a week. In  some cases, you might just write, I  don’t know, or, This question doesn’t 
apply to  me. Y o u r feedback w ill help make fu ture  sessions better. Thank you.
1. W hat was the single most im portant lesson you learned in the training course?
S a m p l e  F o r m  4
Learner Evaluation of Session Over Time
2. W hat do you do d ifferently after having attended the training course?
3. W hat situations still make you uncomfortable when performing duties that have the 
potential fo r H IV  o r H B V  transmission?
4. I f  you could change one thing about the curriculum, what would it  be?
5. Have you done anything since the course to  find out more about H IV  and H B V  o r about 
anything else discussed in  the curriculum?
Name (optional):. Date:.

Section 3: PREVENTING HIV & HBV TRANSMISSION
Set an  agenda.
Welcome learners and give an overview o f the curriculum
Adm inister the pretest
D eliver the lecture
Discuss case studies
Adm inister the posttest
Evaluate the curriculum
W elcom e the  le a rne rs  to  the  session.
I f  the learners do not know one another and the group is 25 people o r less, have them introduce 
themselves.
Next, give the learners an overview o f the curriculum by stating that they w ill learn about the 
viruses that cause A ID S  and hepatitis B. This inform ation w ill include:
1. How the viruses are transmitted
2- How  to  protect oneself against exposure to  these viruses both in personal lifestyle choices 
and when perform ing job-related tasks.
3. Decontamination methods
4. Proper management i f  exposure occurs.
A d m in is te r  the  p re tes t ( i f  you choose to  use one)
D istribute pretest questionnaires and ask learners to complete them. (See Section 2, "Tips for 
Trainers," fo r a sample pretest questionnaire.)
L e c tu re  O u tlin e
The follow ing is an outline w ith  suggested overheads that you can use to  underscore important 
points o f your presentation. The outline covers four topics: a basic set o f  facts about H IV  and 
H B V , protective equipment and procedures, decontamination, and management o f exposure.
By presenting the inform ation in  the lecture outline first, you ensure that the participants have 
common knowledge o f the subject You may choose a case study (see Section 4) and discuss its 
relevant aspects follow ing each topic presentation and discussion. This approach w ill vary the 
pace and variety o f  the lecture. Instructions on how to do this are in the instructions to  the 
tra iner throughout the lecture outline.
Throughout this curriculum, we have used "public-safety workers and emergency-response 
workers " to  refer to  the target audience. Y ou  should substitute the name o f the group you arc 
training: law enforcement o r corrections officers, fire  fighters, paramedics, emergency medical 
technicians.
3 - 1
Lectu re  O utline
Overhead 1
Overhead 2
To the trainer: You may find it 
helpful to add state-specific 
data or data from your locality to 
the presentation at this point. 
These data are available from 
your state and local health 
departments and are published 
weekly in Morbidity and 
Mortality Weekly Report 
(published by CDC).
D E F IN IT IO N  AN D  TRANSM ISSIO N O F H IV  AN D  HBV
1. W hat Is AIDS?
•  A -I-D -S  stands fo r Acquired Immunodeficiency Syndrome.
•  A ID S  is caused by a virus called human immunodeficiency 
virus o r H IV . This virus lives only in  blood and certain other 
body Quids. I t  cannot live outside these environments.
•  The outcome o r manifestation o f illness varies w ith in ­
dividuals who are infected w ith  the virus.
a. Some infected persons have no disease symptoms and may 
not show outward signs o f the disease fo r many years.
b. Some infected persons suffer less severe symptoms than do 
those w ith  diagnosed cases o f  A ID S. These lesser symptoms 
may include loss o f appetite, weight loss, fever, night sweats, 
skin rashes, diarrhea, tiredness, lack o f  resistance to infection, 
and swollen lymph nodes.
c. A ID S  is the result o f  the progressive destruction o f  a 
person’s immune system, which is the body’s defense against 
disease. This destruction allows diseases that the body can 
normally fight to  threaten the person’s health and life.
1. A  particularly dangerous type o f pneumonia and certain 
other infections o ften invade a body weakened by H IV .
2. H IV  can also attack the nervous system and cause damage 
to  the brain. This may take years to  develop. The symp­
toms may include memory loss, indifference, loss o f coor­
dination, partial paralysis, o r mental disorder.
2. How widespread is H IV  infection?
•  As o f  January 1989, there were over 80,000 cases o f  A ID S  
reported in  the U nited States. Over ha lf o f  those cases have 
died o f A ID S  o r A IDS-related causes. These cases have 
been reported from all states, the D istric t o f  Columbia, Puer­
to  R ico and the other territories.
•  I t  is estimated that as many as 1.5 m illion Americans are in ­
fected w ith  H IV . Most o f these do not have symptoms o f 
disease. W e do not know how many o f these w ill develop 
A ID S , but a study o f a group o f H IV-positive men in San 
Francisco showed that 48 percent developed A ID S  over a 
10-year period.
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•  Infected people represent all ages-including infants and 
elderly adults—all races, men and women, and all lifestyles.
Overhead 3 3. How Is H IV  not transm itted?
•  Y ou  cannot "catch" H IV  like  a common cold o r flu. H IV  is 
no t spread through the air like cold viruses.
•  There is no medical evidence o f H IV  transmission by casual, 
everyday contact: sharing kitchens, bathrooms, laundries, 
eating utensils, beds, o r living space w ith  infected people.
•  H IV  is not transmitted in  nonsexual social situations, such as 
at w ork o r through sharing air, food, and water.
•  There is no evidence o f transmission through insects, such as 
mosquitoes.
•  The risk o f H IV  infection through contact w ith  feces, nasal 
secretions, saliva, sputum, sweat, tears, urine and vomitus is 
extremely low or nonexistent
Overhead 4
4. W hat personal behaviors o r practices pu t you at r is k  fo r 
infection w ith  HIV?
•  You can become infected by having homosexual o r 
heterosexual contact-ora l, anal, o r vag ina l-w ith  someone 
who is infected w ith  H IV .
•  You can become infected by sharing drug needles and syrin­
ges w ith  an infected person.
•  A n  infected woman can spread H IV  to  her baby before it is 
bom  o r during birth.
•  Transfusion recipients and hemophiliacs have been infected 
by the blood o r plasma o f  infected donors. However, be­
cause the blood supply has been screened fo r H IV  since 
A p r il 1985, the chance o f  becoming infected through trans­
fusions now is extremely small. There is no risk o f becoming 
infected by donating blood.
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To the trainer: On page 3 of the 
"Guidelines for Prevention of 
Transmission of Human 
Immunodeficiency Virus and 
Hepatitis B Virus to Heafth-Care 
and Public Safety Workers," 
(Section 7) you w ill find a 
discussion of a ll reported cases 
of AIDS among health care 
workers and public safety 
workers. You may want to be 
familiar with these data if there 
are specific questions asked in 
the training session.
Overhead 7
5. How can you prevent H IV  transm ission in  your personal 
life?
Y ou  can prevent HTV transmission by refraining from:
•  anal sex, w ith  o r w ithout a condom
•  vaginal o r oral sex w ith  someone who uses intravenous 
drugs o r engages in  anal sex
•  sex w ith  someone you do not know well o r w ith  someone 
you know has several sex partners
•  unprotected sex (w ithout a condom) w ith  an infected person
•  sharing intravenous drug needles.
I f  you engage in high-risk behavior that puts you in  contact 
w ith  an infected individual, you can become infected w ith H IV . 
Many people th ink  that only certain "high-risk groups" o f  
people are infected by H IV . This is untrue. W ho you are has 
nothing to  do w ith  whether you are in  danger o f  being infected 
w ith  H IV . W hat matters is what you do, and whether you prac­
tice high-risk behavior.
6. Is there a problem  o f occupationally acquired H IV  infection 
among pub lic  safety workers and emergency medical tech­
nicians?
There are few data on H IV  infection among fire  fighters, 
police, law enforcement and corrections officers. There are a 
small number o f  health-care workers who have become in ­
fected w ith  H IV  while perform ing work-related tasks that are 
similar to  those performed by public safety workers in the 
delivery o f  emergency health care.
7. How can workers protect themselves against H IV  transm is­
sion while  perform ing th e ir duties?
Because H IV  is a virus that lives in  blood, you must protect 
yourself against coming in to  contact w ith  blood o r body flu ids  
tha t contain blood. In  addition, certain body fluids present 
some risk o f infection.
a. Semen and vaginal secretions can contain H IV , but occu­
pational transmission through these fluids from  an infected 
person to  a person providing emergency treatment has not 
been documented.
Lectu re  O utline
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To the trainer: You may find it 
helpful to review information 
about exposures in the 
Guidelines (Section 7) or in the 
April 22, 1988 and June 15, 
1988 issues of Morbidity and 
Mortality Weekly Report.
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b. Because the risk o f HTV and H B V  infection in this group o f 
body fluids is unknown, persons providing emergency care 
should take precautions when coming in  contact w ith  fluids 
that are contained in the spine, chest cavity and abdomen, 
and in  the uterus o r womb surrounding an unborn child.
c. The risk o f HTV infection through contact w ith  feces, nasal 
secretions, saliva, sputum, sweat, tears, urine and vomitus is 
extremely low o r nonexistent. However, these body fluids 
may carry other organisms that cause disease. Common sense 
dictates that you should take precautions to  protect yourself.
In  emergency settings, i f  you cannot determine whether a 
body flu id  contains blood—o r even what type o f f lu id  i t  is— 
trea t a ll body flu ids as potentia lly  infectious.
8. W hat does i t  mean to  "come in to  contact”?
Because the virus m ust live in blood o r certain body fluids, it  
has to  enter a body quickly and then enter the bloodstream.
For public-safety workers and emergency-response workers, 
this can happen in  several ways.
a. The most effective way fo r H IV  to  enter the body is through 
a needlestick in jury i f  that needle has been used by someone 
w ith  HTV infection.
b. I f  infected fluids touch the skin, intact o r unbroken skin w ill 
protect against infection. However, i f  there is an open wound, 
a cut, o r the skin is otherwise not intact—which means chapped, 
abraded, weeping, o r having rashes o r eruptions-the  infected 
flu id  can enter the body.
c. I f  infected fluids touch the mucous membranes o f  the eye, 
nose o r mouth, these surfaces can absorb the flu id  and 
transmit the virus.
9. W hat are the relative risks o f these means o f infection?
These entry ways o f infected flu id  in to  the body represent d if­
ferent risks. The needlestick entry has the most potential fo r 
transmitting HTV. Studies indicate that the risk o f  developing 
H IV  infection is about 0.5% follow ing a needlestick from a 
known H IV -in fected person. The risk associated w ith  mucous 
membrane o r chapped o r broken skin exposure is like ly to  be 
far lower than that associated w ith  needlestick injuries.
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10. Are there ways to  test blood to  determine i f  a person is 
infected w ith  H IV?
Antibodies against H IV  in  an infected individual’s blood can be 
detected by a series o f  tests.
•  Tests that show the presence o f antibodies are said to  be 
■positive."
•  Persons usually develop antibody against the virus w ith in  
6-12 weeks after becoming infected.
11. A re there ways to  protect yourself?
•  There are protective procedures and equipment that we w ill 
discuss in  detail that you can use to  protect yourself.
•  A t  present, there is no vaccination against H IV .
12. W hat is hepatitis B?
•  Hepatitis B is caused by hepatitis B virus (H B V ).
•  Hepatitis B  is a disease that causes liver damage, the severity 
o f which can range from  m ild o r even inapparent to severe 
o r fa ta l
a. Approximately 25% o f  infected individuals develop acute 
hepatitis.
b. O f infected individuals, 6%  to  10% w ill become H B V  
carriers. Carriers are at risk o f  developing chronic liver 
disease, including active hepatitis, cirrhosis, and primary 
liver cancer, and are infectious to  others.
13. How widespread Is HBV?
•  In  1987, C D C  estimated the tota l number o f new H B V  infec­
tions in  the U nited States to  be 300,000 per year.
•  C D C  estimates that 12,000 health care workers whose job- 
related duties involve exposure to  blood become infected 
w ith  H B V  each year.
a. 500-600 health-care workers are hospitalized each year.
b. 200-300 infected health-care workers die each year from  dis­
eases associated w ith  chronic o r acute hepatitis caused by 
hepatitis B.
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14. W hat personal behaviors p u t you a t r is k  fo r  infection w ith  
HBV7
•  As w ith  the risks fo r H IV , you can become infected w ith 
H B V  through sexual contact (anal o r vaginal) w ith  someone 
who is infected w ith  H B V .
•  Y ou  can become infected by sharing drug needles and syrin­
ges w ith  an infected person.
•  Since blood is screened fo r H B V , the chance o f being in­
fected through transfusion is extremely small.
15. W hat situations pu t a pub lic  safety w orker o r emergency 
medical technician a t risk?
•  The same situations that cause a w orker to  encounter blood 
o r other possibly infectious fluids w ith  H IV —that is, by need- 
lestick o r contact w ith an open wound o r broken, nonintact 
skin, o r mucous membranes o f  the eyes, nose o r m outh— 
have the potential fo r infection w ith  H B V  also.
•  One additional body flu id  has the potentia l fo r transmission 
o f H B V . Saliva o f an HBV-infected person injected in to  
another person through a b ite  can transmit H B V .
16. How can pub lic  safety workers o r emergency medical tech­
nicians protect themselves against HBV?
The same protective equipment and procedures that w ill be dis­
cussed fo r H IV  in  the rest o f  this training session w ill protect 
the worker against H B V .
17. Are there ways to  test blood to  determine i f  a person is 
infected w ith  HBV?
Blood tests are available that detect antibodies fo r H B V  in an 
infected person.
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To the trainer: When reviewing 
the risk of infection after 
needlestick exposure, explain 
that the different rates for HIV 
and HBV can probably be 
attributed to a much lower 
concentration of HIV in the 
blood than HBV. In other 
words, HBV normally exists in 
much greater concentration 
than HIV does in the same 
amount of blood.
1& Is there a vaccine against HBV?
•  Available vaccines provide protection against H B V  infection 
and provide over 90% protection against hepatitis B fo r 7 o r 
more years.
•  The vaccines are also 70% to 88% effective when given 
w ith in  one week after H B V  exposure.
•  Hepatitis B immune globulin (H B IG ) provides some tem­
porary protection follow ing exposure to  H B V , A fte r ex­
posure to  the virus, a combination o f  the vaccine w ith  H B IG  
is over 90% effective in  preventing hepatitis B.
19. How are H BV and H IV  sim ila r?  different?
M ode o f  transmission:
H B V H IV
Blood yes yes
Semen yes yes
Vaginal secretion yes yes
Saliva (from  a bite) yes no
Target in  the body liver immune system





High number o f  viruses yes no
in blood
Vaccine available yes no
3 - 8
Lectu re  O utline
Overhead 20
To the tra in e r It would be 
helpful to have the equipment in 
class with you so that the 
learners know exactly what you 
are talking about. You should 
also make sure that everyone 
knows how to use the 
equipment. You should 
demonstrate, for example, how 
to properly take the gloves off 
so that blood or other material 
that is on the glove does not 
contaminate other surfaces.
PRECAUTIONARY MEASURES AN D  PROTECTIVE 
E Q U IPM EN T
1. W hat is standard personal protective equipment?
•  Gloves are standard equipm ent Disposable gloves should 
be put on before beginning any tasks involving exposure to 
blood o r body fluids that are associated w ith  H IV  and H B V  
infection o r those that you cannot identify because o f  c ir­
cumstances in  an emergency setting. Heavy gloves o ffer 
protection against sharp surfaces.
a. N o one type o f glove is appropriate fo r all situations. The 
worker must use judgement concerning the advantages o f 
the type o f glove o r the combination o f gloves to use that 
gives a balance o f protection against fluids and sharp objects, 
yet allowing dexterity.
b. In  situations involving broken glass o r sharp edges, gloves 
that meet O S H A  requirements should be worn. Each situa­
tion w ill require your personal judgement concerning the 
use o f  disposable gloves under heavy gloves meant fo r pro­
tection against shart edges.
c. Change gloves i f  they are tom  o r soiled, and always remove 
them before leaving the scene. W hile  wearing the gloves, 
avoid touching personal items, such as a comb. Also avoid 
touching your face, eyes, etc.
d. Change gloves between handling o f d ifferent people (fo r 
example, change gloves when finishing w ith  one victim  o f a 
crash before touching another victim).
•  Masks, eyewear, and gowns should be present on all emer­
gency response vehicles that respond to medical emergen­
cies o r victim  rescues. H ow  and when you use masks, 
eyewear, and gowns depends on the situation.
a. Management o f the person who is not bleeding, and who 
has no bloody fluids present, should not routinely require 
use o f masks, eyewear, o r gowns.
b. Masks and eyewear should be worn together, o r a faces hie Id 
should be used i f  splashes o f blood o r potentia lly contamina­
ted body fluids are like ly to occur. Surgical masks o ffe r ade­
quate protection fo r mucous membranes o f  the mouth and 
nose.
c. Gowns o r aprons that do not allow fluids to  pass through 
should be worn i f  necessary to  avoid soaking o f clothes.
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•  Resuscitation equipment should be available on all emer­
gency response vehicles even though no transmission o f 
H IV  o r H B V  infection during mouth-to-mouth resuscitation 
has been documented Again, other diseases can be trans­
m itted during this emergency procedure, and common sense 
dictates that you should protect yourself against possible in ­
fection.
a. Mechanical respiratory devices (fo r example, bag-valve 
masks, oxygen demand valve resuscitators) should be availa­
ble on all emergency response vehicles and to  all emergency 
response personnel who may respond to  medical emergen­
cies o r victim  rescues.
b. Pocket m outh-to-mouth resuscitation masks should be pro­
vided to  all personnel who may provide emergency treatm ent
2. How can you protect yourse lf against in fection w ith  H IV
and HBV?
•  A ll personnel who perform  tasks that put them in direct con­
tact w ith  blood o r potentially infectious body fluids, e ither 
routinely o r in  emergency situations, should be vaccinated 
against H B V .
•  W ear disposable gloves in  all situations where there is blood 
o r bodily fluids that have the potential o f  H IV  contamina­
tion. You should also wear disposable gloves i f  you cannot, 
in  an emergency situation, determine i f  the fluids are poten­
tia lly  infectious.
•  Put on the appropriate personal protective equipment 
before beginning a procedure i f  the chance o f  exposure to 
blood is high (fo r example, IV  insertion, trauma, delivering 
babies).
•  Personal protective equipment should be available on emer­
gency response vehicles fo r emergency situations. Equip­
ment should also be available in facilities and in IV  drug kits 
at all times.
3. Procedures fo r  Specific S ituations and Incidents
A t this po in t in  the training you should instruct the learners about 
procedures specific to your jurisdiction. You may want to refer to 
pages 17-27 in  the "Guidelines* fo r  information concerning CDC  
recommendations that pertain to fire  and emergency medical per­
sonneland law enforcement and correctional fac ility  officers.
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C A S E  S T U D IE S
To the tra iner: A t  this time, you may choose to  have the group w ork on one o f  the case studies. 
(See Section 4 fo r case studies appropriate fo r firefighters/emergency medical technicians, law 
enforcement officers and corrections officers.) Y ou  should only discuss issues related to  protec­
tive equipment and procedures. The advantage o f  using case studies at this point is the im­
mediate reinforcement o f inform ation just presented and the placing o f  theoretical inform ation 
in to  a "real" situation.
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To the trainer: Some 
workers have expressed 
concern about hew long 
HIVandHBV can live in 
the environment, 
expecialty once the 
medium (blood or body 
fluid) that it lives in 
dries. You may wish to 





D IS IN FEC TIO N , D E C O N TA M IN A TIO N , A N D  DISPOSAL
V ia b ility  o f  HTV and H BV in  the Environm ent
1. Studies at C D C  have shown that drying causes a 90%-99% 
reduction o f H IV  concentration w ith in  several hours.
2. H B V  can live in  a dry environment fo r a longer period than 
can H IV  (fo r at least 7 days and perhaps much longer).
3. Once the virus is no longer active in  dry material, it  cannot be 
"reconstituted" by adding water. A  dead virus is a dead virus. 
Some manufacturers claim to  have special products that are 
necessary to  k ill HTV on environmental surfaces. These are 
not necessary. The cleaning agents needed to  k ill the viruses 
w ill be explained in  detail in  this section.
4. One extensive study* o f  this subject which is o ften quoted in 
publications found that H IV  lived 1-3 days after drying in 
greatly concentrated H IV  samples (10 m illion infectious doses 
per m illilite r). This concentration is at least 100,000 times 
greater than that typically found in  the blood o f  patients w ith 
HTV infection. This study does not in  any way represent a 
"natural" situation.
•  Resnik L , Veren K , Salahudden SZ, Tondreau S., Markham
PD. Stability and inactivation o f H T L V - II I /L A V  under clinical
and laboratory environments. J A M A  1986;255:1887-91.
1. Needles and sharps disposal
•  Needles should not be recapped, purposely bent o r broken 
by hand, removed from  disposable syringes, o r otherwise 
manipulated by hand. Avoid  allowing the tip  o f the used 
needle to  touch any part o f  your body.
•  A fte r use, disposable blades and other sharp items should be 
placed in  puncture-resistant containers fo r disposal
•  Puncture-resistant containers should be located as close as 
practical to  the use area. I f  sharps are carried from  the 
emergency response vehicle to  the scene o f  victim  assis­
tance, a puncture-resistant container should be carried to 
the scene, also.
•  Reusable needles should be placed in  a puncture-resistant 
container fo r transport to  the reprocessing area.
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2. Handwashing: Hands must washed immediately after each 
contact w ith  a potentially contaminated person o r articles. Use 
ordinary soaps. There is no need to  use soaps w ith  an­
tim icrobial agents.
a. Use a u tility  o r restroom sink fo r handwashing. Food 
preparation areas should not be used for decontamination 
o r handwashing.
b. When proper facilities are available, wash hands w ith  soap 
and water.
c. Waterless antiseptic hand cleanser should be available on 
response vehicles. W hen using waterless cleanser, follow 
the manufacturer's recommendations fo r use.
3. Cleaning, disinfecting, and steriliz ing : Current recommen­
dations fo r standard cleaning, sterilization, and disinfection pro­
cedures fo r patient-care equipment are adequate fo r 
instruments, devices, o r o ther items contaminated w ith  blood 
o r other infectious material from persons infected w ith  H IV  or 
H B V .
Carefully read the labels and package inserts w ith  germicidal 
products and fo llow  instructions fo r use and safety.
Sterilization: destroys all forms o f m icrobial life.
Use fo r instruments o r devices that penetrate the skin or contact 
normally sterile parts o f the body (for example, scalpels and need­
les). Often, arrangements can be made with a healthcare fac ility  
fo r processing o f reusable invasive instruments.
Methods:
•  steam under pressure (autoclave)
•  gas (ethylene oxide)
•  dry heat
•  immersion in  EPA-approved chemical sterilant fo r 
prolonged period (6-10 hours o r according to 
manufacturer’s instructions). These chemicals should be 
used only i f  i t  is impossible to  sterilize o r disinfect an instru­
ment w ith a heat process.
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High-level Disinfection: destroys all forms o f  m icrobial life  ex­
cept high numbers o f  bacterial spores.
Use fo r  reusable instruments that come in to contact with mucous 
membranes (laryngoscope blades, endotracheal tubes, etc.)
Methods:
•  hot water pasteurization (80-100 degrees C  fo r 30 minutes)
•  exposure to  an EPA-registered chemical sterilant as above, 
except fo r a short contact time (fo r 10-45 minutes o r as 
directed by the manufacturer).
Intermediate-level Disinfectant: destroys mycobacterium tuber­
culosis, most viruses, vegetative bacteria, and most fungi, but 
not bacterial spores.
Use fo r surfaces that come into contact with intact skin (stetho­
scopes, blood pressure cuffs, splints, etc. )  and that have been 
visibly contaminated with blood o r body fluids. Surfaces must be 
precleaned o f visible m aterial before disinfection.
Methods:
•  use o f  EPA-registered "hospital disinfectant" chemical ger­
micides that claim to  be tuberculocidal on the labeL
•  hard-surface germicides as indicated above o r solutions con­
taining at least 500 ppm free available chlorine (1:100 d ilu ­
tion  o f  common household bleach-approxim ately 1/4 cup 
bleach per gallon o f  water).
Low-level Disinfection: destroys some viruses, most bacteria, 
some fungi, but not mycobacterium tuberculosis o r bacterial 
spores.
Use fo r  routine housekeeping o r removal o f soiling when there is 
no visible blood.
M ethod:
•  use o f  EPA-registered "hospital disinfectants" (no claim on 
label fo r tuberculocidal activity).
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Environmental Disinfection: Surfaces in  the environment such
as floors, ambulance seats, countertops, woodwork, etc. that
have become soiled should be cleaned and disinfected w ith
cleaners o r disinfectant agents intended fo r environmental use.
4. Cleaning and decontaminating sp ills  o f blood
•  First, put on disposable gloves and remove visible material 
by cleaning w ith  disposable towels o r another means that 
w ill ensure against direct skin contact w ith  blood. Place 
soiled towelling in  a plastic bag to  prevent contamination 
w ith  o ther surfaces.
•  W ear appropriate face and eye protection i f  you anticipate 
splashing.
•  I f  the amount o f blood in  the area is great, wear shoe cover­
ings that w ill not allow blood and fluids to  seep through.
•  A fte r removal o f  visible material, decontaminate w ith  ap­
propriate germicide o r a 1:100 solution o f household bleach. 
Use clean towels w ith germicide to  wipe area. Le t the area 
air dry.
•  A fte r decontamination o f  the area, remove contaminated 
items, shoe coverings, and gloves and place in plastic bag fo r 
disposal o r decontamination. Remove gloves la s t
•  Wash hands after removing gloves.
5. Laundry: A lthough soiled clothing o r linen may contain o r­
ganisms that cause disease, the risk o f  actual disease transmis­
sion is negligible. Therefore, simple hygienic measures fo r 
handling and washing linens are recommended.
•  Handle soiled linens as little  as possible to  prevent con­
tamination o f the air and o f persons handling the linen.
•  Bag all soiled linen at the location where it  was used. Place 
linens soiled w ith  blood in  bags that prevent leakage.
•  Wash linens in  normal laundry cycles according to  the recom­
mendations o r instructions o f the washing machine and 
detergent manufacturers.
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6. Decontamination and laundering of protective clothing:
O verhead 29
• Transport clothing in bags or containers that prevent 
leakage.
•  Wear gloves when bagging and placing contaminated cloth­
ing into the washer.
•  Station and work uniforms should be washed and dried ac­
cording to the instructions on their labels.
7. Infective waste: Identifying wastes that require special 
precaution in disposal is largely a matter of judgement about 
the risk that the waste represents. In all cases, follow local 
regulations carefully concerning disposal procedures.
CASE STUDIES
To the trainer: Return to the case study discussion. At this time, discuss decontamination issues 
that are relevant to that case. If  you chose a case study that does not present any decontamina­




O verhead 30 1. What is an "exposure*?
Contact with blood or potentially infectious body fluids 
through the following methods:
• Needlesticks (H IV  and HBV)
•  Contact of blood or blood-contaminated body fluids with 
chapped or nonintact skin, open wounds or mucous 
membranes (H IV  and HBV)
•  Saliva in a human bite (HBV)
An exposed worker is one who is exposed while performing 
normal job duties.
2. Does it matter If we know or not that the source of blood or body fluids was infected with HIV or HBV?
The persons who are the source of blood or potentially infec­
tious body fluids that the worker was exposed to may be known 
carriers of HTV or HBV. Or their status may be unknown. In 
either case, this is an exposure. The follow-up procedures in 
both cases vary as we will explain in the information that is to 
follow.
3. How should an exposure be handled?
• Workers who have been exposed in the ways already 
described should immediately wash the affected area. If  the 
area is mucous membranes, flush the area with water. If  the 
exposed area is skin, wash with soap and water.
•  The exposed worker should be referred to the proper medi­
cal authority for assessment, counseling, and preventive 
treatment as is appropriate. Some types of exposure, for ex­
ample, from a human bite, require attention to prevent 
other types of infection.
4. Procedures for Reporting Exposures




Return to the case study discussion. At this time, discuss reporting issues that are relevant to that 
case. If  you chose a case study that does not present any reporting issues, choose a new case 
study that does.
Administer the posttest and evaluation
After the lecture outline and case studies are done, make sure no one has any additional ques­
tions.
Then distribute the posttest and ask learners to complete the questionnaire. I f  you intend to ask 
learners to complete an evaluation form, have them do so now before closing the training session.
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Section 4: CASE STUDIES
The following case studies describe workplace situations and issues that are likely to challen ge public 
safety workers and emergency-medical workers.
Discuss those cases that are appropriate to the learner group. You should personalize the case 
studies by adding information about what emergency transport vehicles would be dispatched to the 
scene according to your standard operating procedures, and make substitutions in the text that will 
make the case studies more relevant to your department
You may also choose to substitute situations and issues that have come up in your district Or, espe­
cially in follow-up sessions, you might ask learners to share experiences, either real or hypotheti­
cal. When you tailor training in this way, the curriculum becomes more relevant.
The pages that follow contain the case studies that may be copied and handed out to each of the 
learners. The discussion questions are included with the case study to facilitate the discussion. 
During the group interaction, it is very important that everyone joins in the discussion. In this 
learner situation, the people in the class as well as the trainer can bring a wealth of experience to 
the class.
The lecture outline and the "Guidelines" (Section 7) will provide information specific to transmis­
sion of the viruses and background information. The trainer should also be ready to apply local 
operating procedures and laws to these case studies.
Discuss issues in small groups
If  the training session has 20 to 25 or more learners, consider introducing the case and the issues 
raised, and then breaking the group into small groups of 4 to 6 persons.
Tell all groups that they will come back together at a certain time. The amount of time spent dis­
cussing a case depends on the time you have allocated to the entire course and how many cases you 
want to discuss. A recommended amount of time would be about 10 to 15 minutes for one part of 
the case study, 30 minutes for an entire case study.
Allow time for representatives to report the small group discussion summaries to the total group 
for further discussion.
Another option is to assign specific issues or questions to each small group for discussion and feed­
back to the total group.
For more suggestions on leading discussions, see Section 2, "Ups for Trainers."
Be informed about local law concerning ethical/legal issues
During case study discussions, learners may raise issues that require you to know relevant laws, 
policies, goals, and procedures. Consult with local counsel, supervisors, and other authorities. For 
example, if the question comes up," Do you have the right to refuse to treat someone you know or 
suspect is HTV- or HBV-positive?" you must be able to cite the law.
Other questions that learners might raise include, "Do you have the right to delay treatment of 
someone you know or suspect is HTV- or HBV-positive?" "Do you have the right to refuse to work 
with someone who is HTV- or HBV-positive?" "Do you have the right to be told if an individual you 
are treating is HTV- or HBV-positive?" "Do you have the right to be told if a person you are work­
ing with is H IV - or HBV-positive?" "If you have suffered an exposure, do you have the right to 
know if the source person is H IV - or HBV-positive?"
AUTO ACCIDENT
When the call comes in: At approximately 1030 hours, you are dispatched to a report of a 
motor vehicle accident involving two vehicles.
When you arrive on the scene, you find the following:
In the first car, the driver looks like a pregnant woman in her30*swhois conscious and trapped 
in the car. She has severe lacerations to facial and head area and her left arm is covered with 
shattered glass.
The passenger, a young child, is conscious and has minor lacerations.
In the second car, the driver, a male who looks about 20 years old, escaped from the vehicle 
with severe lacerations, including a 4-inch gash on his arm and a bleeding forehead.
The passenger, an unconscious female who looks about 18 years old, is not breathing and has 
multiple lacerations. You cannot get a pulse.
Blood and vomitus are on the ground and on the victims. Broken and shattered glass, jagged 
metal, and gasoline spills are everywhere. It is cold and drizzling rain.
Parti.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What 
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Stabbing
When the caU comes im At 0200 hours you are dispatched to a reported stabbing of a woman 
in a hotel that is known to be frequented by prostitutes.
You work in a community where the normal emergency response for nonbreathing patients 
is the nearest engine company.
When you arrive on the scene, you find a woman in bed bleeding from 2 stab wounds in the 
chest area. She is unconscious and has labored breathing. Red frothy sputum seeps from her 
mouth. Drug paraphernalia is on the bedside table.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What 
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
House fire
When the caB comes in: A t 0200 hours, you are dispatched to a house fire.
When you arrive on the scene you find a working interior fire in progress*
Primary search: You find a male in his mid-30s unconscious, apparently suffering from smoke. 
Once he has been pulled out of the house, you determine that he is not breathing but has a 
heartbeat He has third-degree burns on 30 percent of his body.
Secondary search: As a result of the primary search, you find a mid-30-year-old female lying 
unconscious on the kitchen floor. She has third-degree bums on 20 to 30 percent of her body. 
When treatment begins, she wakes up and becomes combative.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Nursing home patient
When the call comes in: At 0900 hours, you are dispatched to a report of an 85-year-old female 
patient in a nursing home; she is unconscious.
When you arrive on the scene, you find an incontinent elderly woman lying in bed not breath­
ing. Two orderlies are administering chest compressions and bagging her. She has already 
vomited once. You remember that you have a cold sore in your mouth.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Man with labored breathing
When thecaUcomes in: A t 2000 hours, you are dispatched to a report of a 55-year-old man 
experiencing labored breathing.
When you arrive on ihescene, you find a 55-year-old male sitting in a chair, leaning forward, 
coughing blood-tinged sputum. His breathing is noisy and he spits frequently.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have’more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Swimming accident
When the call conies in: At 1430 hours, you are dispatched to a report of a near drowning of 
a small child in a neighbor’s swimming pool
When you arrive on the scene, you find a small child lying unconscious on the ground. Her 
mother is next to her and hysterical. She says that she pulled the child out of the pool a few 
minutes ago, but does not know how to give CPR.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
What are the 
What are the
Stomach pains
When thecaB comes in: A t 2200 hours, you are dispatched to a report of a 27-year-old male 
with stomach pains.
When you arrive on the scene,you find that two men occupy the home. A  man in his late 20s 
meets you at the door and says that his friend in the bedroom has been having severe stomach 
pains. You remember that you have a cut on your hand
The patient. When you enter the bedroom, you find a male In his late 20s lying in bed doubled 
over in pain.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follcrw-up ac­
tions must be taken after an incident or exposure?
Barroom fight
When the caU comes in: At lOtfO p.mn your car is dispatched to a report of a fight in a local 
bar.-
Whenyou arrive on the scene, 2 men are in a violent fight; one has a knife. Both are injured 
and bleeding at mouth, nose, arms, and hands. As you approach the men, you order them to 
break up the fight They ignore you. Your partner draws his nightstick and tries to break up 
the fight As he approaches the men, he slips and falls down. You subdue the other man and 
handcuff him. Next, you pull the man with the knife off your partner and hold him to the 
ground.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Shots fired
When thecatt comes in: At 11:00 p.m., you are dispatched to a report of shots being fired at a 
residence that you know is a drug house.
Whenyou arrive on the scene, the front door is wide open. After checking carefully for anyone 
with a weapon, you enter. A  man is tying on the floor in a pool of blood; he appears to be 
dead. You hear moaning in another room, and go to find a woman in the bed who is shot in 
the side and bleeding profusely. Blood is on her dress and all over the bed. Drug parapher­
nalia is on a bedside table.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Swimming accident
When the caU comes in: At 2:30 p.m., you are dispatched to a report of a near-drowning of a 
young child.
When you arrive on the scene, a 6-year-old girl is lying unconscious on the ground. Her hysteri­
cal mother tells you that she pulled her child out of the pool a few minutes ago, but does not 
know how to give CPR. You receive a radio report that tells you that the ambulance has 
been held up in traffic. You remember that you have a cold sore in your mouth.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
What are the 
What are the
Drug Bust
When the call comes in: Several merchants have complained about the sale and use o flV  drugs 
in their parking lots. As a result, you are one of two undercover officers who have been stak­
ing out the area for several weeks.
When you arrive on the scene ,you observe two people who show suspicious behavior in a parked 
car. You and your partner approach the car from behind and observe that they have nar­
cotics paraphernalia and are preparing to shoot up. You arrest the suspects, and search and 
handcuff them. Next, you conduct a thorough search of the vehicle.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Auto Accident
When the call comes in: At 1 IKK) p.m., 2 cars are dispatched to a report of a personal injury ac­
cident The accident is on a major highway and involves 3 seriously injured people.
When you arrive on the scene:
In the first car, the driver looks about 35 years old. He has severe facial lacerations, and is 
semi-conscious and trapped in the car.
In the second car, the driver looks about 30 years old and in her last months of pregnancy. 
She is hysterical because she is delivering her baby. She hit her head on the windshield and 
has a slight laceration on her head.
A  female passenger looks about 35 years old. She has serious chest wounds and pulsating 
arterial bleeding. Blood is spurting out, but she is conscious.
You remember that your lips are chapped and cracked.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What 
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Man falls downtown
When the caR comes in: It is 1230 p.m. and you are dispatched to a report of a disturbance 
downtown.
When you arrive on the scene, a small crowd is gathered around a 40-year-old man lying on the 
ground. A  witness says that he saw the man walking and then go into convulsions and fall to 
the ground. You recognize the man on the ground as a known drug user. He is unconscious 
and and you cannot find a pulse. CPR is indicated You are 5 minutes from the nearest hospi­
tal.
P arti.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Violent male outside house
When the caU comes im At 2K)0 p.nL, you have been dispatched to a report of an extremely 
violent, distraught person who is yelling and screaming in the front yard.
When you arrive on the scene, you find a 39-year-old male outside the house screaming Take 
me to the hospital! I ’m dying! I ’m dying!" A  witness who identifies herself as a close relative 
teBs you that he is suffering from the later stages of AIDS and has lost control of his mental 
reasoning. When you approach him, he becomes violent and tells you he’s going to kill you.
Part 1.
1. At the beginning of your shift what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2,
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Gay rights rally
When thecaü comes in: You are a part o f a team that is assigned to control the order of a gay 
rights demonstration.
When you arrive on the scene,you witness a violation of a local ordinance when a demonstrator 
trespasses on private property. You must arxest that person. The person resists arrest and 
bites you. To protect yourself, you restrain and handcuff the person.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con* 
ta mina t ion?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Fight
Your assignment: You are called to assist in the break-up of a fight on the cell block.
When you arrive on the scene, you find one of the inmates using a homemade knife. He has 
cut another inmate who is bleeding profusely. Both are bloody around the face and hands. 
The inmate with the weapon has pinned down the other inmate on the ground and is prepar­
ing to slash his throat
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
What are the 
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Inmate collapses
Your assignment: Making regular rounds.
When you arrive on the scene, you are in the television room making your regular rounds. You 
see a prisoner collapse and in need of CPR Forty other inmates have gathered around to 
see what you are going to do. You are the only one in the immediate area that can administer 
CPR.
You begin giving CPR and in the process, the inmate vomits. The inmate looks very bad and 
in need of additional CPR. The medical team has not yet arrived. You remember that you 
cut your face shaving this morning.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Inmate claims to have AIDS
Your assignment. Making rounds in the cell block.
Whenyou arrive on the scene, you pass by one inmate’s cell as the inmate yells out at you that 
he has AIDS and, if he has to die, he’s going to take you with him. He then throws a cup of 
fluid at you.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
1. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
IV drug search in a cell
Yourassignment.You are asked to assist In a search of one of the inmates and his cell He is 
suspected of having drugs and an IV  needle in his possession.
When you arrive on the scene, the inmate is hostile, uses abusive language and pushes you as 
you move toward him. As you try to handcuff him, he bites you, drawing blood from your 
hand. Once you subdue him, you pat search him and search his celL
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
IV drug/booking search
Your assignment: Booking incoming suspects into custody at a local corrections facility:
When you are on the scene, you need to conduct a booking search on an incoming female ar­
rested for possession of drugs- She is wearing a jacket with several pockets and is carrying a 
purse.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? What are the 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? What are the 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
Job injury
Your assignment. Supervision on a job detail in which a group of inmates are involved in cut­
ting sheetmetal that will be used in making signs.
When you are on the scene, an inmate you are supervising cuts himself on the sheet metal and 
is bleeding profusely. You remember that you cut your hand this weekend doing yard work.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you have more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­
tions must be taken after an incident or exposure?
What are the 
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HIV-infected fellow employee
Your assignment. One of the officers on your shift was out with a bad cold for several weeks. 
He came back for a week and was out again for 2 months. When he came back this time, he 
was weak and very thin. He is obviously suffering from a chronic illness. You suspect that 
he might have H IV  infection.
When you an on the scene, you have just been assigned to transport prisoners during the next 
several weeks. The officer in question is your assigned partner.
Part 1.
1. At the beginning of your shift, what personal protective clothing and equipment should be in 
your vehicle to protect you from contamination? What items should be on your person? Why?
2. Once you arrive on the scene, what are the contamination risks?
3. How can you use personal protective clothing and equipment to protect yourself from con­
tamination?
4. What can you do to protect yourself from contamination if you do not have all of this clothing 
or equipment with you? What if you haw more people to treat than you have equipment for?
Part 2.
5. Before leaving the scene, what items must be decontaminated and disposed of? 
correct procedures?
6. What must be decontaminated or disposed of when you return to the workplace? 
correct procedures?
Part 3.
7. What procedures must be followed at the scene in the event of incidents and exposures? What
procedures must be followed immediately upon returning to the workplace? What follow-up ac­tions must be taken after an incident or exposure?




The following resources have been compiled from recommended lists provided by constituen­
cy groups interested in this training course. Representatives from the Centers for Disease Con­
trol have not reviewed this material, nor will the agency endorse any of the titles listed here, 
except for those published by the U.S. government.
In preparing for training, you may wish to research some of these resources. If  you choose to 
use one or more in your training, be certain to review the material carefully for accuracy and to 
make sure the information is relevant to your group.




INFORMATION FOR FIRE FIGHTERS
Print materials
"A 10-Point Approach to Infectious/Contagious Disease Exposure/ Captain Decker Williams. 
International Association of Fire Chiefs Fall 1987.
Advice About AIDS for Public Safety, Health, and Emergency Personnel. (May 1986) 
Seattle/King County Department of Public Health, AIDS Prevention Project, 1116 Summit, 
Seattle, W A 98101.206-587-4999. Washington Department of Social and Health Services, Of­
fice of Disease Prevention and Control, Office on AIDS, Airdustrial Park, Olympia, W A 98504- 
0095. 206-586-3887. Publication no. DSHS 22-456.
"AIDS and the Emergency Provider." Emergency Medical Services 1988; 17 (Number 3).
"AIDS and Your Job - Are There Risks?" American Red Cross/US Public Health Service, Oc­
tober 1986. (Currently under revision. To be released before July 1,1989.)
"AIDS - Are First Responders At Risk?" Chief Fire Executive July/August 1987.
AIDS: Information Bulletin for Employees.
Maine Department of Human Services, Division of Disease Control, Bureau of Health, State 
House Station, M E 04333.
AIDS Precautions for the First Responder. (1987)
Health Education Resource Organization, 100 Maryland Avenue, Suite 240, Rockville, MD
20850.301-762-3385.
"AIDS: The Challenges Ahead." An American Hospital Association Report. Emergency Medi­
cal Services 1988; 17 (Number 3).
"AIDS - What Risk to Save a Life?" Fire Engineering June 1987.
"Blueprint for a Disease-free Station." Decker Williams and Dean Pedrotti. Firehouse 
February 1988.
"Chapter I: Medical." Facility Safety/Medical National Fire Protection Assn. 1500 Committee 
Guidelines, 1987 edition.
"Communicable Diseases." Fire Department of New York City - Bureau of Operations June
3,1988.
"Disease Avoidance on the Job." Dean Pedrotti and Irvine "Decker" Williams. Firehouse Sep­
tember 1987.
Emergency and Public Safety Workers and HTV/AIDS -  A  Duty to Respond" American Red 
Cross. (In progress. To be released before July 1,1989.)
"Emergency Medical Services and AIDS." Fire Chief November 1987.
"Emergency Workers and the AIDS Epidemic: A  Training Model." Marilyn Mitchell and Mike 
Velasquez. The California Fireman May 1988.
"Employee’s Reactions to AIDS in the Workplace." Dr. David M. Herold, Georgia Institute of 
Technology, Center for Work Performance Problems, February 1988.
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"Exposure Reporting and Tracking, and Severity Rating of Infectious Diseases." Irvine "Deck­
er” Williams and Dean PedrottL Firehouse June 1988.
"Federal Report Says No Report of AIDS Among Firefighters, Paramedics.” Fire Service Labor 
Monthly August 1987.
"Firefighters Refuse To Help Baby With AIDS." LAFC on Scene March 1988.
Guidelines To Prevent Transmission of Communicable Disease During Emergency Care for 
Fire Fighters, Paramedics and Emergency Medical Technicians.
International Association of Fire Fighters, 1750 New York Avenue, NW, Washington, DC
20006.202-737-8484.
"How Has the AIDS Scare Affected EMS?" Emergency Medical Services 1988; 17 (Number 
3).
"Infectious Disease Exposure." Dean Pedrotti and Irvine "Decker" Williams. Firehouse August
1987.
Infectious Disease Handbook for Emergency Care Personnel. Katherine H. West, J.B. Lippin- 
cott Company, 1987.
Information for Firefighters, Police, Emergency Medical Staff, and Staff of Correctional In­
stitutions. (June 1985)
Rhode Island Department of Health, Division of Disease Control, 75 Davis Street, Providence, 
R I02908.401-277-2362.
"Instructions for the Preparation and Disposition of Form CD-72; Member Injury Report and 
Form CD-73; Member Exposure Report" Division of Safety; Fire Department of the City of 
New York. Safety Bulletin No. 7, revised July 1988.
"NAEMT Emergency Management Committee Report on Infection and Infection Control." 
National Association of Emergency Medical Technicians July 1988.
"Occupational Exposure to Hepatitis B Virus and Human Immunodeficiency Virus (HTV)." 
Federal Register Friday November 27,1987; 52 (Number 228).
Recommendations for Preventing the Transmission of Human T-Lymphotropic Virus Type I I I  
in the Pre-Hospital Emergency Medical Care Setting. (1986)
Wisconsin Department of Health and Social Services, Division of Health, A IDS/H IV Program, 
1 West Wilson Street, P. O. Box 309, Madison, W I53701-0309. 608-267-5287.
"Two Out for Refusing to Transport AIDS Patient" Fire Chief July 1987.
"Unsuspected Human Immunodeficiency Virus in Critically III Emergency Patients.” James L. 
Baker, M D et al. Journal of the American Medical Association 1987; 257 (Number 19).
Victim Tracking Tag, Addendum No. 1, June 6,1988, Fire Department of the City of New York,
1988.
"Viral Hepatitis Risk in Urban Emergency Medical Services Personnel." Paul E. Pepe, MD, et 
al. Annals of Emergency Medicine April 4,1986.





AIDS and Your Job - What You Should Know. 1986.
Modern Talking Picture Service, 5000 Park Street North, St. Petersburg, FL 33709. 
813-541-5763.
Developed for police officers, firefighters, and paramedics, this video outlines the precautions 
that can be taken to reduce the risk of exposure to the AIDS virus on the job.
First Responders: Infection Control from Theory to Practice (1988)
Media Library, University of Michigan Medical Campus, R4440 Kresge 1, Box 56, Ann Arbor, 
M I 48109. 313-763-2074.
The Hidden Danger. 1988.
IAFF, 1750 New York Ave., NW, Washington, DC 20006. 202-737-8484.
This videotape describes hepatitis B and how to protect against it through vaccination. The 
tape includes an interview with a registered nurse whose father, Jim Condron, was infected with 
hepatitis B while serving as a Ere fighter/paramedic in Norwood, Ohio.
Organizations and clearinghouses
The American Red Cross, National Headquarters, AIDS Education Program, 17th & D Streets, 
N.W., Washington, D .C  20006. 202-639-3441.
Education services, training, workshops, seminars, audiovisuals and print material dissemina­
tion.
The American Red Cross AIDS Education Program provides HTV/AIDS-related products and 
education services through the H IV/AIDS coordinators of local Red Cross chapters nationwide 
and American Red Cross offices on military installations worldwide. Some chapters offer 
HIV/AIDS workplace education programs, including health care and public safety. Other 
HIV/AIDS-related services available at some chapters include counseling, alternative testing, 
and home care. Chapter phone numbers are listed in local phone directories. If  there is no 
local chapter, or information regarding other chapters’ services is needed, callers may contact 
the HIV/A IDS coordinator at one of the Operations Headquarters: Eastern (Alexandria, VA) 
703-838-8744; Midwestern (St Louis, MO) 314-997-9105; Western (Burlingame, CA) 415-692- 
5201.




Louisiana State University, AIDS Education and Training Center, 1542 Tulane Ave., New Or* 
leans, LA 70112.
The AIDS Education and Training Center (ETC) program for the States of Louisiana, Arkan­
sas, and Mississippi is supported by the Louisiana State University, Tulane University, the 
University of Arkansas, and the Mississippi Medical School Trainees are expected to be 
physicians, physician assistants, nurses and nurse practitioners, social workers, dental workers, 
emergency service workers, and human service workers, for a total of about 1400 annually, fifty  
percent of health professionals in the ETC activities would represent minority populations. 
Robert L. Marier, MD, 504-568-3855.
National AIDS Information Clearinghouse, P.O. Box 6003, Rockville, M D 20850, 301-762- 
5111.
National Safety Council, 444 N. Michigan Ave., Chicago, IL  60611.
Meetings, Conferences, Databases, Electronic Media, Printed Material Dissemination, 
Audiovisual material Production, Printed Material Production.
The National Safety Council (NSC) is a voluntary nongovernmental organization. It promotes 
accident reduction by providing a forum for the exchange of safety and health ideas, techniques, 
and experiences and the discussion of accident prevention methods. NSC has produced several 
AIDS-related brochures aimed at workers, parents, and teenagers. J. C  Gilchrest, President 
312-527-4800.
Santa Clara County Health Department, AIDS Program, 2220 Moorpark Ave., San Jose, CA 
95128
Support Groups, H IV  Test Related Counseling, H IV  Antibody Testing Services, Home Nurs­
ing Care, Training, Workshops, Seminars, Workplace Programs, Hotlines, Referral Services, 
Physician Referral Services, Epidemiological Data Analysis,
The AIDS Program is intended to decrease the morbidity and mortality caused by HTV infec­
tion through education. Health educators and public health nurses with special AIDS training 
provide training in schools, the workplace, and the health care environment First responders, 
persons engaging in high-risk behavior, correctional inmates and the general public are the tar­
get audiences. Certain services are available in Spanish. 408-299-4151.
US Department of Labor, Occupational Safety and Health Administration, Internal AIDS 
Policy, 200 Constitution Ave., NW, Washington, DC 20210.
Education Services, Information Dissemination Services, Policy Analysis, Recommendations.
The Occupational Safety and Health Administration (OSHA) has a program that focuses on 
enforcement of currently applicable occupational safety and health standards pertaining to 
health care workers; standards promulgation activities in connection with AIDS, hepatitis B, 
and other bloodbome diseases; and information and educational activities in coordination with 




INFORMATION FOR LAW ENFORCEMENT OFFICERS
Print materials
AIDS: A  Guide for Officials and Students of Law Enforcement. (October 1987)
Wyoming Health and Medical Services» STD/AIDS Prevention Program, Hathaway Building, 
4th Floor, Cheyenne, W Y 82002-0710. 307-777-7953.
AIDS and intravenous drug use. Don Des Jarlais and Dana Huint US Dept of Justice, Na­
tional Institute of Justice. February 1988. For free single copies, call 301-251-5500.
"AIDS and the Law Enforcement Officer." by Theodore H. Hammett
US Dept of Justice, National Institute of Justice. NCJ 107541. November/December 1987.
For free single copies, call 301-251-5500.
"AIDS and Your Job - Are There Risks?" American Red Cross/US Public Health Service, Oc­
tober 1986. (Currently under revision. To be released before July 1,1989.)
AIDS from Policy to Practice, Volume 1: Model Policies and Procedures. Anna T. Laslow. 
Alexandria, VA: National Sheriffs Association. 1989 (forthcoming). 800-424-7827.
AIDS in Correctional Facilities: Issues and Options, by Theodore H. Hammett Third edition. 
US Dept of Justice, National Institute of Justice. NCJ 109943. April 1988. For free single 
copies, call 301-251-5500.
"AIDS In the Workplace: Confronting the Challenge." Hotel/Motel Security and Safety 
Management March 1988.
AIDS: Information Bulletin for Employees. Maine Department of Human Services, Division 
of Disease Control, Bureau of Health, State House Station, M E 04333.
AIDS Precautions for the First Responder. (1987)
Health Education Resource Organization, 100 Maryland Avenue, Suite 240, Rockville, MD
20850.301-762-3385.
The cause, transmission, and incidence of AIDS. Theodore H. Hammett, Harold Jaffe, and 
Bruce Johnson.
US Dept. O f Justice, National Institute of Justice. NCJ 106678. June 1987. For free single 
copies, call 301-251-5500.
"Employee’s Reactions to AIDS in the Workplace." Dr. David M. Herold, Georgia Institute of 
Technology, Center for Work Performance Problems, February 1988.
Facts on AIDS: A Law Enforcement Guide.
New Jersey Department of Health, AIDS Prevention/Education Unit, John Fitch Plaza, CN 
360, Trenton, NJ 08625-0360.609-633-2751.
H IV  antibody testing: procedures, interpretation, and reliability of results. Theodore H. Ham­
mett
US Dept of Justice, National Institute of Justice. October 1988. For free single copies, call 
301-251-5500.
Information for Firefighters, Police, Emergency Medical Staff, and Staff of Correctional In­
stitutions. (June 1985)




"Occupational Exposure to Hepatitis B Virus and Human Immunodeficiency Virus (HIV)." 
Federal Register Friday November 27,1987; 52 (Number 228).
One Hundred Questions and Answers about AIDS. Alexandria, VA. National Sheriffs Associa­
tion. 1987. (English and Spanish) $ 1.50/copy, 800-424-7827.
Precautionary measures and protective equipment: Developing a reasonable response. 
Theodore M. Hammett
US Dept of Justice, National Institute of Justice. NCJ108619. February 1988. For free single 
copies, call 301-251-5500.
Risk of Infection with the AIDS virus through exposures to blood. Theodore H. Hammett and 
Walter Bond.
US Dept of Justice, National Institute of Justice. October 1987. For free single copies, call 
301-251-5500.
"Worker Exposure to AIDS and Hepatitis B." US Department of Labor/Occupational Safety 
and Health Administration.
Audiovisuals
AIDS and Your Job - What You Should Know. 1986.
Modern Talking Picture Service, 5000 Park Street North, St Petersburg, FL 33709.813-541- 
5763.
Developed for police officers, firefighters, and paramedics, this video outlines the precautions 
that can be taken to reduce the risk of exposure to the AIDS virus on the job.
AIDS Videotape. 1985.
University of British Columbia, A V-TV Media Library, Instructional Resources Center, Van­
couver, BC, Canada V6T1 W5. 604-228-3467.
First Responders: Infection Control from Theory to Practice (1988)
Media Library, University of Michigan Medical Campus, R4440 Kresge 1, Box 56, Ann Arbor, 
M I 48109. 313-763-2074.
On Guard: Infection Control for Safety and Health-Care Professionals, (videotape), 1988. 
Jem Bookstore, P. O. Box 1026, Solana Beach, CA 92075. 619-481-1128.
Organizations and clearinghouses
American Correctional Association, Training Division, 4321 Hartwick RcL, Suite L-208, Col­
lege Park, M D  20740.
Meetings, Conferences, Training, Workshops, Seminars. 301*699-7600.
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American Correctional Health Services Association, 5530 Wisconsin Ave., NW, Ste. 1149, 
Washington, DC 20815. 301-652-1172. Education Services.
American Red Cross, National Headquarters, AIDS Education Program, 17th & D Streets, 
N.W., Washington, D. C. 20006. 202-639-3441.
Education Services, Training, Workshops, Seminars, Audiovisuals and Print Material
The American Red Cross AIDS Education Program provides HIV/AIDS-related products and 
education services through the HIV/AIDS coordinators of local American Red Cross chapters 
nationwide and American Red Cross offices on military installations worldwide. Some chap­
ters offer H IV/AIDS workplace education programs, including health care and public safety. 
Other HIV/AIDS-related services available at some chapters include counseling, alternative 
testing, and home care. Chapter phone numbers are listed in local phone directories. If  there 
is no local chapter, or information regarding other chapters’ services is needed, callers may con­
tact the H IV/A IDS coordinator at one of the Operations Headquarters: Eastern (Alexandria, 
VA) 703-838-8744; Midwestern (St Louis, MO) 314-997-9105; Western (Burlingame, CA) 415- 
692-5201.
Comprehensive AIDS Program of Palm Beach County, HTV/AIDS Services Demonstration 
Project, P.O. Box 3084, Lantana, FL 33465-3084.
Case Management, Administration Services, Counseling Services, Crisis Intervention Counsel­
ing, Support Groups, Medical Services, Home Nursing Care, Companions, Buddies to AIDS 
Patients, Financial Services to Individuals, Outreach Education Services, Training, Workshops, 
Seminars, Information Dissemination Services, Physician Referral Services, Information 
Production Services.
The Program provides mobilization of resources, advocacy, and educational programs for busi­
nesses, health professionals, law enforcement personnel, municipalities, schools, religious or­
ganizations, and the public. Shauna Dunn, Project Director. 407-582-4357.
Eugene and Agnes E. Meyer Foundation, 120015th St, NW, Ste. 500, Washington, DC 20005. 
Donations, Grants, Donors.
The Foundation assists in the development of community services and facilities in metropolitan 
Washington, DC. Grants are principally for welfare, education, health and mental health, the 
arts and humanities, law and justice, preferably to provide new or improved services rather than 
to support existing programs. 202-659-2435.
Federal Bureau of Investigation, Forensic Training Unit, 10th Sc Pennsylvania Ave., NW, 
Washington, DC 20533.
Speakers Bureaus, Information Dissemination Services, Epidemiological Research.
The Forensic Laboratory Safety project provides educational materials and/or speakers to 
Forensic Laboratory personnel, as well as Federal, state and local law enforcement agencies 
throughout the US. It has developed a technique for using gamma and X-ray irradiation to in­
activate HTV in liquid body fluid specimens submitted to forensic laboratories for examination
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and analysis. Several booklets are available, as is a resource person to all US law enforcement 
agencies and forensic laboratories, clinical laboratories, pathologists and personnel in other 
medical areas, and in select instances, the public. Federal Bureau of Investigation Academy, 
Quantico, VA  22135. John D. Bigbee, Special Agent. 703-640-6131.
Forensic AIDS Project, 798 Brannan St, San Francisco, CA 94103.
Extended Counseling, Therapy, Substance Abuse Counseling, H IV  Test Related Counseling, 
Education Services, Outreach Education Services.
The Project, a program of the San Francisco Department of Health and Social Services, serves 
the inmate population of San Francisco County and all first responders. Follow up programs 
for prison inmate populations and emergency first responders are also provided. Ralle Green­
berg, LCSW, Program Director. Eugene Jackson, Office Manager. 415-863-8237.
Georgia Department of Human Resources, Division of Public Health, Community Health Sec­
tion, 878 Peachtree St, NE, Ste. 102, Atlanta, GA 30309.
H IV  Test Related Counseling, H IV  Antibody Testing Services, Education Services, Outreach 
Education Services, Training, Workshops, Seminars, Hotlines, Referral Services, 
Epidemiological Research.
The AIDS Unit in the Office of Infectious Disease provides planning, surveillance, special 
studies and laboratory, medical, health education and training, and clinical services. A program 
to identify, educate and test high risk women has been implemented. A street team conducts 
educational outreach programs to IV  drug users (STARR). Minority outreach programs 
operate through a coordinated effort between the State AIDS Program and Morehouse School 
of Medicine. A  Public Information Program disseminates information about the AIDS projects 
and related activities. The State has developed a confidential list of physicians in each health 
district who do medical and/or psychological evaluation of H IV  positive patients. Surveillance 
programs include seroprevalence studies on STD clinic clients, methadone center patients, H IV  
positive reports, data for court ordered testing, confirming diagnosed or suspected case of 
AIDS. Surveillance staff provide education, technical assistance, and consultation to 
physicians, hospital staff, and infection control nurses in order to ensure that AIDS cases are 
properly reported- Phil Kaufman, Public Information Officer. 404-894-4282. Office of Infec­
tious Disease: Jane Carr» Director, State AIDS Program Coordinator. 404-894-6428. Kathy 
Bush, Deputy Director. Joseph Wilber, MD, Medical Director. Bill Boyd, Sexually Transmitted 
Diseases. 404-894-4405. Minority Outreach: Shaunette Crawford, Coordinator.
National Safety Council, 444 N. Michigan Ave., Chicago, IL  60611.
Meeting?, Conferences, Databases, Electronic Media, Printed Material Dissemination, 
Audiovisual Material Production, Printed Material Production.
The National Safety Council (NSC) is a voluntary nongovernmental organization. It promotes 
accident reduction by providing a forum for the exchange of safety and health ideas, techniques, 
and experiences and the discussion of accident prevention methods. NSC has produced several 




National Sheriffs’ Association, 1450 Duke St, Alexandria, VA  22314.
Education Services, Audiovisual Material Production, Book, Monograph, Pamphlet Produc­
tion, Policy Analysis.
The AIDS Project of the National Sheriffs’ Association developed a textbook for correctional 
officials on AIDS information and management within the criminal justice system. The As­
sociation has also developed videorecordings in English and Spanish. A model H IV  policy and 
training curriculum is being developed for use by the justice community and for drug and al­
cohol abuse treatment providers, (forthcoming Summer, 1989). Anna T. Laszlo, Director. 703- 
836-7827,800-424-7827.
South Jersey AIDS Alliance, 1616 Pacific Ave., Ste. 201, Atlantic City, NJ 08401.
Practical Support Services, Companions, Buddies to AIDS Patients, Financial Services to In­
dividuals, Training, Workshops, Seminars, Hotlines, Referral Services.
The South Jersey AIDS Alliance serving Atlantic, Cape May, Salem, Ocean, Cumberland, 
Gloucester, Camden, and Burlington counties is a volunteer organization with a professional 
staff. Its money is used for the Spanish and English hotlines, PSA’s (Public Service Announ­
cements), an information center and risk reduction efforts (condom distribution). In-service 
training is offered to hospitals, schools, churches, and law enforcement officials. Michelle 
Brunetti, Coordinator. 609-347-8799.
US Department of Justice, 10th & Constitution Ave., NW, Rm. 1612, Washington, DC 20530.
Meetings, Conferences, Speakers Bureaus, Training, Workshops, Seminars, Newsletter, 
Periodical Production.
The Law Enforcement Coordinating Committees (LECC’s) are coalitions of Federal, State, 
and local law enforcement agencies, chaired by US Attorneys in each of the 94 judicial districts. 
Groups meet to hear speakers and receive written materials about the risk to law enforcement 
personnel who are in contact with those in high-risk categories. The LECC Victim-Witness 
Staff in the Executive Office for US Attorneys provides technical assistance to LECC’s who 
wish to present a training program of this kind. Assistance includes acting as a liaison between 
the Federal and State/local AIDS service providers; finding speakers on the topic; and finding 
available resource materials. Virginia I. Bell, Attorney. 202-633-4024.
US Department of Justice, National Institute of Justice, AIDS Program, 633 Indiana Ave., 
NW., Washington, DC 20531.
Training, Workshops, Seminars, Information Dissemination Services, Research, Policy 
Analysis, Recommendations.
Since 1985, the National Institute of Justice (NU) has worked closely with the Centers for Dis­
ease Control and other organizations to provide accurate information on AIDS to criminal jus­
tice professionals. Reports have been published on AIDS for law enforcement, corrections, 
and new probation and parole professionals. In 1987, the NU AIDS Clearinghouse was estab­
lished as an information and dissemination service for criminal justice professionals. NU also 
sponsors AIDS-related research and development, which currently includes studies on the in­
cidence of AIDS in prison, policy and procedures development, and relationships between
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AIDS and crime. Cheryl Crawford, AIDS Program Manager. 202-272-6010.
US Department of Justice, National Institute of Justice, National Criminal Justice Reference 
Service, National Institute of Justice AIDS Clearinghouse, P. O. Box 6000, Rockville, M D  
20850.
Databases, Electronic Media, Library Services, Printed Material Production.
The National Institute of Justice (NU) AIDS Clearinghouse serves as an international central­
ized source for criminal justice practitioners to direct their questions about AIDS as it impacts 
their daily responsibilities. An information specialist is available to answer questions, make 
referrals, and suggest publications. The Clearinghouse also offers a public reading room, inter- 
library loans, microfiche and database searches. Information resources also include: NU  
Reports (bimonthly publication); AIDS Bulletin Series; AIDS in Correctional Facilities: Issues 
and Options (updated annually); AIDS and the Law Enforcement Officer Concerns and Policy 
Responses; and AIDS in Probation and Parole (pre-publication). In addition to the NIJ’s pub­
lications, the Clearinghouse has access to information developed by the Centers for Disease 
Control and other agencies of the US Public Health Service, and the Department of Justice, as 
well as materials prepared by professional associations, State and local governments, and cor­
rections and law enforcement agencies. The Clearinghouse accepts telephone, written, and on­
site inquiries about resources. While the primary audience is criminal justice practitioners, 
there are no user restrictions. With the exception of postage and handling fees for bulk order 
of publications, there are no fees associated with the services of the Clearinghouse. Cheryll A. 
Bissell, AIDS Information Specialist 301-251-5500.
US Department of Justice, Office of Justice Programs, Bureau of Justice Assistance, 
Drug/Abuse Information Systems Branch, Criminal Justice Management of High Risk 
Population, 633 Indiana Ave., NW, Rm  600J, Washington, DC 20531.
Educational Services, Training, Workshops, Seminars, Policy Analysis, Recommendations.
This national project is designed to equip local and State criminal justice officials with the neces­
sary knowledge and management skills to develop and implement policies and procedures for 
offenders in high-risk groups suspected of, or diagnosed with, AIDS. This 18-month project 
with the National Sheriffs’ Association will develop model policies and corresponding training 
curricula. In addition, at least four regional training sessions will be held, a newsletter will be 
prepared, and appropriate articles will be submitted for publication. This project will reach a 
wide range of criminal justice personnel, law enforcement, pretrial services, corrections, proba­
tion, parole, victim services, and drug and alcohol treatment providers. Jody Forman, Program 
Manager. 202-272-4601 or Anna T. Laszlo, National Sheriffs’ Assn. 800-424-7827.
US Department of Justice, Office of Justice Programs, Office of Juvenile Justice and Delin­
quency Prevention, 633 Indiana Ave., NW, Washington, DC 20531.
Meetings, Conferences, Training, Workshops, Seminars, Information Dissemination Services. 
The Office of Justice Programs provides juvenile correctional and detention administrators with 
information pertaining to AIDS, including how to conduct workshops and conferences; how to 




US Department of Labor, Occupational Safety and Health Administration, Internal AIDS 
Policy, 200 Constitution Ave., NW, Washington, DC 20210.
Education Services, Information Dissemination Services, Policy Analysis, Recommendations.
The Occupational Safety and Health Administration (OSHA) has a program that focuses on 
enforcement of currently applicable occupational safety and health standards pertaining to 
health care workers; standards promulgation activities in connection with AIDS, hepatitis B, 
and other bloodborne diseases; and information and educational activities in coordination with 
the Department of Health and Human Services. Candace L. Strother, Deputy Assistant 
Secretary. 202-523-6091.
Washoe County District Health Department, 1001 E. 9th St, Reno, N V 89520.
H IV  Test Related Counseling, H IV  Antibody Testing Services, Home Nursing Care, Speakers 
Bureaus, Hotlines, Referral Services.
Wende Pappas, RN, Assistant Division Director. 702-328-2478. Ellen Marston, RN, Com­




INFORMATION FOR EMERGENCY MEDICAL TECHNICIANS & 
PARAMEDICS
Print materials
"A 10-Point Approach to Infectious/Contagious Disease Exposure." Captain Decker Williams. 
International Association of Fire Chiefs Fall 1987.
Advice About AIDS for Public Safety, Health, and Emergency Personnel. (May 1986) 
Seattle/King County Department of Public Health, AIDS Prevention Project, 1116 Summit, 
Seattle, W A 98101.206-587-4999. Washington Department of Social and Health Services, Of­
fice of Disease Prevention and Control, Office on AIDS, Airdustrial Park, Olympia, W A98504- 
0095. 206-586-3887. Publication no. DSHS 22-456.
"AIDS and the Emergency Provider." Emergency Medical Services 1988; 17 (Number 3).
"AIDS and Your Job - Are There Risks?" American Red Cross/US Public Health Service, Oc­
tober 1986.
The AIDS Answer Book: Facts on AIDS, Hepatitis B and Infection Control Techniques. (1988) 
Jems Publishing Company, Incorporated, P.O. Box 1026, Solana Beach, CA 92075. 619-481- 
1128.
"AIDS - Are First Responders At Risk?" Chief Fire Executive July/August 1987.
AIDS: Information Bulletin for Employees.
Maine Department of Human Services, Division of Disease Control, Bureau of Health, State 
House Station, ME 04333.
"AIDS - Precautions for Health-Care Workers and Allied Professionals." AIDS Recommen­
dations and Guidelines, Centers for Disease Control, September 2,1983.
AIDS Precautions for the First Responder. (1987)
Health Education Resource Organization, 100 Maryland Avenue, Suite 240, Rockville, MD
20850.301-762-3385.
"AIDS - What Risk to Save a Life?" Fire Engineering June 1987.
"AIDS: The Challenges Ahead." An American Hospital Association Report. Emergency Medi­
cal Services 1988; 17 (Number 3).
"Blueprint for a Disease-free Station." Decker Williams and Dean Pedrotti. Firehouse February
1988.
"Chapter I: Medical." Facility Safety/Medical National Fire Protection Assn. 1500 Committee 
Guidelines, 1987 edition.
"Communicable Diseases." Fire Department of New York City - Bureau of Operations June
3,1988.
"Disease Avoidance on the Job." Dean Pedrotti and Irvine "Decker" Williams. Firehouse Sep­
tember 1987.
"Emergency Medical Services and AIDS." Fire Chief November 1987.
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"Emergency Workers and the AIDS Epidemic: A  Training Model." Marilyn Mitchell and Mike 
Velasquez. The California Fireman May 1988.
"Employee’s Reactions to AIDS in the Workplace." Dr. David M. Herald, Georgia Institute of 
Technology, Center for Work Performance Problems, February 1988.
"Exposure Reporting and Tracking, and Severity Rating of Infectious Diseases." Irvine "Deck­
er" Williams and Dean Pedrotti. Firehouse June 1988.
"Federal Report Says No Report of AIDS Among Firefighters, Paramedics." Fire Service Labor 
Monthly August 1987.
"Firefighters Refuse To Help Baby With AIDS." IAFC on Scene March 1988.
Guidelines To Prevent Transmission of Communicable Disease During Emergency Care for 
Fire Fighters, Paramedics and Emergency Medical Technicians.
International Association of Fire Fighters, 1750 New York Avenue, NW, Washington, DC
20006.202-737-8484.
House of Representatives Bill No. 3418: To Establish Certain Grant Programs, Requirements 
and Prohibitions for the Purpose of Protecting Emergency Response Employees from Infec­
tious Diseases, including AIDS.
"How Has the AIDS Scare Affected EMS?" Emergency Medical Services 1988; 17 (Number
3).
Infection Control for Ambulance Personnel. (September 1987)
New Jersey Department of Health, AIDS Prevention/Education Unit, John Fitch Plaza, CN 
360, Trenton, NJ 08625-0360. 609-633-2751.
"Infectious Disease Exposure." Dean Pedrotti and Irvine "Decker" Williams. Firehouse August
1987.
Infectious Disease Handbook for Emergency Care Personnel. Katherine H. West, J.B. Lippin- 
cott Company, 1987.
Information for Firefighters, Police, Emergency Medical Staff, and Staff of Correctional In­
stitutions. (June 1985)
Rhode Island Department of Health, Division of Disease Control, 75 Davis Street, Providence, 
R I02908.401-277-2362.
"Instructions for the Preparation and Disposition of Form CD-72; Member Injury Report and 
Form CD-73; Member Exposure Report" Division of Safety: Fire Department of the City of 
New York. Safety Bulletin No. 7, reused July 1988.
"NAEMT Emergency Management Committee Report on Infection and Infection Control." 
National Association of Emergency Medical Technicians July 1988.
"Occupational Exposure to Hepatitis B Virus and Human Immunodeficiency Virus (HTV)." 
Federal Register Friday November 27,1987; 52 (Number 228).
Recommendations for Preventing the Transmission of Human T-Lymphotropic Virus Type I I I  
in the Pre-Hospital Emergency Medical Care Setting. (1986)
Wisconsin Department of Health and Social Services, Division of Health, A IDS/H IV Program, 
1 West Wilson Street, P. O. Box 309, Madison, W I53701-0309. 608-267-5287.
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"Two Out for Refusing to Transport AIDS Patient" Fire Chief July 1987.
"Unsuspected Human Immunodeficiency Virus in Critically Dl Emergency Patients." James L. 
Baker, M D  et aL Journal of the American Medical Association 1987; 257 (Number 19).
"Viral Hepatitis Risk in Urban Emergency Medical Services Personnel." Paul E. Pepe, MD, et 
al. Annals of Emergency Medicine April 4,1986.
"Worker Exposure to AIDS and Hepatitis B." US Department of Labor/Occupational Safety 
and Health Administration.
Victim Tracking Tag, Addendum No. 1, June6,1988, Fire Department of the City of New York,
1988.
Audiovisuals
AIDS and Your Job - What You Should Know. 1986.
Modern Talking Picture Service, 5000 Park Street North, St Petersburg, FI 33709. 813-541- 
5763.
First Responders: Infection Control from Theory to Practice (1988)
Media Library, University of Michigan Medical Campus, R4440 Kresge 1, Box 56, Ann Arbor, 
M I 48109. 313-763-2074.
On Guard: Infection Control for Safety and Health-Care Professionals, (videotape), 1988. 
Jem Bookstore, P. O. Box 1026, Solana Beach, CA 92075. 619-481-1128.
Organizations and clearinghouses
American Ambulance Association, 1888 K St, NW, Ste. 1105, Washington, DC 20006. 
Education Services nationwide. 202-887-5144.
The American Red Cross, National Headquarters, AIDS Education Program, 17th & D Streets, 
N.W., Washington, D.C. 20006. 202-639-3441.
Education services, training, workshops, seminars, audiovisuals and print material dissemina­
tion.
The American Red Cross AIDS Education Program provides HTV/AIDS-related products and 
education services through the H IV/AIDS coordinators of local Red Cross chapters nationwide 
and American Red Cross offices on military installations worldwide. Some chapters offer 
HTV/AIDS workplace education programs, including health care and public safety. Other 
HTV/AIDS-related services available at some chapters include counseling, alternative testing, 
and home care. Chapter phone numbers are listed in local phone directories. If  there is no 
local chapter, or information regarding other chapters’ services is needed, callers may contact 
the HTV/AIDS coordinator at one of the Operations Headquarters: Eastern (Alexandria, VA)
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703-838-8744; Midwestern (St Louis, MO) 314-997-9105; Western (Burlingame, CA) 415-692- 
5201.
Louisiana State University, AIDS Education and Training Center, 1542 Tulane Ave., New Or­
leans, LA 70112.
Training, Workshops, Seminars.
The AIDS Education and Training Center (ETC) program for the States of Louisiana, Arkan­
sas, and Mississippi is supported by the Louisiana State University, Tulane University, the 
University of Arkansas, and the Mississippi Medical School. Trainees are expected to be 
physicians, physician assistants, nurses and nurse practitioners, social workers, dental workers, 
emergency service workers, and human service workers, for a total of about 1400 annually. Fifty 
percent of health professionals in the ETC activities would represent minority populations. 
Robert L. Marier, MD. 504-568-3855.
Philadelphia County Medical Society, 2100 Spring Garden St, Philadelphia, PA 19130. 
Education Services, Training, Workshops, Seminars, Book, Monograph, Pamphlet Dissemina­
tion, Physician Referral Services. John F. X. Trevi, Executive Director, 215-563-5343.
Santa Clara County Health Department, AIDS Program, 2220 Moorpark Ave., San Jose, CA 
95128
Support Groups, H IV  Test Related Counseling H IV  Antibody Testing Services, Home Nurs­
ing Care, Training, Workshops, Seminars, Workplace Programs, Hotlines, Referral Services, 
Physician Referral Services, Epidemiological Data Analysis.
The AIDS Program is intended to decrease the morbidity and mortality caused by H IV  infec­
tion through education. Health educators and public health nurses with special AIDS training 
provide training programs in schools, the workplace, and the health care environment First 
responders, groups at risk, correctional inmates and the general public are the target audien­
ces. Certain services are available in Spanish. 408-299-4151.
US Department of Labor, Occupational Safety and Health Administration, Internal AIDS 
Policy, 200 Constitution Ave., NW, Washington, DC 20210.
Education Services, Information Dissemination Services, Policy Analysis, Recommendations.
The Occupational Safety and Health Administration (OSHA) has a program that focuses on 
enforcement of currently applicable occupational safety and health standards pertaining to 
health care workers; standards promulgation activities in connection with AIDS, hepatitis B, 
and other bloodborne diseases; and information and educational activities in coordination with 




INFORMATION FOR CORRECTIONS PERSONNEL
Print materials
AIDS and the Law Enforcement Officer. Theodore H. Hammett
US Dept of Justice, National Institute of Justice. NCJ 107541. November/December 1987. 
For free single copies, call 301-251-5500.
AIDS and intravenous drug use. Don Des Jarlais and Dana Hunt
US Dept of Justice, National Institute of Justice. February 1988. For free single copies, call 
301-251-5500.
"AIDS and Your Job - Are There Risks?" American Red Cross/US Public Health Service, Oc­
tober 1986. Currently under revision. To be released before July 1,1989.)
AIDS: From Policy to Practice, Vol. 1: Model Policies and Procedures. A  T. Laszlow. 
Alexandria, V A  National Sheriffs’ Assn. (forthcoming) 1989. Call 800-424-7827.
AIDS: From Policy to Practice: The Trainer’s Manual. A  T. Laszlow. Alexandria, V A  Na­
tional Sheriffs* Assn. (forthcoming) 1989. Call 800-424-7827.
AIDS: Improving the Response of the Correctional System. A T . Laszlow and M.B. Ayres. 
Alexandria, V A  National Sheriffs’ Assn. 1986. 2nd Edition Spring 1989. $ 10/copy. Call 800- 
424-7827.
AIDS in Correctional Facilities: Issues and Options, by Theodore M. Hammett Third Edition. 
US Dept of Justice, National Institute of Justice. NCJ 109943. April 1988. For free single 
copies, call 301-251-5500.
AIDS: Information Bulletin for Employees.
Maine Department of Human Services, Division of Disease Control, Bureau of Health, State 
House Station, M E 04333.
The cause, transmission, and incidence of AIDS. Theodore H. Hammett, Harold Jaffe, and 
Bruce Johnson.
US Dept O f Justice, National Institute of Justice. N C I 106678. June 1987. For free single 
copies, call 301-251-5500.
Emergency and Public Safety Workers and HIV/AIDS — A  Duty to Respond. American Red 
Cross. (In progress. To be released before July 1,1989.)
"Employee’s Reactions to AIDS in the Workplace." Dr. David M. Herald, Georgia Institute of 
Technology, Center for Work Performance Problems, February 1988.
H IV  antibody testing: procedures, interpretation, and reliability of results. Theodore H. Ham­
mett US Dept of Justice, National Institute of Justice. October 1988. For free single copies, 
call 301-251-5500.
Information for Firefighters, Police, Emergency Medical Staff, and Staff of Correctional In­
stitutions. June 1985. Rhode Island Department of Health, Division of Disease Control, 75 
Davis Street, Providence, R I02908.401-277-2362.
"Occupational Exposure to Hepatitis B Virus and Human Immunodeficiency Virus (HIV)." 
Federal Register Friday November 27,1987; 52 (Number 228).
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Oregon Department of Corrections Response to H IV  Infection and Acquired Im ­
munodeficiency (AIDS) in State Correctional Settings. 1988.
Oregon Department of Corrections, 2575 Center Street, NE, Salem OR 97310.503-378-2467.
Precautionary measures and protective equipment: Developing a reasonable response. 
Theodore M. Hammett
US Dept of Justice, National Institute of Justice. NCJ108619. February 1988. For free single 
copies, call 301-251-5500.
Risk of Infection with the AIDS virus through exposures to blood. Theodore H. Hammett and 
Walter Bond.
US Dept, of Justice, National Institute of Justice. October 1987. For free single copies, call 
301-251-5500.
"Worker Exposure to AIDS and Hepatitis B.” US Department of Labor/Occupational Safety 
and Health Administration.
100 Questions and Answers about AIDS. Alexandria. VA: National Sheriffs’ Assn. 1987. (also 
available in Spanish). $ 1.50/copy. Call 800-424-7827.
Audiovisuals
AIDS: A  Bad Way to Die. (videotape, 45 min.) 1987.
For inmates. Free with blank cassette. Charles Hernandez, Supt, Taconic Correctional Institu­
tion, Short Hills, NY.
AIDS: The Challenge for Corrections. (17 min.) 1987
National Sheriffs’ Assn., 1450 Duke St, Alexandria, VA 22314. 800-424-7827.
AIDS Videotape. 1985.
University of British Columbia, A V-TV Media Library, Instructional Resources Center, Van­
couver, BC, Canada V6T1 W5. 604-228-3467.
First Responders: Infection Control from Theory to Practice (1988)
Media Library, University of Michigan Medical Campus, R4440 Kresge 1, Box 56, Ann Arbor, 
M I 48109. 313-763-2074.
On Guard: Infection Control for Safety and Health-Care Professionals, (videotape), 1988. 
Jem Bookstore, P. O. Box 1026, Solana Beach, CA 92075. 619-481-1128.
Preventing AIDS: It’s a Matter of Life or Death. (15 min.) 1987.
For inmates, also available in Spanish. National Sheriffs’ Assn., 1450 Duke St., Alexandria, VA  
22314. 800-424-7827.
Organizations and Clearinghouses
American Correctional Health Services Association, 5530 Wisconsin Ave., NW, Ste. 1149, 




The American Red Cross, National Headquarters, AIDS Education Program, 17th & D Streets, 
N.W., Washington, D .C  20006. 202-639-3441.
Education services, training, workshops, seminars, audiovisuals and print material dissemina­
tion.
The American Red Cross AIDS Education Program provides HIV/AIDS-related products and 
education services through the HIV/AIDS coordinators of local Red Cross chapters nationwide 
and American Red Cross offices on military installations worldwide. Some chapters offer 
HIV/A IDS workplace education programs, including health care and public safety. Other 
HIV/AIDS-related services available at some chapters include counseling, alternative testing, 
and home care. Chapter phone numbers are listed in local phone directories. I f  there is no 
local chapter, or information regarding other chapters’ services is needed, callers may contact 
the HIV/A IDS coordinator at one of the Operations Headquarters: Eastern (Alexandria, VA) 
703-838-8744; Midwestern (St Louis, MO) 314-997-9105; Western (Burlingame, CA) 415-692- 
5201.
National Sheriffs’ Association, 800-424-7827; in VA, 703-836-7827.
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GENERAL INFORMATION ON HIV, HBV, & AIDS
"AIDS and Intravenous Drug Use." Don Des Jarlais and Dana E. Hunt US Dept, of Justice, 
National Institute of Justice. NCJ 108620. February 1988.
For free single copies, call 301-251-5500.
"AIDS." World Book Encyclopedia, 1987 edition; 1:52-53.
The AIDS Book: Information for Workers, 2nd Edition. (1987) Service Employees Interna­
tional Union, AFL-CIO, CLC, 1313 L Street, NW, Washington, DC 20005.202-898-3200. San 
Francisco AIDS Foundation, 333 Valencia Street, 4th Floor, P. O. Box 6182, San Francisco, 
CA 94101-6182.415- 861-3397.
This manual for union field representatives, stewards, and others, provides education and in­
formation on AIDS to employees. It begins with a series of questions and answers covering in­
formation on workers’ rights, screening, high-risk groups, and precautions. It then discusses 
what unions can do to address AIDS in the workplace, including model contract language for 
infection control programs. Occupation-specific precautions for preventing exposure to AIDS 
in the workplace are presented. Occupations covered include nurses, technicians, and aides; 
health care workers; laboratory workers; cleaning, housekeeping, and custodial staff; laundry 
and food service workers; incinerator attendants; central sterilization and supply staff; morgue 
attendants; police and firefighters; correctional staff and mental health institution workers; am­
bulance workers; sewage workers; mortuary attendants and cemetery workers; and teachers and 
teaching assistants. An appendix lists disinfectants effective in killing the AIDS virus. Reprints 
of several Morbidity and Mortality Weekly Reports articles are also included.
"Casual Contact at the Worksite Shows No Link to AIDS Virus." Occupational Health and 
Safety News Digest March 1987; 3 (Number 3).
"Confronting AIDS: Directions for Public Health Care and Research." National Academy of 
Sciences, Institute of Medicine, National Academy Press, October 1986.
"Facts About AIDS." US Dept of Health and Human Services, Public Health Service, Centers 
for Disease Control, Spring 1987.
"Human Immunodeficiency Virus Infection in the United States: A  Review of Current 
Knowledge." Morbidity and Mortality Weekly Report Centers for Disease Control, December 
18,1987; 36 (Number S-6).
"Information and Procedural Guidelines for Providing Services to Persons With AIDS/HTV." 
February 1987. Montana Department of Health and Environmental Sciences, Cogswell Build­
ing, Helena, M T 59260.406-444-4740.
This guide presents basic information on AIDS and its transmission, and procedural guidelines 
for disinfection, protection of staff and patients, and dealing with soiled items and spills of body 
fluids and blood in facilities with AIDS patients or clients. Specific guidelines are also given for 
home health care, prehospital emergency care, morticians, optometrists, and providers of prena­
tal care and dialysis, as well as invasive procedures. Additionally, recommendations are out­
lined for public accommodations, institutions, swimming pool and custodial and correctional 
care. Schools and day care facilities are given instructions on attendance, general precautions, 
personal contact with students and employees with AIDS, and other workplace concerns. 
Reporting requirements, confidentiality, resources for further information and H IV  antibody 
test sites are listed. Appendixes present definitions for national and provisional-case reporting
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of AIDS in children, and other materials.
"Prevention and Control of AIDS." Report of the Board of Trustees, American Medical As­
sociation, June 1987.
"Recommendations for Prevention of HTV Transmission in Health Care Setting?." Morbidity 
and Mortality Weekly Report, Centers for Disease Control August 21,1987; 36 (Number 2S).
"Risk of Infection with the AIDS Virus through Exposures to Blood." Theodore M. Hammett 
and Walter Bond. US Dept of Justice, National Institute of Justice. NCJ 107538. October 
1987. For free single copies, call 301-251-5500.
"Strategies for Dealing With AIDS in the Workplace." Robert E. Stein. The Arbitration Jour­
nal September 1987; 42 (Number 3).
"The Cause, Transmission, and Incidence of AIDS." Theodore M. Hammett, Harold Jaffe, and 
Bruce Johnson. US Dept of Justice, National Institute of Justice. NCJ 106678. June 1987. For 
free single copies, call 301-251-5500.
"Update on Hepatitis B Prevention." Morbidity and Mortality Weekly Report, Centers for Dis­
ease Control, June 19,1987; 36 (Number 23).
"Update: Acquired Immunodeficiency Syndrome and Human Immunodeficiency Virus Infec­
tion Among Health-Care Workers." Morbidity and Mortality Weekly Report Centers for Dis­
ease Control April 22,1988; 37 (Number 15).
"Update: Universal Precautions for Prevention of Transmission of Human Immunodeficiency 
Virus, Hepatitis B Virus, and Other Bloodbome Pathogens in Health-Care Settings." Mor­
bidity and Mortality Weekly Report, Centers for Disease Control, June 24,1988; 37 (Number 
24).
"Worker Exposure to AIDS and Hepatitis B." US Department of Labor/Occupational Safety 
and Health Administration.
Be Informed About AIDS: Information for Health-Care Personnel and Other Care Providers. 
(1987)
Channing L. Bete Company, Incorporated, 200 State Road, South Deerfield, M A 01373. 413- 
665-7611.
Coolfont Report: "A PHS Plan for Prevention and Control of AIDS & the AIDS Virus." Public 
Health Reports July-August 1986; 101 (Number 4).
Indiana AIDS Prevention (1987)
Indiana State Board of Health, Bureau of Disease Intervention, Division of Acquired Disease, 
AIDS Program, 1330 West Michigan Street, P. O. Box 1964, Indianapolis, IN  46206. 317-633- 
0851.
This report is a discussion of the epidemiology of AIDS in Indiana and a coordinated approach 
to dealing with the AIDS problem. Members of the Indiana AIDS Advisory Committee are 
named along with telephone numbers and addresses. An overview of the Indiana State Board 
of Health (ISBH) AIDS Education Program is presented and a summary of the ISBH response 
to the educational need is included. Special target groups for education include members of 
high-risk groups, such as dental health personnel, nurses, ancillary health care workers, and 
emergency medical services personnel Others include school personnel, correctional systems 
personnel, Blacks and other minority groups. Policy development is discussed, including the
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reporting of AIDS, field services, treatment services, reduction of high-risk behavior, research, 
foundation support, AIDS and mental health, and cooperative agreements. Other attachments 
are also provided.
Northern Kentucky AIDS Task Force, 401 Park Ave., Newport, KY 41071.
H IV  Test Related Counseling, H IV  Antibody Testing Services, Homemakers, Home Health 
Aides, Education Services.
The AIDS Task Force gathers and disseminates information pertaining to AIDS. Members 
from the community represent many health fields. H IV  testing and counseling is available. 
Daniel French, MD, Chairman AIDS. 606-344-3800. Julane Doll, RN. 606-291-0770.
Preventing AIDS: A Practical Guide for Everyone. 1987. JALSCO, Incorporated, P. O. Box 
30226, Cincinnati, OH 45230. ISBN 0-9617818-0-7.
This booklet provides an overview of AIDS etiology, transmission, risk factors, symptoms, and 
prevention. General preventive measures for reducing the risk of human immunodeficiency 
virus infection are presented. Recommendations for specific populations also are provided, in­
cluding those for high-risk persons (male and female), health care workers, clinical and 
laboratory staff, personal service workers, food service workers, and health care personnel. 
Recommendations also cover dental and invasive procedures.
Public Health Task Force on Acquired Immunodeficiency Syndrome (AIDS), Summary 
Report (November 1986)
Wisconsin Department of Health and Social Services, Division of Health, A IDS/H IV Program, 
1 West Wilson Street, P.O. Box 309, Madison, W I53701-0309. 608-267-5287.
This report contains a background summary of the entire AIDS problem and review of task 
force intentions and obligations. The report also contains the names of task force members, 
meeting agendas, and summaries of the recommendations ultimately made. These include 
recommendations for schools, prisons Jails, hospitals, nursing homes, mental health institutions, 
the workplace, funeral directors and pathologists, emergency medical service personnel, den­
tal personnel, home care, child care, serologic screening, contact notification, health care ser­
vices for the chronically ill, neuropsychiatric aspect of AIDS, and public and professional 
education issues. This summary also details the availability of documents used by the task force 
and recommendations for legislative changes. Four appendixes are also included.
Recommendations for Preventing Transmission of Infection With Human T-Lymphotropic 
Virus Type m/Lymphadenopathy-Associated Virus in the Workplace (1985)
US Department of Health and Human Services, Public Health Service, Centers for Disease 
Control, Technical Information Activity, AIDS Program, Atlanta, GA 30333.404-639-2891.
This report contains detailed recommendations for precautions to prevent transmission of 
H T L V -III infection among health care workers and others who may be exposed in the course 
of their occupations. It covers exposure to possibly contaminated blood or body fluids during 
home care, emergency services, and other health services. Transmission from health care 
workers to patients is covered. Procedures for sterilization, disinfection, housekeeping, and 
waste disposal also are described.
Utah Medical Association, 540 E. 500 S., Salt Lake City, UT 84102.
Education Services, Speakers Bureaus, Information Dissemination Services, Policy Analysis, 
Recommendations.
The Utah Medical Association has established a task force to study AIDS issues and proposed
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legislation, to act as "voice of the medical community" on AIDS issues, and to help educate 
member physicians on the care of AIDS patients. Several articles have been published in 
monthly magazine, the UM A Bulletin. An informal speakers bureau /  media resource guide 
has been compiled listing various AIDS related topics and physicians who can address topics. 
The Utah Medical Association acts as resource to state and local governments in the develop­
ment of legislation and policy on AIDS. It also provides education information to physicians 




acute (disease) of short duration, usually with an abrupt onset, and sometimes severe (as
opposed to chronic disease).
AIDS (Acquired Immunodeficiency Syndrome) the most severe manifestation of infection with 
the human immunodeficiency virus (H IV ).
amniotic fluid the watery fluid that surrounds the fetus or unborn child in the uterus.
antibody substance that a person’s immune system develops to help fight infection.
antibody positive the result of a test or series of tests to detect antibodies in blood. A  positive 
result means that antibodies are present.
antigen substance such as H IV , that is foreign to a person’s body. An antigen
causes the immune system to form antibodies to fight the antigen.
antiviral drug a drug that can interfere with the life cycle of a virus.
ARC (AIDS-Related Complex or Condition) a term that has been used to describe a variety of 
symptoms caused by H IV  infection. These symptoms are usually less severe 
than those associated with AIDS and can include loss of appetite, weight loss, 
fever, night sweats, skin rashes, diarrhea, tiredness, lack of resistance to infec­
tion, and swollen lymph nodes.
asymptomatic having a disease-causing agent in the body but showing no outward signs of
disease.
asymptomatic H IV seropositive the condition of testing positive for H IV  antibody without
showing any symptoms of disease. A  person who is HIV-positive, even without 
symptoms, is capable of transmitting the virus to others.
AZT the first FDA-approved drug used to treat AIDS.
body fluids fluids that the body makes, for example, semen, blood, vaginal secretions, and
breast milk.
carrier a person who apparently is healthy, but who is infected with some disease-causing
organism (such as H IV  or HBV) that can be transmitted to another person.
Centers for Disease Control (CDC) Federal health agency that is a branch of the U.S. Depart­
ment of Health and Human Services. The CDC provides national health and 
safety guidelines and statistical data on AIDS and other diseases.
chronic (disease) lasting a long time, or recurring often.
Glossary
cytomegalovirus (CMV) A  viral infection that may occur without any symptoms or result in mild
flu-like symptoms. Severe CM V infections can result in hepatitis, mononucleosis, 
or pneumonia. CMV is "shed" in body fluids (urine, semen, sputum and saliva). 
In the presence of immune deficiency, such as AIDS, it can also affect other 
internal organs and vision, sometimes leading to blindness.
decontamination removing disease-causing agents, thus making the environment or specific ob­
ject safe to handle.
identifying a disease by its signs, symptoms, course, and laboratory findings.
a screening blood test for the presence of antibodies to HTV. A positive result 
from an Elisa test always needs to be confirmed by a second Elisa test, and a 
more specific test
the study of the incidence, distribution, and control of a disease in a population, 
the causes or origins of disease.
the act or condition of coming in contact with, but not necessarily being in­
fected by, a disease-causing agent
incorrect test result indicating that no antibodies are present when they are.
incorrect test result indicating that antibodies are present when they are not.
hepatitis 8  immune globulin, which is a preparation that provides some tem­
porary protection following exposure to HBV if given within 7 days after ex­
posure.
helper/suppressor T-cells white blood cells that are part of the immune system.
hepatitis B a viral infection that affects the liver. The effects of the disease on the liver
can range from mild, even inapparent, to severe or fatal.
high-risk behavior a term that describes certain activities that increase the risk of transmitting 
H IV  or HBV. These include anal intercourse, vaginal intercourse without a 
condom, oral-anal contact, semen in the mouth, sharing intravenous needles, 
intimate blood contact
H IV  antibody screening test a blood test that reveals the presence of antibodies to H IV .
H IV (human immunodeficiency vims) the cause of AIDS.
H IV  antibody positive a test result indicating that H IV  antibodies are found.
HTV antigen positive the result of antigen testing where it has been found that HTV is present 











H IV disease the term to describe the spectrum of H IV  infection, chronologically described
as a progression from asymptomatic seropositive to AIDS.
immune status the state of the body’s immune system. Factors affecting immune status include
heredity, age, diet, and physical and mental health.
immune system a body system that helps resist disease-causing germs, viruses, or other infec­
tions.
immunosuppressed a condition or state of the body in which the immune system does not work 
normally.
incubation period the time period between infection and appearance of disease symptoms, 
infection a condition or state of the body in which a disease-causing agent has entered it.
intravenous drugs drugs injected by needle directly into a vein, 
latency a period when a virus is in the body but is inactive.
MMWR (Morbidity and Mortality Weekly Report) a CDC weekly publication that gives
information on current trends in the nation’s health.
mucous membrane a moist layer of tissue that lines the mouth, eyes, nostrils, vagina, anus, or 
urethra.
nonintact skin skin that is chapped, abraded, weeping, or that has rashes or eruptions.
opportunistic infection infection that usually is warded off by a healthy immune system. If  the 
immune system is not strong and effective, these infections "take the opportu­
nity" to harm the body.
pathogen a disease-causing substance.
percutaneously entering the body through the skin, for example, by needlestick or on broken
skin.
pericardial fluid a clear fluid contained in the thin, membranous sac that surrounds the heart.
perinatal happening just before, during, or immediately after birth.
peritoneal fluid fluid contained in the membrane lining of the abdominal cavity.
person with AIDS (FWA) a preferred term for a person diagnosed with AIDS.
pleural fluid fluid contained in the membrane that covers the lung and lines the chest cavity.
Pneumocystis carinii pneumonia (pep) a lung infection that has been common among people in­














Western blot test 
window period
any substance or steps taken to prevent something from happening (for exam­
ple, condoms, vaccines).
sexual practices that involve no exchange of blood, semen, or vaginal secretions.
the process by which a person previously known to be antibody negative con­
verts to testing positive for H IV  antibodies.
any number of tests that are performed on blood. Usually refers to a test that 
measures antibodies to a virus.
a condition in which antibodies to a disease-causing agent are found in the 
blood; a positive reaction to a blood test The presence of antibodies indicates 
that a person has been exposed to the agent
destruction of all microbial life by means of steam, gas, or liquid agents.
beneath or introduced beneath the skin (for example, subcutaneous injections).
a collection of signs and symptoms that occur together.
capable of killing a moderately resistant bacterium, Mycobacterium tuberculosis 
var. bovis. This organism is one used in laboratory tests to classify disinfectant 
chemicals according to their power.
a substance that produces or increases immunity and protection against a par­
ticular disease.
organism that causes disease.
a blood test used to detect antibodies to H IV . The test can be used to confirm 
Elisa test results (see Elisa test).
the time it takes the immune system to develop antibodies to the virus after 
exposure to it
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I. Introduction
A. Background
This document is a response to recently enacted legislation, Public Law 100-607, The Health Omnibus 
Programs Extension Act of 1988, Title n, Programs with Respect to Acquired Immune Deficiency 
Syndrome (“AIDS Amendments of 1988”). Subtitle E, General Provisions, Section 253(a) of Title II 
specifies that “the Secretary of Health and Human Services, acting through the Director of the Centers 
for Disease Control, shall develop, issue, and disseminate guidelines to all health workers, public safety 
workers (including emergency response employees) in the United States concerning—
(1) methods to reduce the risk in the workplace of becoming infected with the etiologic agent for acquired 
immune deficiency syndrome; and
(2) circumstances under which exposure to such etiologic agent may occur.”
It is further noted that “The Secretary [of Health and Human Services] shall transmit the guidelines issued 
under subsection (a) to the Secretary of Labor for use by the Secretary of Labor in the development of 
standards to be issued under the Occupational Safety and Health Act of 1970,” and that “the Secretary, 
acting through the Director of the Centers for Disease Control, shall develop a mode] curriculum for 
emergency response employees with respect to the prevention of exposure to the etiologic agent for 
acquired immune deficiency syndrome during the process of responding to emergencies.”
Following development of these guidelines and curriculum, “[t]he Secretary shall —
(A) transmit to State public health officers copies of the guidelines and the model curriculum 
developed under paragraph (1) with the request that such officers disseminate such copies as 
appropriate throughout the State; and
(B) make such copies available to the public.”
B. Purpose and Organization of Document
The purpose of this document is to provide an overview of the modes of transmission of human 
immunodeficiency virus (HIV) in the workplace, an assessment of the risk of transmission under various 
assumptions, principles underlying the control of risk, and specific risk-control recommendations for 
employers and workers. This document also includes information on medical management of persons who 
have sustained an exposure at the workplace to these viruses (e.g., an emergency medical technicians who 
incur a needle-stick injury while performing professional duties). These guidelines are intended for use 
by a technically informed audience. As noted above, a separate model curriculum based on the principles 
and practices discussed in this document is being developed for use in training workers and will contain 
less technical wording.
Information concerning the protection of workers against acquisition of the human immunodeficiency virus 
(HIV) while performing job duties, the virus that causes AIDS, is presented here. Information on hepatitis 
B virus (HBV) is also presented in this document on the basis of the following assumptions:
•  the modes of transmission for hepatitis B virus (HBV) are similar to those of HIV,
•  the potential for HBV transmission in the occupational setting is greater than for HTV,
•  there is a larger body of experience relating to controlling transmission of HBV in the workplace, and
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•  general practices to prevent the transmission of HBV will also minimize the risk of transmission of 
HIV.
Blood-borne transmission of other pathogens not specifically addressed here will be interrupted by 
adherence to the precautions noted below. It is important to note that the implementation of control 
measures for HTV and HBV does not obviate the need for continued adherence to general infection- 
control principles and general hygiene measures (e.g., hand washing) for preventing transmission of other 
infectious diseases to both worker and client General guidelines for control of these diseases have been 
published (1,2,3).
This document was developed primarily to provide guidelines for fire-service personnel, emergency medical 
technicians, paramedics (see section IV, page 14), and law-enforcement and correctional-facility personnel 
(see section V, page 16). Throughout the report, paramedics and emergency medical technicians are called 
“emergency medical workers” and fire-service, law-enforcement, and correct ional-facility personnel, “public - 
safety workers.” Previously issued guidelines address the needs of hospital-, laboratory-, and clinic-based 
health-care workers and are reprinted in Appendix A (see page 31) and Appendix B (see page 36). A 
condensation of general guidelines for protection of workers from transmission of blood-borne pathogens, 
derived from the Joint Advisory Notice of the Departments of Labor and Health and Human Services (4), 
is provided in section III (see page 8).
C. Modes and Risk of Virus Transmission in the Workplace
Although the potential for HBV transmission in the workplace setting is greater than for HTV, the modes 
of transmission for these two viruses are similar. Both have been transmitted in occupational settings only 
by percutaneous inoculation or contact with an open wound, nonintact (e.g., chapped, abraded, weeping, 
or dermatitic) skin, or mucous membranes to blood, blood-contaminated body fluids, or concentrated virus. 
Blood Is the single most important source of HTV and HBV in the workplace setting. Protection measures 
against HTV and HBV for workers should focus primarily on preventing these types of exposures to blood 
as well as on delivery of HBV vaccination.
The risk of hepatitis B infection following a parenteral (Le., needle stick or cut) exposure to blood is 
directly proportional to the probability that the blood contains hepatitis B surface antigen (HBsAg), the 
immunity status of the recipient, and on the efficiency of transmission (5). The probability of the source 
of the blood being HBsAg positive varies from 1 to 3 per thousand in the general population to 5%-15% 
in groups at high risk for HBV infection, such as immigrants from areas of high endemidty (China and 
Southeast Asia, sub-Saharan Africa, most Pacific islands, and the Amazon Basin); clients in institutions 
for the mentally retarded; intravenous drug users; homosexually active males; and household (sexual and 
non-sexual) contacts of HBV carriers. Of persons who have not had prior hepatitis B vaccination or 
postexposure prophylaxis, 6%-30% of persons who receive a needle-stick exposure from an HBsAg- 
positive individual will become infected (5).
The risk of infection with HIV following one needle-stick exposure to blood from a patient known to be 
infected with HTV is approximately 0.5% (6,7). This rate of transmission is considerably lower than that 
for HBV, probably as a result of the significantly lower concentrations of virus in the blood of HTV- 
infected persons. Table 1 (see page 24) presents theoretical data concerning the likelihood of infection 
given repeated needle-stick injuries involving patients whose HIV serostatus is unknown. Though 
inadequately quantified, the risk from exposure of nonin tact skin or mucous membranes is likely to be far 
less than that from percutaneous inoculation.
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D. Transmission of Hepatitis B Virus to Workers
1. Health-care workers
In 1987, the CDC estimated the total number of HBV infections in the United States to be 300,000 
per year, with approximately 75,000 (25%) of infected persons developing acute hepatitis. Of these 
infected individuals, 18,000-30,000 (6%-10%) will become HBV carriers, at risk of developing chronic 
liver disease (chronic active hepatitis, cirrhosis, and primary liver cancer), and infectious to others.
CDC has estimated that 12,000 health-care workers whose jobs entail exposure to blood become 
infected with HBV each year, that 500-600 of them are hospitalized as a result of that infection, and 
that 700-1,200 of those infected become HBV carriers. Of the infected workers, approximately 250 
will die (12-15 from fulminant hepatitis, 170-200 from cirrhosis, and 40-50 from liver cancer). 
Studies indicate that 10%-30% of health-care or dental workers show serologic evidence of past or 
present HBV infection.
2. Emergency medical and public-safety workers
Emergency medical workers have an increased risk for hepatitis B infection (8,9,10). The degree of 
risk correlates with the frequency and extent of blood exposure during the conduct of work activities. 
A few studies are available concerning risk of HBV infection for other groups of public-safety workers 
(law-enforcement personnel and correctional-facility workers), but reports that have been published 
do not document any increased risk for HBV infection (11,12,13). Nevertheless, in occupational 
settings in which workers may be routinely exposed to blood or other body fluids as described below, 
an increased risk for occupational acquisition of HBV infection must be assumed to be present.
3. Vaccination for hepatitis B virus
A safe and effective vaccine to prevent hepatitis B has been available since 1982. Vaccination has 
been recommended for health-care workers regularly exposed to blood and other body fluids 
potentially contaminated with HBV (5,14,15). In 1987, the Department of Health and Human Services 
and the Department of Labor stated that hepatitis B vaccine should be provided to all such workers 
at no charge to the worker (4).
Available vaccines stimulate active immunity against HBV infection and provide over 90% protection 
against hepatitis B for 7 or more years following vaccination (5). Hepatitis B vaccines also are 
70-88% effective when given within 1 week after HBV exposure. Hepatitis B immune globulin 
(HBIG), a preparation of immunoglobulin with high levels of antibody to HBV (anti-HBs), provides 
temporary passive protection following exposure to HBV. Combination treatment with hepatitis B 
vaccine and HBIG is over 90% effective in preventing hepatitis B following a documented exposure 
(5).
E. Transmission of Human Immunodeficiency Virus to Workers
1. Health-care workers with AIDS
As of September 19,1988, a total of 3,182 (5.1%) of 61,929 adults with AIDS, who had been reported 
to the CDC national surveillance system and for whom occupational information was available, 
reported being employed in a health-care setting. Of the health-care workers with AIDS, 95%
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reported high-risk behavior; for the remaining 5% (169 workers), the means of HIV acquisition was 
undetermined.
Of these 169 health-care workers with AIDS with undetermined risk, information is incomplete for 
28 (17%) because of death or refusal to be interviewed; 97 (57%) are still being investigated The 
remaining 44 (26%) health-care workers were interviewed directly or had other follow-up information 
available. The occupations of these 44 were nine nursing assistants (20%); eight physicians (18%), 
four of whom were surgeons; eight housekeeping or maintenance workers (18%); six nurses (14%); 
four clinical laboratory technicians (9%); two respiratory therapists (5%); one dentist (2%); one 
paramedic (2%); one embalmer (2%); and four others who did not have contact with patients (9%). 
Eighteen of these 44 health-care workers reported parenteral and/or other non-needle-stick exposure 
to blood or other body fluids from patients in the 10 years preceding their diagnosis of AIDS. None 
of these exposures involved a patient with AIDS or known HIV infection, and HTV seroconversion 
of the health-care worker was not documented following a specific exposure.
2. Human immunodeficiency virus transmission in the workplace
As of July 31, 1988, 1,201 health-care workers had been enrolled and tested for HTV antibody in 
ongoing CDC surveillance of health-care workers exposed via needle stick or splashes to skin or 
mucous membranes to blood from patients known to be HTV-infected (16). Of 860 workers who had 
received needle-stick injuries or cuts with sharp objects (Le., parenteral exposures) and whose serum 
had been tested for HTV antibody at least 180 days after exposure, 4 were positive, yielding a 
seroprevalence rate of 0.47%. Three of these individuals experienced an acute retroviral syndrome 
associated with documented seroconversion. Investigation revealed no nonoccupational risk factors 
for these three workers. Serum collected within 30 days of exposure was not available from the fourth 
person. This worker had an HIV-seropositive sexual partner, and heterosexual acquisition of infection 
cannot be excluded. None of the 103 workers who had contamination of mucous membranes or 
nonintact skin and whose serum had been tested at least 180 days after exposure developed serologic 
evidence of HIV infection.
Two other ongoing prospective studies assess the risk of nosocomial acquisition of HTV infection 
among health-care workers in the United States. As of April 1988, the National Institutes of Health 
had tested 983 health-care workers, 137 with documented needle-stick injuries and 345 health-care 
workers who had sustained mucous-membrane exposures to blood or other body fluids of HTV-infected 
patients; none had seroconverted (17) (one health-care worker who subsequently experienced an 
occupational HIV seroconversion has since been reported from NIH [JS]). As of March 15,1988, a 
similar study at the University of California of 212 health-care workers with 625 documented accidental 
parenteral exposures involving HTV-infected patients bad identified one seroconversion following a 
needle stick (19). Prospective studies in the United Kingdom and Canada show no evidence of HTV 
transmission among 220 health-care workers with parenteral, mucous-membrane, or cutaneous 
exposures (20,21).
In addition to the health-care workers enrolled in these longitudinal surveillance studies, case histories 
have been published in the scientific literature for 19 HTV-infected health-care workers (13 with 
documented seroconversion and 6 without documented seroconversion). None of these workers 
reported nonoccupational risk factors (see Table 2, pages 25, 26).
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3. Emergency medical service and public-safety workers
In addition to the one paramedic with undetermined risk discussed above, three public-safety workers 
(law-enforcement officers) are classified in the undetermined risk group. Follow-up investigations of 
these workers could not determine conclusively if HTV infection was acquired during the performance 
of job duties.
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II. Principles of Infection Control and Their Application to Emergency and Public-Safety Workers
A- General Infection Control
Within the health-care setting, general infection control procedures have been developed to minimize the 
risk of patient acquisition of infection from contact with contaminated devices, objects, or surfaces or of 
transmission of an infectious agent from health-care workers to patients (1,2,3). Such procedures also 
protect workers from the risk of becoming infected. General infection-control procedures are designed 
to prevent transmission of a wide range of microbiological agents and to provide a wide margin of safety 
in the varied situations encountered in the health-care environment
General infection-control principles are applicable to other work environments where workers contact 
other individuals and where transmission of infectious agents may occur. The modes of transmission noted 
in the hospital and medical office environment are observed in the work situations of emergency and 
public-safety workers, as welL Therefore, the principles of infection control developed for hospital and 
other health-care settings are also applicable to these work situations. Use of general infection control 
measures, as adapted to the work environments of emergency and public-safety workers, is important to 
protect both workers and individuals with whom they work from a variety of infectious agents, not just 
HIV and HBV.
Because emergency and public-safety workers work in environments that provide inherently unpredictable 
risks of exposures, general infection-control procedures should be adapted to these work situations. 
Exposures are unpredictable, and protective measures may often be used in situations that do not appear 
to present risk. Emergency and public-safety workers perform their duties in the community under 
extremely variable conditions; thus, control measures that are simple and uniform across all situations have 
the greatest likelihood of worker compliance. Administrative procedures to ensure compliance also can 
be more readily developed than when procedures are complex and highly variable.
B. Universal Blood and Body Fluid Precautions to Prevent Occupational HTV and HBV Transmission
In 1985, CDC developed the strategy of “universal blood and body fluid precautions” to address concerns 
regarding transmission of HIV in the health-care setting (6). The concept, now referred to simply as 
“universal precautions” stresses that all patient» should be assumed to be Infections for HIV and other 
Mood-borne pathogens. In the hospital and other health-care setting, “universal precautions” should be 
followed when workers are exposed to blood, certain other body fluids (amniotic fluid, pericardial fluid, 
peritoneal fluid, pleural fluid, synovial fluid, cerebrospinal fluid, semen, and vaginal secretions), or any body 
fluid visibly contaminated with blood. Since HIV and HBV transmission has not been documented from 
exposure to other body fluids (feces, nasal secretions, sputum, sweat, tears, urine, and vomitus), “universal 
precautions'* do not apply to these fluids. Universal precautions also do not apply to saliva, except in the 
dental setting, where saliva is likely to be contaminated with blood (see Appendix A, page 32).
For the purpose of this document, human “exposure” is defined as contact with blood or other body fluids 
to which universal precautions apply through percutaneous inoculation or contact with an open wound, 
nonintact skin, or mucous membrane during the performance of normal job duties. An “exposed worker” 
is defined, for the purposes of this document, as an individual exposed, as described above, while 
performing normal job duties.
The unpredictable and emergent nature of exposures encountered by emergency and public-safety workers 
may make differentiation between hazardous body fluids and those which are not hazardous very difficult 
and often impossible. For example, poor lighting may limit the worker’s ability to detect visible blood in
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vomitus or feces. Therefore, when emergency medical and publlc-safetv workers encounter body fluids 
under uncontrolled, emergency circumstances in which differentiation between fluid types is difficult 
if not Impossible, they should treat all body fluids as potentially hazardous.
The application of the principles of universal precautions to the situations encountered by these workers 
results in the development of guidelines (listed below) for work practices, use of personal protective 
equipment and other protective measures. To minimize the risks of acquiring HIV and HBV during 
performance of job duties, emergency and public-safety workers should be protected from exposure to 
blood and other body fluids as circumstances dictate. Protection can be achieved through adherence to 
work practices designed to minimize or eliminate exposure and through use of personal protective 
equipment (Le., gloves, masks, and protective clothing), which provide a barrier between the worker and 
the exposure source. In some situations, redesign of selected aspects of the job through equipment 
modifications or environmental control can further reduce risk. These approaches to primary prevention 
should be used together to achieve maximal reduction of the risk of exposure.
If exposure of an individual worker occurs, medical management consisting of collection of pertinent 
medical and occupational history, provision of treatment, and counseling regarding future work and 
personal behaviors, may reduce risk of developing disease as a result of the exposure episode (22). 
Following episodic (or continuous) exposure, decontamination and disinfection of the work environment, 
devices, equipment, and clothing or other forms of personal protective equipment can reduce subsequent 
risk of exposures. Proper disposal of contaminated waste has similar benefits.
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in . Employer Responsibilities
A. General
¡Detailed recommendations for employer responsibilities in protecting workers from acquisition of blood- 
borne diseases in the workplace have been published in the Department of Labor and Department of 
Health and Human Services Joint Advisory Notice and are summarized here (4). In developing programs 
to protect workers, employers should follow a series of steps: 1) classification of work activity, 2) 
development of standard operating procedures, 3) provision of training and education, 4) development of 
procedures to ensure and monitor compliance, and 5) workplace redesign. As a first step, every employer 
should classify work activities into one of three categories of potential exposure (see Table 3, page 27). 
Employers should make protective equipment available to all workers when they are engaged in Category 
I or II activities. Employers should ensure that the appropriate protective equipment is used by workers 
when they perform Category I activities.
As a second step, employers should establish a detailed work practices program that includes standard 
operating procedures (SOPs) for all activities having the potential for exposure. Once these SOPs are 
developed, an initial and periodic worker education program to assure familiarity with work practices 
should be provided to potentially exposed workers. No worker should engage in such tasks or activities 
before receiving training pertaining to the SOPs, work practices, and protective equipment required for 
that task. Examples of personal protective equipment for the prehospital setting (defined as a setting 
where delivery of emergency health care takes place away from a hospital or other health-care setting) 
are provided in Table 4 (page 28). (A curriculum for such training programs is being developed in 
conjunction with these guide lines and should be consulted for further information concerning such training 
programs.)
To facilitate and monitor compliance with SOPs, administrative procedures should be developed and 
records kept as described in the Joint Advisory Notice (4). Employers should monitor the workplace to 
ensure that required work practices are observed and that protective clothing and equipment are provided 
and properly used. The employer should maintain records documenting the administrative procedures used 
to classify job activities and copies of all SOPs for tasks or activities involving predictable or unpredictable 
exposure to blood or other body fluids to which universal precautions apply. In addition, training records, 
indicating the dates of training sessions, the content of those training sessions along with the names of 
all persons conducting the training, and the names of all those receiving training should also be maintained.
Whenever possible, the employer should identify devices and other approaches to modifying the work 
environment which will reduce exposure risk. Such approaches are desirable, since they don’t require 
individual worker action or management activity. For example, jails and correctional facilities should have 
classification procedures that require the segregation of offenders who indicate through their actions or 
words that they intend to attack correctional-fadlity staff with the intent of transmitting HIV or HBV.
B. Medical
In addition to the general responsibilities noted above, the employer has the specific responsibility to make 
available to the worker a program of medical management This program is designed to provide for the 
reduction of risk of infection by HBV and for counseling workers concerning issues regarding HIV and 
HBV. These services should be provided by a licensed health professional All phases of medical 
management and counseling should ensure that the confidentiality of the worker’s and client’s medical data 
is protected.
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1. Hepatitis B vaccination
All workers whose jobs involve participation in tasks or activities with exposure to blood or other body 
fluids to which universal precautions apply (as defined above on page 6) should be vaccinated with 
hepatitis B vaccine.
2. Management of percutaneous exposure to blood and other infectious body fluids
Once an exposure has occurred (as defined above on page 6), a blood sample should be drawn after 
consent is obtained from the individual from whom exposure occurred and tested for hepatitis B 
surface antigen (HBsAg) and antibody to human immunodeficiency virus (HIV antibody). Local laws 
regarding consent for testing source individuals should be followed Policies should be available for 
testing source individuals in situations where consent cannot be obtained (e.g., an unconscious patient). 
Testing of the source individual should be done at a location where appropriate pretest-counseling is 
available; posttest counseling and referral for treatment should be provided It is extremely important 
that all individuals who seek consultation for any HIV-related concerns receive counseling as outlined 
in the “Public Health Service Guidelines for Counseling and Antibody Testing to Prevent HIV 
Infection and AIDS” (22).
a. Hepatitis B virus postexposure management
For an exposure to a source individual found to be positive for HBsAg, the worker who has 
not previously been given hepatitis B vaccine should receive the vaccine series. A single dose 
of hepatitis B immune globulin (HBIG) is also recommended, if this can be given within 7 days 
of exposure. For exposures from an HBsAg-positive source to workers who have previously 
received vaccine, the exposed worker should be tested for antibody to hepatitis B surface 
antigen (anti-HBs), and given one dose of vaccine and one dose of HBIG if the antibody level 
in the worker’s blood sample is inadequate (Le., < 10 SRU by RIA, negative by EIA) (5).
If the source individual is negative for HBsAg and the worker has not been vaccinated, this 
opportunity should be taken to provide hepatitis B vaccination.
If the source individual refuses testing or he/she cannot be identified, the unvaccinated worker 
should receive the hepatitis B vacdne series. HBIG administration should be considered on 
an individual basis when the source individual is known or suspected to be at high risk of HBV 
infection. Management and treatment, if any, of previously vaccinated workers who receive 
an exposure from a source who refuses testing or is not identifiable should be individualized 
(*)•
b. Human immunodeficiency virus postexposure management
For any exposure to a source individual who has AIDS, who is found to be positive for HIV 
infection (as defined in Appendix B, see page 42), or who refuses testing, the worker should 
be counseled regarding the risk of infection and evaluated clinically and serologically for 
evidence of HIV infection as soon as possible after the exposure. In view of the evolving 
nature of HIV postexposure management, the health-care provider should be well informed 
of current PHS guidelines on this subject The worker should be advised to report and seek 
medical evaluation for any acute febrile illness that occurs within 12 weeks after the exposure. 
Such an illness, particularly one characterized by fever, rash, or lymphadenopathy, may be 
indicative of recent HIV infection. Following the initial test at the time of exposure,
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seronegative workers should be retested 6 weeks, 12 weeks, and 6 months after exposure to 
determine whether transmission has occurred. During this follow-up period (especially the first 
6-12 weeks after exposure, when most infected persons are expected to seroconvert), exposed 
workers should follow U.S. Public Health Service (PHS) recommendations for preventing 
transmission of HTV (22). These include refraining from blood donation and using appropriate 
protection during sexual intercourse (23). During all phases of follow-up, it is vital that 
worker confidentiality be protected.
If the source individual was tested and found to be seronegative, baseline testing of the 
exposed worker with follow-up testing 12 weeks later may be performed if desired by the 
worker or recommended by the health-care provider.
If the source individual cannot be identified, decisions regarding appropriate follow-up should 
be individualized. Serologic testing should be made available by the employer to all workers 
who may be concerned they have been infected with HIV through an occupational exposure 
as defined above (see page 6).
3. Management of human bites
On occasion, police and correctional-facility officers are intentionally bitten by suspects or prisoners. 
When such bites occur, routine medical and surgical therapy (including an assessment of tetanus 
vaccination status) should be implemented as soon as possible, since such bites frequently result in 
infection with organisms other than HIV and HBV. Victims of bites should be evaluated as described 
above (see page 9) for exposure to blood or other infectious body fluids.
(As noted below in Appendix A, page 32, saliva of some persons infected with HBV has been shown 
to contain HBV-DNA at concentrations 1/1,000 to 1/10,000 of that found in the infected person’s 
serum (24). HbsAg-positive saliva has been shown to be infectious when injected into experimental 
animals and in human bite exposures (25-27). However, HBsAg-positive saliva has not been shown 
to be infectious when applied to oral mucous membranes in experimental primate studies (27) or 
through contamination of musical instruments or cardiopulmonary resuscitation dummies used by HBV 
carriers (28,29). Epidemiologic studies of nonsexual household contacts of HIV-infected patients, 
including several small series in which HTV transmission failed to occur after bites or after 
percutaneous inoculation or contamination of cuts and open wounds with saliva from HIV-infected 
patients, suggest that the potential for salivary transmission of HTV is remote (7,30,31,32,33). One 
case report from Germany has suggested the possibility of transmission of HIV in a household setting 
from an infected child to a sibling through a human bite (34). The bite did not break the skin or 
result in bleeding. Since the date of seroconversion to HIV was not known for either child in this 
case, evidence for the role of saliva in the transmission of virus is unclear (34).)
4. Documentation of exposure and reporting
As part of the confidential medical record, the circumstances of exposure should be recorded. 
Relevant information includes the activity in which the worker was engaged at the time of exposure, 
the extent to which appropriate work practices and protective equipment were used, and a description 
of the source of exposure.
Employers have a responsibility under various federal and state laws and regulations to report 
occupational Alnesses and injuries. Existing programs in the National Institute for Occupational Safety 
and Health (NIOSH), Department of Health and Human Services; the Bureau of Labor Statistics,
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Department of Labor (DOL); and the Occupational Safety and Health Administration (DOL) receive 
such information for the purposes of surveillance and other objectives. Cases of infectious disease, 
including AIDS and HBV infection, are reported to the Centers for Disease Control through State 
health departments.
5. Management of HBV- or HIV-infected workers
Transmission of HBV from health-care workers to patients has been documented. Such transmission 
has occurred during certain types of invasive procedures (e.g., oral and gynecologic surgery) in which 
health-care workers, when tested, had very high concentrations of HBV in their blood (at least 100 
million infectious virus particles per milliliter, a concentration much higher than occurs with HIV 
infection), and the health-care workers sustained a puncture wound while performing invasive 
procedures or had exudative or weeping lesions or microlacerations that allowed virus to contaminate 
instruments or open wounds of patients (35,36). A worker who is HBsAg positive and who has 
transmitted hepatitis B virus to another individual during the performance of his or her job duties 
should be excluded from the performance of those job duties which place other individuals at risk for 
acquisition of hepatitis B infection.
Workers with impaired immune systems resulting from HIV infection or other causes are at increased 
risk of acquiring or experiencing serious complications of infectious disease. Of particular concern 
is the risk of severe infection following exposure to other persons with infectious diseases that are 
easily transmitted if appropriate precautions are not taken (e.g., measles, varicella). Any worker with 
an impaired immune system should be counseled about the potential risk associated with providing 
health care to persons with any transmissible infection and should continue to follow existing 
recommendations for infection control to minimize risk of exposure to other infectious agents (2,3). 
Recommendations of the Immunization Practices Advisory Committee (ACIP) and institutional policies 
concerning requirements for vaccinating workers with Live-virus vaccines (e.g., measles, rubella) should 
also be considered.
The question of whether workers infected with HFV can adequately and safely be allowed to perform 
patient-care duties or whether their work assignments should be changed must be determined on an 
individual basis. These decisions should be made by the worker’s personal physician(s) in conjunction 
with the employer’s medical advisors.
C. Disinfection, Decontamination, and Disposal
As described in Section I.C. (see page 2), the only documented occupational risks of HIV and HBV 
infection are associated with parenteral (including open wound) and mucous membrane exposure to blood 
and other potentially infectious body fluids. Nevertheless, the precautions described below should be 
routinely followed.
1. Needle and sharps disposal
All workers should take precautions to prevent injuries caused by needles, scalpel blades, and other 
sharp instruments or devices during procedures; when cleaning used instruments; during disposal of 
used needles; and when handling sharp instruments after procedures. To prevent needle-stick injuries, 
needles should not be recapped, purposely bent or broken by hand, removed from disposable syringes, 
or otherwise manipulated by hand. After they are used, disposable syringes and needles, scalpel blades, 
and other sharp items should be placed in puncture-resistant containers for disposal; the 
puncture-resistant containers should be located as close as practical to the use area (e.g., in the
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ambulance or, if sharps arc carried to the scene of victim assistance from the ambulance, a small 
puncture-resistant container should be carried to the scene, as well). Reusable needles should be left 
on the syringe body and should be placed in a puncture-resistant container for transport to the 
reprocessing area.
2. Hand washing
Hands and other skin surfaces should be washed immediately and thoroughly if contaminated with 
blood, other body fluids to which universal precautions apply, or potentially contaminated articles. 
Hands should always be washed after gloves are removed, even if the gloves appear to be intact Hand 
washing should be completed using the appropriate facilities, such as utility or restroom sinks. 
Waterless antiseptic hand cleanser should be provided on responding units to use when hand-washing 
facilities are not available. When hand-washing facilities are available, wash hands with warm water 
and soap. When hand-washing facilities are not available, use a waterless antiseptic hand cleanser. 
The manufacturer’s recommendations for the product should be followed
3. Cleaning, disinfecting, and sterilizing
Table 5 (see pages 29, 30) presents the methods and applications for cleaning, disinfecting, and 
sterilizing equipment and surfaces in the prehospital setting. These methods also apply to 
housekeeping and other cleaning tasks. Previously issued guidelines for health-care workers contain 
more detailed descriptions of these procedures and may be found in Appendix B (see page 40).
4. Cleaning and decontaminating spills of blood
All spills of blood and blood-contaminated fluids should be promptly cleaned up using an EPA- 
approved germicide or a 1:100 solution of household bleach in the following manner while wearing 
gloves. Visible material should first be removed with disposable towels or other appropriate means 
that will ensure against direct contact with blood If splashing is anticipated, protective eyewear should 
be worn along with an impervious gown or apron which provides an effective barrier to splashes. The 
area should then be decontaminated with an appropriate germicide. Hands should be washed following 
removal of gloves. Soiled cleaning equipment should be cleaned and decontaminated or placed in an 
appropriate container and disposed of according to agency policy. Plastic bags should be available for 
removal of contaminated items from the site of the spilL
Shoes and boots can become contaminated with blood in certain instances. Where there is massive 
blood contamination on floors, the use of disposable impervious shoe coverings should be considered 
Protective gloves should be worn to remove contaminated shoe coverings. The coverings and gloves 
should be disposed of in plastic bags. A plastic bag should be included in the crime scene kit or the 
car which is to be used for the disposal of contaminated items. Extra plastic bags should be stored 
in the police cruiser or emergency vehicle.
5. Laundry
Although soiled linen may be contaminated with pathogenic microorganisms, the risk of actual disease 
transmission is negligible. Rather than rigid procedures and specifications, hygienic storage and 
processing of clean and soiled linen are recommended Laundry facilities and/or services should be 
made routinely available by the employer. Soiled linen should be handled as little as possible and with 
minimum agitation to prevent gross microbial contamination of the air and of persons handling the 
linen. All soiled linen should be bagged at the location where it was used Linen soiled with blood
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should be placed and transported in bags that prevent leakage. Normal laundry cycles should be used 
according to the washer and detergent manufacturers’ recommendations.
6. Decontamination and laundering of protective clothing
Protective work clothing contaminated with blood or other body fluids to which universal precautions 
apply should be placed and transported in bags or containers that prevent leakage. Personnel involved 
in the bagging, transport, and laundering of contaminated clothing should wear gloves. Protective 
clothing and station and work uniforms should be washed and dried according to the manufacturer’s 
instructions. Boots and leather goods may be brush-scrubbed with soap and hot water to remove 
contamination.
7. Infective waste
The selection of procedures for disposal of infective waste is determined by the relative risk of disease 
transmission and application of local regulations, which vary widely. In all cases, local regulations 
should be consulted prior to disposal procedures and followed. Infective waste, in general, should 
either be incinerated or should be decontaminated before disposal in a sanitary landfill. Bulk blood, 
suctioned fluids, excretions, and secretions may be carefully poured down a drain connected to a 
sanitary sewer, where permitted Sanitary sewers may also be used to dispose of other infectious 
wastes capable of being ground and flushed into the sewer, where permitted Sharp items should be 
placed in puncture-proof containers and other blood-contaminated items should be placed in leak- 
proof plastic bags for transport to an appropriate disposal location.
Prior to the removal of protective equipment, personnel remaining on the scene after the patient has 
been cared for should carefully search for and remove contaminated materials. Debris should be 
disposed of as noted above.
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IV. Fire and Emergency Medical Services
The guidelines that appear in this section apply to fire and emergency medical services. This includes 
structural fire fighters, paramedics, emergency medical technicians, and advanced life support personnel. Fire 
fighters often provide emergency medical services and therefore encounter the exposures common to 
paramedics and emergency medical technicians. Job duties are often performed in uncontrolled environments, 
which, due to a lack of time and other factors, do not allow for application of a complex decision-making 
process to the emergency at hand.
The general principles presented here have been developed from existing principles of occupational safety and 
health in conjunction with data from studies of health-care workers in hospital settings. The basic premise 
is that workers must be protected from exposure to blood and other potentially infectious body fluids in the 
course of their work activities. There is a paucity of data concerning the risks these worker groups face, 
however, which complicates development of control principles. Thus, the guidelines presented below are based 
on principles of prudent public health practice.
Fire and emergency medical service personnel are engaged in delivery of medical care in the prehospital setting. 
The following guidelines are intended to assist these personnel in making decisions concerning use of personal 
protective equipment and resuscitation equipment, as well as for decontamination, disinfection, and disposal 
procedures.
A. Personal Protective Equipment
Appropriate personal protective equipment should be made available routinely by the employer to reduce 
the risk of exposure as defined above. For many situations, the chance that the rescuer will be exposed 
to blood and other body fluids to which universal precautions apply can be determined in advance. 
Therefore, if the chances of being exposed to blood is high (e.g., CPR, IV insertion, trauma, delivering 
babies), the worker should put on protective attire before beginning patient care. Table 4 (see page 28) 
sets forth examples of recommendations for personal protective equipment in the prehospital setting; the 
list is not intended to be all-inclusive.
1. Gloves
Disposable gloves should be a standard component of emergency response equipment, and should be 
donned by all personnel prior to initiating any emergency patient care tasks involving exposure to 
blood or other body fluids to which universal precautions apply. Extra pairs should always be 
available. Considerations in the choice of disposable gloves should include dexterity, durability, fit, and 
the task being performed. Thus, there is no single type or thickness of glove appropriate for 
protection in all situations. For situations where large amounts of blood are likely to be encountered, 
it is important that gloves fit tightly at the wrist to prevent blood contamination of hands around the 
cuff. For multiple trauma victims, gloves should be changed between patient contacts, if the 
emergency situation allows.
Greater personal protective equipment measures are indicated for situations where broken glass and 
sharp edges are likely to be encountered, such as extricating a person from an automobile wreck. 
Structural fire-fighting gloves that meet the Federal OSHA requirements for fire fighters gloves (as 
contained in 29 CFR 1910.156 or National Fire Protection Association Standard 1973, Gloves for 
Structural Fire Fighters) should be worn in any situation where sharp or rough surfaces are likely to 
be encountered {37).
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While wearing gloves, avoid handling personal items, such as combs and pens, that could become soiled 
or contaminated Gloves that have become contaminated with blood or other body fluids to which 
universal precautions apply should be removed as soon as possible, taking care to avoid skin contact 
with the exterior surface. Contaminated gloves should be placed and transported in bags that prevent 
leakage and should be disposed of or, in the case of reusable gloves, cleaned and disinfected properly.
2. Masks, eyewear, and gowns
Masks, eyewear, and gowns should be present on all emergency vehicles that respond or potentially 
respond to medical emergencies or victim rescues. These protective barriers should be used in 
accordance with the level of exposure encountered. Minor lacerations or small amounts of blood do 
not merit the same extent of barrier use as required for exsanguinating victims or massive arterial 
bleeding. Management of the patient who is not bleeding, and who has no bloody body fluids present, 
should not routinely require use of barrier precautions. Masks and eyewear (e.g., safety glasses) should 
be worn together, or a faceshield should be used by all personnel prior to any situation where splashes 
of blood or other body fluids to which universal precautions apply are likely to occur. Gowns or 
aprons should be worn to protect clothing from splashes with blood If large splashes or quantities 
of blood are present or anticipated, impervious gowns or aprons should be worn. An extra change 
of work clothing should be available at all times.
3. Resuscitation equipment
No transmission of HBV or HTV infection during mouth-to-mouth resuscitation has been documented 
However, because of the risk of salivary transmission of other infectious diseases (e.g., Herpes simplex 
and Neisseria meningitidis) and the theoretical risk of HTV and HBV transmission during artificial 
ventilation of trauma victims, disposable airway equipment or resuscitation bags should be used 
Disposable resuscitation equipment and devices should be used once and disposed of or, if reusable, 
thoroughly cleaned and disinfected after each use according to the manufacturer's recommendations.
Mechanical respiratory assist devices (e.g., bag-valve masks, oxygen demand valve resuscitators) should 
be available on all emergency vehicles and to all emergency response personnel that respond or 
potentially respond to medical emergencies or victim rescues.
Pocket mouth-to-mouth resuscitation masks designed to isolate emergency response personnel (Le., 
double lumen systems) from contact with victims' blood and blood-contaminated saliva, respiratory 
secretions, and vomitus should be provided to all personnel who provide or potentially provide 
emergency treatment
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V. Law-Enforcement and Correctional-Facillty Officers
Law-enforcement and correctional-facility officers may face the risk of exposure to blood during the conduct 
of their duties. For example, at the crime scene or during processing of suspects, law-enforcement officers 
may encounter blood-contaminated hypodermic needles or weapons, or be called upon to assist with body 
removal. Correctional-facility officers may similarly be required to search prisoners or their cells for 
hypodermic needles or weapons, or subdue violent and combative inmates.
The following section presents information for reducing the risk of acquiring HIV and HBV infection by law- 
enforcement and correctional-facility officers as a consequence of carrying out their duties. However, there 
is an extremely diverse range of potential situations which may occur in the control of persons with 
unpredictable, violent, or psychotic behavior. Therefore, informed judgment of the individual officer is 
paramount when unusual circumstances or events arise. These recommendations should serve as an adjunct 
to rational decision making in those situations where specific guidelines do not exist, particularly where 
immediate action is required to preserve life or prevent significant injury.
The following guidelines are arranged into three sections: a section addressing concerns shared by both law- 
enforcement and correctional-facility officers, and two sections dealing separately with law-enforcement officers 
and correctional-facility officers, respectively. Table 4 (see page 28) contains selected examples of personal 
protective equipment that may be employed by law-enforcement and correctional-facility officers.
A. Law-Enforcement and Correctional-Facilities Considerations
1. Fights and assaults
Law-enforcement and correctional-facility officers are exposed to a range of assaultive and disruptive 
behavior through which they may potentially become exposed to blood or other body fluids containing 
blood. Behaviors of particular concern are biting, attacks resulting in blood exposure, and attacks with 
sharp objects. Such behaviors may occur in a range of law-enforcement situations including arrests, 
routine interrogations, domestic disputes, and lockup operations, as well as in correctional-facility 
activities. Hand-to-hand combat may result in bleeding and may thus incur a greater chance for blood- 
to-blood exposure» which increases the chances for blood-borne disease transmission.
Whenever the possibility for exposure to blood or blood-contaminated body fluids exists, the 
appropriate protection should be worn, if feasible under the circumstances. In all cases, extreme 
caution must be used in dealing with the suspect or prisoner if there is any indication of assaultive or 
combative behavior. When blood is present and a suspect or an inmate is combative or threatening 
to staff, gloves should always be put on as soon as conditions permit In case of blood contamination 
of clothing, an extra change of clothing should be available at all times.
2. Cardiopulmonary resuscitation
Law-enforcement and correctional personnel are also concerned about infection with HIV and HBV 
through administration of cardiopulmonary resuscitation (CPR). Although there have been no 
documented cases of HTV transmission through this mechanism, the possibility of transmission of other 
infectious diseases exists. Therefore, agencies should make protective masks or airways available to 
officers and provide training in their proper use. Devices with one-way valves to prevent the patients’ 
saliva or vomitus from entering the caregiver’s mouth are preferable.
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B. Law-Enforcement Considerations
1. Searches and evidence handling
Criminal justice personnel have potential risks of acquiring HBV or HTV infection through exposures 
which occur during searches and evidence handling. Penetrating injuries are known to occur, and 
puncture wounds or needle sticks in particular pose a hazard during searches of persons, vehicles, or 
cells, and during evidence handling. The following precautionary measures will help to reduce the risk 
of infection:
•  An officer should use great caution in searching the clothing of suspects. Individual discretion, 
based on the circumstances at hand, should determine if a suspect or prisoner should empty 
his own pockets or if the officer should use his own skills in determining the contents of a 
suspect's clothing.
•  A safe distance should always be maintained between the officer and the suspect.
•  Wear protective gloves if exposure to blood is likely to be encountered.
•  Wear protective gloves for all body cavity searches.
•  If cotton gloves are to be worn when working with evidence of potential latent fingerprint
value at the crime scene, they can be worn over protective disposable gloves when exposure 
to blood may occur.
•  Always carry a flashlight, even during daylight shifts, to search hidden areas. Whenever 
possible, use long-handled mirrors and flashlights to search such areas (e.g., under car seats).
•  If searching a purse, carefully empty contents directly from purse, by turning it upside down 
over a table.
•  Use puncture-proof containers to store sharp instruments and clearly marked plastic bags to 
store other possibly contaminated items.
•  To avoid tearing gloves, use evidence tape instead of metal staples to seal evidence.
•  Local procedures for evidence handling should be followed. In general, items should be air 
dried before sealing in plastic.
Not all types of gloves are suitable for conducting searches. Vinyl or latex rubber gloves provide little 
protection against sharp instruments, and they are not puncture-proof. There is a direct trade-off 
between level of protection and manipulability. In other words, the thicker the gloves, the more 
protection they provide, but the less effective they are in locating objects. Thus, there is no single 
type or thickness of glove appropriate for protection in all situations. Officers should select the type 
and thickness of glove which provides the best balance of protection and search efficiency.
Officers and crime scene technicians may confront unusual hazards, especially when the crime scene 
involves violent behavior, such as a homicide where large amounts of blood are present. Protective 
gloves should be available and worn in this setting. In addition, for very large spills, consideration 
should be given to other protective clothing, such as overalls, aprons, boots, or protective shoe covers.
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They should be changed if torn or soiled, and always removed'prior to leaving the scene. While 
wearing gloves, avoid handling personal items, such as combs and pens, that could become soiled or 
contaminated.
Face masks and eye protection or a face shield are required for laboratory and evidence technicians 
whose jobs which entail potential exposures to blood via a splash to the face, mouth, nose, or eyes.
Airborne particles of dried blood may be generated when a stain is scraped. It is recommended that 
protective masks and eyewear or face shields be worn by laboratory or evidence technicians when 
removing the blood stain for laboratory analyses.
While processing the crime scene, personnel should be alert for the presence of sharp objects such 
as hypodermic needles, knives, razors, broken glass, nails, or other sharp objects.
2. Handling deceased persons and body removal
For detectives, investigators, evidence technicians, and others who may have to touch or remove a 
body, the response should be the same as for situations requiring CPR or first aid: wear gloves and 
cover all cuts and abrasions to create a barrier and carefully wash all exposed areas after any contact 
with blood. The precautions to be used with blood and deceased persons should also be used when 
handling amputated limbs, hands, or other body parts. Such procedures should be followed after 
contact with the blood of anyone, regardless of whether they are known or suspected to be infected 
with HIV or HBV.
3. Autopsies
Protective masks and eyewear (or face shields), laboratory coats, gloves, and waterproof aprons should 
be worn when performing or attending all autopsies. All autopsy material should be considered 
infectious for both HIV and HBV. Onlookers with an opportunity for exposure to blood splashes 
should be similarly protected. Instruments and surfaces contaminated during postmortem procedures 
should be decontaminated with an appropriate chemical germicide following recommendations in 
Appendix B, page 40. Many laboratories have more detailed standard operating procedures for 
conducting autopsies; where available, these should be followed. (More detailed recommendations for 
health-care workers in this setting are found in Appendix B, page 39.)
4. Forensic laboratories
Blood from all individuals should be considered infective. To supplement other worksite precautions, 
the following precautions are recommended for workers in forensic laboratories.
a. All specimens of blood should be put in a well-constructed, appropriately labelled container with 
a secure lid to prevent leaking during transport. Care should be taken when collecting each 
specimen to avoid contaminating the outside of the container and of the laboratory form 
accompanying the specimen.
b. AH persons processing blood specimens should wear gloves. Masks and protective eyewear or face 
shields should be worn if mucous-membrane contact with blood is anticipated (e.g., removing tops 
from vacuum tubes). Hands should be washed after completion of specimen processing.
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c. For routine procedures, such as histologic and pathologic studies or microbiological culturing, a 
biological safety cabinet is not necessary. However, biological safety cabinets (Class I or II) should 
be used whenever procedures are conducted that have a high potential for generating droplets. 
These include activities such as blending, sonicating, and vigorous mixing.
d. Mechanical pipetting devices should be used for manipulating all liquids in the laboratory. Mouth 
pipetting must not be done.
e. Use of needles and syringes should be limited to situations in which there is no alternative, and 
the recommendations for preventing injuries with needles outlined under universal precautions 
should be followed.
f. Laboratory work surfaces should be cleaned of visible materials and then decontaminated with an 
appropriate chemical germicide after a spill of blood, semen, or blood-contaminated body fluid and 
when work activities are completed.
g. Contaminated materials used in laboratory tests should be decontaminated before reprocessing 
or be placed in bags and disposed of in accordance with institutional and local regulatory policies 
for disposal of infective waste.
h. Scientific equipment that has been contaminated with blood should be cleaned and then 
decontaminated before being repaired in the laboratory or transported to the manufacturer.
L All persons should wash their hands after completing laboratory activities and should remove 
protective clothing before leaving the laboratory.
j. Area posting of warning signs should be considered to remind employees of continuing hazard of 
infectious disease transmission in the laboratory setting.
C. Correctional-Facility Considerations
1. Searches
Penetrating injuries are known to occur in the correctional-facility setting, and puncture wounds or 
needle sticks in particular pose a hazard during searches of prisoners or their cells. The following 
precautionary measures will help to reduce the risk of infection:
•  A correctional-facility officer should use great caution in searching the clothing of prisoners. 
Individual discretion, based on the circumstances at hand, should determine if a prisoner should 
empty his own pockets or if the officer should use his own skills in determining the contents 
of a prisoner’s clothing.
•  A safe distance should always be maintained between the officer and the prisoner.
•  Always carry a flashlight, even during daylight shifts, to search hidden areas. Whenever 
possible, use long-handled mirrors and flashlights to search such areas (e.g., under commodes, 
bunks, and in vents in jail cells).
•  Wear protective gloves if exposure to blood is likely to be encountered.
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•  Wear protective gloves for all body cavity searches.
Not all types of gloves are suitable for conducting searches. Vinyl or latex rubber gloves can provide 
little, if any, protection against sharp instruments, and they are not puncture-proof. There is a direct 
trade-off between level of protection and manipulability. In other words, the thicker the gloves, the 
more protection they provide, but the less effective they are in locating objects. Thus, there is no 
single type or thickness of glove appropriate for protection in all situations. Officers should select 
the type and thickness of glove which provides the best balance of protection and search efficiency.
2. . Decontamination and disposal
Prisoners may spit at officers and throw feces; sometimes these substances have been purposefully 
contaminated with blood. Although there are no documented cases of HTV or HBV transmission in 
this manner and transmission by this route would not be expected to occur, other diseases could be 
transmitted. These materials should be removed with a paper towel after donning gloves, and the area 
then decontaminated with an appropriate germicide. Following clean-up, soiled towels and gloves 
should be disposed of properly.
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VII. Tables
Tabic 1. The Risk of HIV Infection 
Following Needles tick Injury: Hypothetical Model
Probability of 
Infection Given Probability of Probability of Probability of
Prevalence Needlestick Injury Infection Given Infection Given Infection Given
of HIV with Blood Random Needlestick 10 Random 100 Random
Infection Containing HIV (Unknown Serostatus) Needles ticks Needlesticks
(A) (B) A * B = (C) l-(l-C )10 l-(l-C )100
0.0001 0.001 0.0000001 0.000001 0.00001
0.0001 0.005 0.0000005 0.000005 0.00005
0.001 0.001 0.000001 0.00001 0.0001
0.001 0.005 0.000005 0.00005 0.0005
0.01 0.001 0.00001 0.0001 0.001
0.01* 0.005 0.00005 0.0005 0.005
0.05 0.001 0.00005 0.0005 0.005
0.05 0.005 0.00025 0.0025 0.025
* For example, if the prevalence of infection in the population is 0.01 (Le., 1 per 100) and the risk 
of a seroconversion following a needlestick with blood known to contain HIV is 0.005 (Le., 1 in 
200), then the probability of HIV infection given a random needlestick is 0.00005 (Le., 5 in 
100,000). If an individual sustains 10 needlestick injuries, the probability of acquiring HIV 
infection is 0.0005 (Le., 1 in 2,000); if the individual sustains 100 needlestick injuries, the 
probability of acquiring HIV infection is 0.005 (Le., 1 in 200).
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Table 2.
HIV-infected health-care workers with no reported nonoccupational 
risk factors and for whom case histories have been
Case Occupation
published in the scientific literature 
Cases with Documented Seroconversion
Country Type of Exposure Source
1* NSt United States Needlestick AIDS patient
2 NS United States Needlestick AIDS patient
3 NS United States Needlestick AIDS patient
4 NS United States 2 Needlesticks AIDS patient,




6 Nurse England Needlestick AIDS patient
7 Nurse France Needlestick HIV-infected
8 Nurse Martinique Needlestick
patient 
AIDS patient
9 Research United States Cut with sharp Concentrated
10
lab worker 







NS United States Nonintact skin AIDS patient
12 Phlebotomist United States Mucous -membrane HIV-infected
13 Technologist United States Nonintact skin
patient
HIV-infected
14 NS United States Needlestick
patient 
AIDS patient
15 Nurse Italy Mucous membrane HIV-infected
16 Nurse France Needlestick
patient 
AIDS patient
17 Navy medic United States Needlestick AIDS patient
18 Clinical United States Cut with sharp AIDS patient
lab worker object
* AIDS case
t  Not specified
#  Mother who provided nursing care for her child with HTV infection; extensive contact with the child’s blood 
and body secretions and excretions occurred; the mother did not wear gloves and often did not wash her hands 
immediately after exposure.
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Table 2, continued 
HIV-infected health-care workers with no reported nonoccupational 
risk factors and for whom case histories have been published 
in the scientific literature
Cases without Documented Seroconversion
Case Occupation Country Type of Exposure Source
1 NS United States Puncture wound AIDS patient
2 NS United States 2 Needlesticks 2 AIDS patients
3 Research lab 
worker




England Nonintact skin AIDS patient
5 Dentist United States Multiple needle­
sticks
Unknown














Table 3. Summary of Task Categorization and 
Implications for Personal Protective Equipment
Personal protective equipment should be: 
Nature of Task/Activity Available? Worn?
Direct contact with blood Yes Yes
or other body fluids to which 
universal precautions apply
Activity performed without Yes No
blood exposure but exposure 
may occur in emergency
Task/activity does not entail No No
predictable or unpredictable 
exposure to blood
1 U.S. Department of Labor, U.S. Department of Health and Human Services. Joint advisory notice: 
protection against occupational exposure to hepatitis 6  virus (HBV) and human immunodeficiency virus 
(HIV). Washington, DC: US Department of Labor, US Department of Health and Human Services, 1987.
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Tabic 4. Examples of Recommended Personal Protective Equipment for






Bleeding control with 
with spurting blood
Yes Yes Yes Yes
Bleeding control with 
minimal bleeding
Yes No No No
Emergency childbirth Yes Yes Yes, if splashing 
is likely
Yes, if splashing 
is likely
Blood drawing At certain times 4 No No No
Starting an intravenous 
(IV) line
Yes No No No
Endotracheal intubation, 
esophageal obturator use
Yes No No, unless splashing 
is likely




Yes5 No No, unless splashing 
is likely
No, unless splashing 
is likely
Handling and cleaning 
instruments with 
microbial contamination
Yes No, unless sailing 
is likely
No No
Measuring blood pressure No No No No
Measuring temperature No No No No
Giving an injection No No No No
1The examples provided in this tab!« are based on application of universal precautions. Universal precautions are intended to supplement rather 
than replace recommendations for routine infection control, such as handwashing and using gloves to prevent gross microbial contamination 
of bands (e.g., contact with urine or feces).
2Defined as setting where delivery of emergency health care takes place away from a hospital or other health-care facility.
3Refers to protective masks to prevent exposure of mucous membranes to blood or other potentially contaminated body fluids. The use of
resuscitation devices, some of which are also referred to as “masks,” is discussed on page 16.
*For clarification see Appendix A, page 33, and Appendix B, page 38.
sWhile not dearly necessary to prevent HIV or HBV transmission unless blood is present, gloves are recommended to prevent transmission 
of other agents (e.g-, H e r p e s  s im p le x ) .





Table 5. Reprocessing Methods for Equipment Used in the 
Prehospital1 Health-Care Setting
Destroys: All forms of microbial life including high numbers of bacterial
spores.
Methods: Steam under pressure (autoclave), gas (ethylene oxide), dry heat,
or immersion in EPA-approved chemical “sterilant” for 
prolonged period of time, e.g., 6-10 hours or according to 
manufacturers’ instructions. Note: liquid chemical “sterilants” 
should be used only on those instruments that are impossible 
to sterilize or disinfect with heat.
Use: For those instruments or devices that penetrate skin or contact 
normally sterile areas of the body, e.g., scalpels, needles, etc. 
Disposable invasive equipment eliminates the need to reprocess 
these types of items. When indicated, however, arrangements 








All forms of microbial life except high numbers of bacterial 
spores.
Hot water pasteurization (80-100 C, 30 minutes) or exposure 
to an EPA-registered wsterilant” chemical as above, except for 
a short exposure time (10 — 45 minutes or as directed by the 
manufacturer).
For reusable instruments or devices that come into contact with 
mucous membranes (e.g., laryngoscope blades, endotracheal 
tubes, etc.).
Mycobacterium tuberculosis, vegetative bacteria, most viruses, 
and most fungi, but does not kill bacterial spores.
EPA-registered “hospital disinfectant” chemical germicides that 
have a label claim for tuberculocidal activity; commercially 
available hard-surface germicides or solutions containing at least 
500 ppm free available chlorine (a 1:100 dilution of common 
household bleach —approximately V* cup bleach per gallon of 
tap water).
For those surfaces that come into contact only with intact skin,
e.g., stethoscopes, blood pressure cuffs, splints, etc., and have 
been visibly contaminated with blood or bloody body fluids. 
Surfaces most be precleaned of visible material before the 
germicidal chemical is applied for disinfection.
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Low-Level Disinfection: Destroys:
Methods:
Most bacteria, some viruses, some fungi, but not Mycobacterium 
tuberculosis or bacterial spores.
HPA-registered “hospital disinfectants” (no label claim for 
tuberculocidal activity).
Use: These agents are excellent cleaners and can be used for routine 
housekeeping or removal of soiling in the absence of visible 
blood contamination.
Environmental Disinfection: Environmental surfaces which have become soiled should be
cleaned and disinfected using any cleaner or disinfectant agent 
which is intended for environmental use. Such surfaces include 
floors, woodwork, ambulance seats, countertops, etc
IMPORTANT: To assure the effectiveness of any sterilization or disinfection process, equipment
and instruments must first be thoroughly cleaned of all visible soil.
1 Defined as setting where delivery of emergency health-care takes place prior to arrival at hospital or other 
health-care facility.
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Appendix A  Update: Universal Precautions for Prevention of Transmission of Human Immunodeficiency 
Virus, Hepatitis B Virus, and Other Blood borne Pathogens in Health-Care Settings (Reprinted 
from Morbidity and Mortality Weekly Report, 1988; 37:377- 382,387,388.)
Introduction
The purpose of this report is to clarify and supplement the CDC publication entitled “Recommendations for Prevention of HIV 
Transmission in Health-Care Settings” (7).*
In 1983, CDC published a document entitled “Guideline for Isolation Precautions in Hospitals" (2 )  that contained a section entitled 
“Blood and Body Fluid Precautions.” The recommendations in this section called for blood and body fluid precautions when a patient 
was known or suspected to be infected with Mood borne pathogens. In August 1987, CDC published a document entitled 
“Recommendations for Prevention of HIV Transmission in Health-Care Settings" (/). In contrast to the 1983 document, the 1987 
document recommended that blood and body fluid precautions be consistently used for all patients regardless of their blood borne infection 
status. This extension of blood and body fluid precautions to all patients is referred to as “Universal Blood and Body Fluid Precautions” 
or "Universal Precautions.” Under universal precautions, blood and certain body fluids of all patients are considered potentially infectious 
for human immunodeficiency virus (HIV), hepatitis B virus (HBV), and other blood borne pathogens.
Universal precautions are intended to prevent parenteral, mucous membrane, and nonintact skin exposures of health-care workers to 
blood borne pathogens. In addition, Immunization with HBV vaccine is recommended as an important adjunct to universal precautions 
for health care workers who have exposures to blood (3 ,4 ) .
Since the recommendations for universal precautions were published in August 1987, CDC and the Food and Drug Administration (FDA) 
have received requests for clarification of the following issues: 1) body fluids to which universal precautions apply, 2 ) use of protective 
barriers, 3) use of gloves for phlebotomy, 4) selection of gloves for use while observing universal precautions, and 5) need for making 
changes in waste management programs as a result of adopting universal precautions.
Body Fluids to Which Universal Precautions Apply
Universal precautions apply to blood and to other body fluids containing visible blood. Occupational transmission of HIV and HBV to 
health-care workers by blood is documented (4 ,5 )- Blood is the single moat important source of HIV, HBV, and other bloodbome 
pathogens in the occupational setting. Infection control efforts for HIV, HBV, and other bloodbome pathogens most focus on 
preventing exposures to blood as well as on delivery of HBV Immunization.
Universal precautions also apply to semen and vaginal secretions. Although both of these fluids have been implicated in the sexual 
transmission of HIV and HBV, they have not been implicated in occupational transmission from patient to health-care worker. This 
observation is not unexpected, since exposure to semen in the usual health-care setting is limited, and the routine practice of wearing 
gloves for performing vaginal examinations protects health-care workers from exposure to potentially infectious vaginal secretions.
Universal precautions also apply to tissues and to the following fluids: cerebrospinal fluid (CSF), synovial fluid, pleural fluid, peritoneal 
fluid, pericardia] fluid, and amniotic fluid. The risk of transmission of HIV and HBV from these fluids is unknown; epidemiologic studies 
in the health-care and community setting are currently inadequate to assess the potential risk to health-care workers from occupational 
exposures to them. However, HIV has been isolated from CSF, synovial, and amniotic fluid ( 6 —8 ) , and HBsAg has been detected in 
synovial fluid, amniotic fluid, and peritoneal fluid (9 -/7 ). One case of HIV transmission was reported after a percutaneous exposure 
to bloody pleural fluid obtained by needle aspiration (1 2 ). Whereas aseptic procedures used to obtain these fluids for diagnostic or 
therapeutic purposes protect health-care workers from skin exposures, they cannot prevent penetrating injuries due to contaminated 
needles or other sharp instruments.
Body Fluids to Which Universal Precautions Do Not Apply
Universal precautions do not apply to feces, nasal secretions, sputum, sweat, tears, urine, and vomitus unless they contain visible blood. 
The risk of transmission of HIV and HBV from these fluids and materials is extremely low or nonexistent. HIV has been isolated and 
HBsAg has been demonstrated in some of these fluids; however, epidemiologic studies in the health-care and community setting have 
not implicated these fluids or materials in the transmission of HIV and HBV infections (1 3 ,1 4 ). Some of the above fluids and excretions
* The August 1987 publication should be consulted for general information and specific recommendations not addressed in this
update.
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represent a potential source for nosocomial and community-acquired infections with other pathogens, and recommendations for preventing 
the transmission of non-blood borne pathogens have been published (2 ).
Precautions for Other Body Fluids in Special Settings
Human breast milk has been implicated in perinatal transmission of HIV, and HBsAg has been found in the milk of mothers infected 
with HBV {1 0 ,1 3 ). However, occupational exposure to human breast milk has not been implicated in the transmission of HIV nor HBV 
infection to health-care workers. Moreover, the health-care worker will not have the same type of intensive exposure to breast milk as 
the nursing neonate. Whereas universal precautions do not apply to human breast milk, gloves may be worn by health-care workers in 
situations where exposures to breast milk might be frequent, for example, in breast milk banking.
Saliva of some persons infected with HBV bas been shown to contain HBV-DNA at concentrations 1/1,000 lo 1/10,000 of that found 
in the infected person’s scrum [ IS ) . HbsAg-positive saliva has been shown to be infectious when injected into experimental animals and 
in human bite exposures (1 6 -1 8 ) . However, HBsAg-posilive saliva has not been shown to be infectious when applied to oral mucous 
membranes in experimental primate studies (1 8 ) or through contamination of musical instruments or cardiopulmonary resuscitation 
dummies used by HBV carriers (1 9 ,2 0 ). Epidemiologic studies of nonsexual household contacts of HIV-infected patients, including several 
small series in which HIV transmission failed to occur after bites or after percutaneous inoculation or contamination of cuts and open 
wounds with saliva from HIV-infected patients, suggest that the potential for salivary transmission of HIV is remote (5 ,1 3 ,1 4 ,2 1 ,2 2 ). 
One case report from Germany has suggested the possibility of transmission erf HIV in a household setting from an infected child to a 
sibling through a human bite (23 ). The bite did not break the skin or result in bleeding. Since the date of seroconversion to HIV was 
not known for either child in this case, evidence for the role of saliva in the transmission of virus is unclear (2 3 ). Another case report 
suggested the possibility of transmission of HIV from husband to wife by contact with saliva during kissing (2 4 ). However, follow-up 
studies did not confina HIV infection in the wife (2 1 ).
Universal precautions do not apply to saliva. General infection control practices already in existence—including the use of gloves for 
digital examination of mucous membranes and endotracheal suctioning, and handwashing after exposure to saliva — should further minimtrg 
the minute risk, If any, for salivary transmission of HIV and HBV (7,25). Gloves need not be worn when feeding patients and when 
wiping saliva from the skin.
Special precautions, however, are recommended for dentistry (7). Occupationally acquired infection with HBV in dental workers has been 
documented (4), and two possible cases of occupationally acquired HIV infection involving dentists have been reported (5 ,2 6 ) . During 
dental procedures, contamination of saliva with blood is predictable, trauma to health-care workers hands is common, and blood 
spattering may occur. Infection control precautions for dentistry minimize the potential for nonintact skin and mucous membrane contact 
ofdental health-care workers to blood-contaminated saliva of patients. In addition, the use of gloves for oral examinations and treatment 
in the dental setting may also protect the patient's oral mucous membranes from exposures to blood, which may occur from breaks in 
the skin of dental workers’ hands.
Use of Protective Barriers
Protective barriers reduce the risk of exposure of the health-care worker's skin or mucous membranes to potentially infective materials. 
For universal precautions, protective barriers reduce the risk of exposure to blood, body fluids containing visible blood, and other fluids 
to which universal precautions apply. Examples of protective barriers include gloves, gowns, masks, and protective eyewear. Gloves 
should reduce the incidence of contamination of hands, but they cannot prevent penetrating injuries due to needles or other sharp 
instruments. Masks and protective eyewear or face shields should reduce the incidence of contamination of mucous membranes of the 
mouth, nose, and eyes.
Universal precautions are intended to supplement rather than replace recommendations for routine infection control, such as handwashing 
and using gloves to prevent gross microbial contamination of hands (2 7 ). Because specifying the types of barriers needed for every 
possible clinical situation is impractical, some judgment must be exercised.
The risk of nosocomial transmission of HIV, HBV, and other blood borne pathogens can be minimized if health-care workers use the 
following general guidelines:
1. Take care to prevent injuries when using needles, scalpels, and other sharp instruments or devices; when handling sharp 
instruments after procedures; when cleaning used instruments; and when disposing of used needles. Do not recap used 
needles by hand; do not remove used needles from disposable syringes by hand; and do not brad, break, or otherwise
* The August 1987 publication should be consulted for general information and specific recommendations not addressed in this
update.
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manipulate used needles by hand. Place used disposable syringes and needles, scalpel blades, and other sharp items in 
puncture-resistant containers for disposal. Locate the puncture-resistant containers as close to the use area as is practical.
2. Use protective barriers to prevent exposure to blood, body fluids containing visible blood, and other fluids to which universal 
precautions apply. The type of protective barrier(s) should be appropriate for the procedure being performed and the type 
of exposure anticipated.
3. Immediately and thoroughly wash bands and other skin surfaces that are contaminated with blood, body fluids containing 
visible blood, or other body fluids to which universal precautions apply.
Glove Use for Phlebotomy
Gloves should reduce the incidence of blood contamination of hands during phlebotomy (drawing blood samples), but they cannot prevent 
penetrating injuries caused by needles or other sharp instruments. The likelihood of band contamination with blood containing HIV, 
HBV, or other blood borne pathogens during phlebotomy depends on several factors: 1) the skill and technique of the health-care worker, 
2) the frequency with which the health-care worker performs the procedure (other factors being equal, the cumulative risk of blood 
exposure is higher for a health-care worker who performs more procedures), 3) whether the procedure occurs in a routine or emergency 
situation (where blood contact may be more likely), and 4) the prevalence of infection with blood borne pathogens in the patient 
population. The likelihood of infection after skin exposure to blood containing HTV or HBV will depend on the concentration of virus 
(viral concentration is much higher for hepatitis B than for HIV), the duration of contact, the presence of skin lesions on the hands of 
the health-care worker, and-for HBV—the immune status of the health-care worker. Although not accurately quantified, the risk of 
HIV infection following intact skin contact with infective blood is certainly much less than the 0.5% risk following percutaneous 
needlestick exposures (5). In universal precautions, all blood is assumed to be potentially infective for blood borne pathogens, but in 
certain settings (e.g., volunteer blood-donation centers) the prevalence of infection with some blood borne pathogens (e.g., HIV, HBV) 
is known to be very low. Some institutions have relaxed recommendations for using gloves for phlebotomy procedures by skilled 
phlebotomists in settings where the prevalence of blood borne pathogens is known to be very low.
Institutions that judge that routine gloving for all phlebotomies is not necessary should periodically reevaluate their policy. Gloves should 
always be available to health-care workers who wish to use them for phlebotomy. In addition, the following general guidelines apply:
1. Use gloves for performing phlebotomy when the health-care worker has cuts, scratches, or other breaks in his/her skin.
2. Use gloves in situations where the health-care worker judges that hand contamination with blood may occur, for example, 
when performing phlebotomy on an uncooperative patient.
3. Use gloves for performing finger and/or heel sticks on infants and children.
4. Use gloves when persons are receiving training in phlebotomy.
Selection of Gloves
The Center for Devices and Radiological Health, FDA, has responsibility for regulating the medical glove industry. Medical gloves 
include those marketed as sterile surgical or nonsterile examination gloves made of vinyl or latex. General purpose utility (“rubber”) 
gloves are also used in the health-care setting, but they are not regulated by FDA since they are not promoted for medical use. There 
are no reported differences io barrier effectiveness between intact latex and intact vinyl used to manufacture gloves. Thus, the type of 
gloves selected should be appropriate for the task being performed.
The following general guidelines are recommended:
1. Use sterile gloves for procedures involving contact with normally sterile areas of the body.
2. Use examination gloves for procedures involving contact with mucous membranes, unless otherwise indicated, and for other
patient care or diagnostic procedures that do not require the use of sterile gloves.
3. Change gloves between patient contacts.
4. Do not wash or disinfect surgical ex* examination gloves for reuse. Washing with surfactants may cause “wicking,” i.e., the 
enhanced penetration of liquids through undetected holes in the glove. Disinfecting agents may cause deterioration.
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5. Use general-purpose utility gloves (e,g., rubber household gloves) for housekeeping chores Involving potential blood contact 
and for instrument cleaning and decontamination procedures. Utility gloves may be decontaminated and reused but should 
be discarded if they are peeling, cracked, or discolored, or if they have punctures, tears, or other evidence of deterioration.
Waste Management
Universal precautions are not intended to change waste management programs previously recommended by CDC for health-care settings 
(1 ) . Policies for defining, collecting, storing, decontaminating, and disposing of infective waste are generally determined by institutions 
in accordance with state and local regulations. Information regarding waste management regulations in health-care settings may be 
obtained from state or local health departments or agencies responsible for waste management.
R e p o r te d  b y : C enter f o r  D ev ices a n d  R a d io lo g ica l H ea lth , F o o d  a n d  D r u g  A  ¿m in is tra tio n . H o s p ita l  I n fe c t io n s  P ro g ra m , A I D S  
P ro g ra m , a n d  H e p a tit is  B r , D iv  o f  V ira l D iseases, C enter f o r  I n fe c t io u s  D iseases, N a tio n a l In s titu te  f o r  O c c u p a tio n a l S a f e t y  a n d  
H e a lth , C D C .
Editorial Note: Implementation of universal precautions does not eliminate the need for other category- or disease-specific isolation 
precautions, such as enteric {«cautions for infectious diarrhea or isolation for pulmonary tuberculosis (1,2). In addition to universal 
precautions, detailed precautions have been developed for the following procedures and/or settings in which prolonged or intensive 
exposures to blood occur: invasive procedures, dentistry, autopsies or morticians’ services, dialysis, and the clinical laboratory. These 
detailed precautions are found in the August 21,1987, ’'Recommendations for Prevention of HIV Transmission in Health-Care Settings” 
(1 ) . In addition, specific precautions have been developed for research laboratories (28 ).
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Appendix B. Recommendations for Prevention of HIV Transmission in Health-Care Settings (Reprinted 
from Morbidity and Mortality Weekly Report 1987; 36 [no. 2S].) 
Introduction
Human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), is transmitted through sexual 
contact and exposure to infected blood or blood components and perina tally from mother to neonate. HIV has been isolated from Mood, 
semen, vaginal secretions, saliva, tears, breast milk, cerebrospinal fluid, amniotic fluid, and urine and is likely to be isolated from other 
body fluids, secretions, and excretions. However, epidemiologic evidence has implicated only blood, semen, vaginal secretions, and possibly 
breast milk in transmission.
The increasing prevalence of HIV increases the risk that health-care workers will be exposed to blood from patients infected with HIV, 
especially when blood and body-fluid precautions are not foil owed for all patients. Thus, this document emphasizes the need for 
health-care workers to consider afl patients as potentially infected with HTV and /or other blood-borne pathogens and to adhere rigorously 
to infection-control precautions for minimizing the risk of exposure to blood and body fluids of all patients.
The recommendations contained in this document consolidate and update CDC recommendations published earlier for preventing HIV 
transmission in health-care settings: precautions for clinical and laboratory staffs (/)  and precautions for health-care workers and allied 
professionals (2); recommendations for preventing HIV transmission in the workplace (J) and during invasive procedures {4)\ 
recommendations for preventing possible transmission of HIV from tears (5); and recommendations for providing dialysis treatment for 
HIV-infected patients (0). These recommendations also update portions of the “Guideline for Isolation Precautions in Hospitals" (7) 
and reemphasize some of the recommendations contained in ‘Infection Control Practices for Dentistry" (5). The recommendations 
contained in this document have been developed for use In health-care settings and emphasize the need to treat Mood and other body 
fluids from all patients as potentially infective. These same prudent precautions also should be taken in other settings in which persons 
may be exposed to blood or other body fluids.
Definition of Health-Care Workers
Health-care wprkers are defined as persons, including students and trainees, whose activities involve contact with patients or with blood 
or other body fluids from patients in a health-care setting.
Health-Care Workers with AIDS
As of July 10,1987, a total of 1,875 (5-8%) of 32^395 adults with AIDS, who had been reported to the CDC national surveillance system 
and for whom occupational information was available, reported being employed in a health-care or clinical laboratory setting. In 
comparison, 6.8 million person*—representing 5.6% of the U.S. labor force—were employed in health services. Of the health-care workers 
with AIDS, 95% have been reported to exhibit high-risk behavior; for the remaining 5%, the means of HIV acquisition was undetermined. 
Health-care worked with AIDS were significantly more likely than other workers to have an undetermined risk (5% versus 3%, 
respectively). For both health-care and non-health-care workers with AIDS, the proportion with an undetermined risk has not increased 
since 1982.
AIDS patients initially reported as not belonging to recognized risk groups are investigated by state and local health departments to 
determine whether possible risk factors cast. Of all health-care workers with AIDS reported to CDC who were initially characterized 
as not having an identified risk and for whom follow-up information was available, 66% have been reclassified because risk factors were 
identified or because the patient was found not to meet the surveillance case definition for AIDS. Of the 87 health-care workers currently 
categorized as having no identifiable risk, information is incomplete on 16 (18%) because of death or refusal to be interviewed; 38 (44%) 
are still being investigated. The remaining 33 (38%) health-care workers were interviewed or had other follow-up information available. 
The occupations of these 33 were as follows: five physicians (15%), three of whom were surgeons; one dentist (3%); three nurses (9%); 
nine nursing assistants (27%); seven housekeeping or maintenance workers (21%); three clinical laboratory technicians (9%); one therapist 
(3%); and four others who did not have contact with patients (12%). Although 15 of these 33 health-care workers reported parenteral 
and/or other non-needlestick exposure to Mood or body fluids from patients in the 10 yean preceding their diagnosis of AIDS, none of 
these exposures involved a patient with AIDS or known HIV infection.
Risk to Health-Care Workers of Acquiring HIV In Health-Care Settings
Health-care workers with documented percutaneous or mucous-membrane exposures to blood or body fluids of HIV-infected patients 
have been prospcctivefy evaluated to determine the risk of infection after such exposures. As of June 30,1987,883 health-care workers 
have been tested for antibody to HIV in an ongoing surveillance project conducted by CDC (0). Of these, 708 (80%) had percutaneous 
exposures to Mood, and 175 (20%) had a mucous membrane or an open wound contaminated by Mood or body fluid. Of 396 health­
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care workers, each of whom had only a convalescent-phase serum sample obtained and tested j>90 days postexposure, one—for whom 
heterosexual transmission could not be ruled out—was seropositive for HIV antibody. For 425 additional health care workers, both acute- 
and convalescent-phase serum samples were obtained and tested; none of 74 health-care workers with nonpercutaneous exposures 
seroconverted, and three (0.9% ) of 351 with percutaneous exposures seroconverted. None of these three health-care workers had other 
documented risk factors for infection.
Two other prospective studies to assess the risk of nosocomial acquisition of HIV infection for health-care workers are ongoing in the 
United States. As of April 30,1987,332 health-care workers with a total of 453 needlestick or mucous-membrane exposures to the blood 
or other body fluids of HIV-infected patients were tested for HIV antibody at the National Institutes of Health (10 ). These exposed 
workers included 103 with needlestick Injuries and 229 with mucous-membrane exposures; none had seroconverted. A similar study at 
the University of California of 129 health care workers with documented needlestick injuries or mucous-membrane exposures to blood 
or other body fluids from patients with HIV infection has not identified any seroconversion* (11). Results of a prospective study in the 
United Kingdom identified no evidence of transmission among 150 health-care workers with parenteral or mucous-membrane exposures 
to blood or other body fluids, secretions, or excretions from patients with HIV infection (12).
In addition to health-care workers enrolled in prospective studies, eight persons who provided care to infected patients and denied other 
risk factors have been reported to have acquired HIV infection. Three of these health-care workers had needlestick exposures to blood 
from infected patients (13-15). Two were persons who provided nursing care to infected persons; although neither sustained a needlestick, 
both had extensive contact with blood or other body fluids, and neither observed recommended barrier precautions (1 6 ,1 7 ) . The other 
three were health-care workers with non-needles lick exposures to blood from infected patients (1 8 ). Although the exact route of 
transmission for these last three infections is not known, all three persons had direct contact of their skin with blood from infected 
patients, all had skin lesions that may have been contaminated by blood, and one also had a mucous-membrane exposure.
A total of 1,231 dentists and hygienlsts, many of whom practiced in areas with many AIDS cases, participated in a study to determine 
the prevalence of antibody to HIV; one dentist (0.1%) had HIV antibody. Although no exposure to a known HIV-infected person could 
be documented, epidemiologic investigation did not identify any other risk factor for infection. The infected dentist, who also had a 
history of sustaining needlestick injuries and trauma to his hands, did not routinely wear gloves when providing dental care (19).
Precautions To Prevent Transmission of HIV
Universal Precautions
Since medical history and examination cannot reliably identify all patients infected with HIV or other blood borne pathogens, blood and 
body-fluid precautions should be consistently used for aU patients. This approach, previously recommended by CDC (3 ,4 ) , and referred 
to as "universal blood and body-fluid precautions” or “universal precautions," should be used in the care of aU patients, especially 
including those in emergency-care lettings In which the risk of Mood exposure is increased and the infection status of the patient is usually 
unknown (2 0 ).
1. AU health-care workers should routinely use appropriate barrier precautions to prevent skin and mucous-membrane exposure when 
contact with blood or other body fluids of any patient is anticipated. Gloves should be worn for touching blood and body fluids, 
mucous membranes, or non-intact skin of all patients, for handling items or surfaces soiled with blood or body fluids, and for 
performing venipuncture and other vascular access procedures. Gloves should be changed after contact with each patient Masks and 
protective eyewear or face shields should be worn during procedures that are likely to generate droplets of blood or other body fluids 
to prevent exposure of mucous membranes of the mouth, nose, and eyes. Gowns or aprons should be worn during procedures that 
are likely to generate splashes of blood or other body fluids.
2. Hands and other skin surfaces should be washed immediately and thoroughly if contaminated with blood or other body fluids. Hands 
should be washed immediately after gloves are removed.
3. All health-care workers should take precautions to prevail injuries caused by needles, scalpels, and other sharp instruments or devices 
during procedures; when cleaning used Instruments; during disposal of used needles; and when handling sharp instruments after 
procedures. To prevent needlestick injuries, needles should not be recapped, purposely bent or broken by hand, removed from 
disposable syringes, or otherwise manipulated by hand. After they are used, disposable syringes and needles, scalpel blades, and other 
sharp items should be placed in puncture-resistant containers for disposal; the puncture-resistant containers should be located as close 
as practical to the use area. Large-bore reusable needles should be placed in a puncture-resistant container for transport to the 
reprocessing area.
4. Although saliva has not been implicated in HIV transmission, to minimize the need for emergency mouth-to-mouth resuscitation, 
mouthpieces, resuscitation bags, or other ventilation devices should be available for use in areas in which the need for resuscitation 
is predictable.
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5. Health-care workers who have exudative lesions or weeping dermatitis should refrain from all direct patient care and from handling 
patient-care equipment until the condition resolves.
6. Pregnant health-care workers are not known to be at greater risk of contracting HIV infection than health-care workers who are not 
pregnant; however, if a health-care worker develops HIV infection during pregnancy, the infant b at risk of infection resulting from 
perinatal transmission. Because of this risk, pregnant health-care workers should be especially familiar with and strictly adhere to 
precautions to minimi« the risk of HIV transmission.
Implementation of universal blood and body-fluid precautions for aU patients eliminates the need for use of the isolation category of 
"Blood and Body Fluid Precautions” previously recommended by CDC (7) for patients known or suspected to be infected with blood- 
borne pathogens. Isolation precautions (e.g., enteric, "AFB” [7]) should be used as necessary if associated conditions, such as infectious 
diarrhea or tuberculosis, are diagnosed or suspected.
Precautions for Invasive Procedures
In this document, an invasive procedure is defined as surgical entry into tissues, cavities, or organs or repair of major traumatic injuries 
1) in an operating or delivery room, emergency department, or outpatient setting, including both physicians’ and dentists1 offices; 2 )  
cardiac catheterization and angiographic procedures; 3) a vaginal or cesarean delivery or other invasive obstetric procedure during which 
bleeding may occur; or 4) the manipulation, cutting, or removal of any oral or perioral tissues, including tooth structure, during which 
bleeding occurs or the potential for Weeding exists. The universal blood and body-fluid precautions listed above, combined with the 
precautions listed below, should be the minimum precautions for all such invasive procedures.
1. All health-care workers who participate in invasive procedures must routinely use appropriate barrier precautions to prevent skin 
and mucous-membrane contact with blood and other body fluids of all patients. Gloves and surgical masks must be worn for all 
invasive procedures. Protective eyewear or face shields should be worn for procedures that commonly result in the generation of 
droplets, splashing of Mood or other body fluids, or the generation of bone chips. Gowns or aprons made of materials that provide 
an effective barrier should be worn during invasive procedures that are likely to result in the splashing of Mood or other body fluids. 
AD health-care workers who perform or assist in vaginal or cesarean deliveries should wear gloves and gowns when handling the 
placenta or the infant until Mood and amniotic Quid have been removed bom the infant's «Hn and should wear gloves during post­
delivery care of the umbilical cord.
2. If a glove is torn or a needlestick or other injury occurs, the glove should be removed and a new glove used as promptly as patient 
safety permits; the needle or instrument involved in the incident should also be removed bom the sterile field.
Precautions for Den Us try*
Blood, saliva, and gingival Quid bom an dental patients should be considered infective. Special emphasis should be placed on the 
following precautions for preventing transmission of Mood-borne pathogens in dental practice in both institutional and non-Institutional 
settings.
1. In addition to wearing gloves for contact with oral mucous membranes of all patients, all dental workers should wear surgical masks 
and protective eyewear or chin-length plastic face shields during dental procedures in which splashing or spattering of Mood, saliva, 
or gingival fluids is likely. Rubber dams, high-speed evacuation, and proper patient positioning, when appropriate, should be utilized 
to minimize generation of droplets and spatter.
2. Handpieces should be sterilized after use with each patient, since Mood, saliva, or gingival fluid of patients may be aspirated into 
the handpiece or waterline. Handpieces that cannot be sterilized should at least be flushed, the outside surface cleaned and wiped 
with a suitable chemical germicide, and then rinsed. Handpieces should be flushed at the beginning of the day and after use with 
each patient Manufacturers' recommendations should be followed for use and maintenance of waterline* and check valves and for 
flushing of handpieces. The same precautions should be used for ultrasonic scalers and air/water syringes.
3. Blood and saliva should be thoroughly and carefully deaned bom material that has been used in the mouth (e.g., impression 
materials, bite registration), especially before polishing and grinding intra-oral devices. Contaminated materials, impressions, and 
intra-oral devices should also be deaned and disinfected before being handled in the dental laboratory and before they are placed 
in the patient's mouth. Because of the increasing variety of dental materials used in tra-orally, dental workers should consult with 
manufacturers as to the stability of specific materials when using disinfection procedures.
* General infection-control precautions are more specifically addressed in previous recommendations for infection-control practices 
for dentistry (8 ).
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4. Dental equipment and surfaces that are difficult to disinfect (e.g., light handles or X-ray-unit heads) and that may become 
contaminated should be wrapped with impervious-backed paper, aluminum foil, or clear plastic wrap. The coverings should be 
removed and discarded, and clean coverings should be put in place after use with each patient.
Precautions for Autopsies or Morticians’ Services
In addition to the universal Mood and body-fluid precautions listed above, the following precautions should be used by persons performing 
postmortem procedures:
1. All persons performing or assisting in postmortem procedures should wear gloves, masks, protective eyewear, gowns, and waterproof 
aprons.
2. Instruments and surfaces contaminated during postmortem procedures should be decontaminated with an appropriate chemical 
germicide.
Precautions for Dialysis
Patients with end-stage renal disease who are undergoing maintenance dialysis and who have HIV infection can be dialyzed in hospital' 
based or free-standing dialysis units using conventional infection-control precautions (2 1 ). Universal blood and body-fluid precautions 
should be used when dialyzing aU patients.
Strategies for disinfecting the dialysis fluid pathways of the hemodialysis machine are targeted to control bacterial contamination and 
generally consist of using 500-750 parts per million (ppm) of sodium hypochlorite (household bleach) for 30-40 minutes or 1.5%-2.0% 
formaldehyde overnight. In addition, several chemical germicides formulated to disinfect dialysis machines are commercially available. 
None of these protocols or procedures need to be changed for dialyzing patients infected with HIV.
Patients infected with HIV can be dialyzed by either hemodialysis or peritoneal dialysis and do not need to be isolated from other patients. 
The* type of dialysis treatment (i.e., hemodialysis or peritoneal dialysis) should be based on the needs of the patient. The diatyzer may 
be discarded after each use. Alternatively, centers that reuse dialyzers —i.e., a specific single-use diatyzer is issued to a specific patient, 
removed, cleaned, disinfected, and reused several times on the same patient only-may include HIV-infected patients in the diatyzer 
reuse program. An individual dialyzer must never be used on more than one patient.
Precautions for Laboratories
Blood and other body fluids from all patients should be considered infective. To supplement the universal blood and body-fluid 
precautions listed above, the following precautions are recommended for health-care workers in clinical laboratories.
1. All specimens of Mood and body fluids should be put in a well-constructed container with a secure lid to prevent leaking during 
transport. Care should be taken when collecting each specimen to avoid contaminating the outside of the container and of the 
laboratory form accompanying the specimen.
2. All persons processing blood and body-fluid specimens (e.g., removing tops from vacuum tubes) should wear gloves. Masks and 
protective eyewear should be worn if mucous-membrane contact with blood or body fluids is anticipated. Gloves should be changed 
and hands washed after completion of specimen processing.
3. For routine procedures, such as histologic and pathologic studies or micro biologic culturing, a biological safety cabinet is not 
necessary. However, biological safety cabinets (Class I or II) should be used whenever procedures are conducted that have a high 
potential for generating droplets. These include activities such as blending, sonicating, and vigorous mixing.
4. Mechanical pipetting devices should be used for manipulating all liquids in the laboratory. Mouth pipetting must not be done.
5. Use of needles and syringes should be limited to situations in which there is no alternative, and the recommendations for preventing 
injuries with needles outlined under universal precautions should be followed.
6. Laboratory work surfaces should be decontaminated with an appropriate chemical germicide after a spill of blood or other body 
fluids and when work activities are completed.
* Additional precautions for research and industrial laboratories are addressed elsewhere (2 2 ,2 3 ).
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7. Contaminated materials used in laboratory tests should be decontaminated before reprocessing or be placed in hags and disposed 
of in accordance with institutional policies for disposal of infective waste (2 4 ).
8. Scientific equipment that has been contaminated with blood or other body fluids should be decontaminated and cleaned before being 
repaired in the laboratory or transported to the manufacturer.
9. All persons should wash their hands after completing laboratory activities and should remove protective clothing before leaving the 
laboratory.
Implementation of universal blood and body-fluid precautions for all patients eliminates the need for warning labels on specimens since 
blood and other body fluids from all patients should be considered infective.
Environmental Considerations for HIV Transmission
No environmentally mediated mode of HIV transmission has been documented. Nevertheless, the precautions described below should 
be taken routinely in the care of aU patients.
Sterilization and Disinfection
Standard sterilization and disinfection procedures for patient-care equipment currently recommended for use (2 5 ,2 6 ) in a variety of health­
care settings—including hospitals, medical and dental clinics and offices, hemodialysis centers, emergency-care facilities, and long-term 
nursing-care facilities—are adequate to sterilize or disinfect instruments, devices, or other items contaminated with blood or other body 
fluids from persons infected with Wood-borne pathogens including HIV (2 1 ,2 3 ).
Instruments or devices that enter sterile tissue or the vascular system of any patient or through which blood flows should be sterilized 
before reuse. Devices or items that contact intact mucous membranes should be sterilized or receive high-level disinfection, a procedure 
that kills vegetative organisms and viruses but not necessarily large numbers of bacterial spores. Chemical germicides that are registered 
with the U.S. Environmental Protection Agency (EPA) as "sterilants" may be used either for sterilization or for high-level disinfection 
depending on contact time.
Contact lenses used in trial fittings should be disinfected after each fitting by using a hydrogen peroxide contact lens disinfecting system 
or, if compatible, with heat (78 C-80 C [172.4 F-17G.0 F]) for 10 minutes.
Medical devices or instruments that require sterilization or disinfection should be thoroughly cleaned before being exposed to the 
germicide, and the manufacturer’s instructions for the use of the germicide should be followed. Further, it is important that the 
manufacturer’s specifications for compatibility of the medical device with chemical germicides be closely followed. Information on specific 
label claims of commercial germicides can be obtained by writing to the Disinfectants Branch, Office of Pesticides, Environmental 
Protection Agency, 401 M Street, SW, Washington, D C. 20460.
Studies have shown that HIV is inactivated rapidly after being exposed to commonly used chemical germicides at concentrations that are 
much lower than used in practice (2 7 -3 0 ) . Embalming fluids are similar to the types of chemical germicides that have been tested and 
found to completely inactivate HIV. In addition to commercially available chemical germicides, a solution of sodium hypochlorite 
(household bleach) prepared daily is an inexpensive and effective germicide. Concentrations ranging from approximately 500 ppm (1:100 
dilution of household bleach) sodium hypochlorite to 5000 ppm (1:10 dilution of household bleach) are effective depending on the amount 
of organic material (eg., blood, mucus) present on the surface to be cleaned and disinfected. Commercially available chemical germicides 
may be more compatible with certain medical devices that might be corroded by repeated exposure to sodium hypochlorite, especially 
to the 1:10 dilution.
Sarrival of HIV In the Environment
The most extensive study on the survival of HIV after drying involved greatly concentrated HTV samples, i.e., 10 million tissue-culture 
infectious doses per milliliter (3/)- This concentration is at least 100,000 times greater than that typically found in the blood or serum 
of patients with HTV infection. HIV was detectable by tissue-culture techniques 1-3 days after drying, but the rate of inactivation was 
rapid. Studies performed at CDC have also shown that drying HTV causes a rapid (within several hours) 1-2 log (9 0 % -9 9 % )  reduction 
in HTV concentration. In tissue-culture fluid, cell-free HIV could be detected up to 15 days at room temperature, up to 11 days at 37 
C (98.6 F)f and up to 1 day if the HTV was cell-associated.
When considered in the context of environmental conditions in health-care facilities, these results do not require any changes in currently 
recommended sterilization, disinfection, or housekeeping strategies. When medical devices are contaminated with Wood or other body 
fluids, costing recommendations indude the cleaning of these instruments, followed by disinfection or sterilization, depending on the type
Centers for Disease Control, February 1989 41
of medical device. These protocols assume “worst-case'’ conditions of extreme virologic and microbiological contamination, and whether 
viruses have been inactivated after drying plays no role in formulating these strategies. Consequently, no changes in published procedures 
for cleaning, disinfecting, or sterilizing need to be made.
Housekeeping
Environmental surfaces such as walls, floors, and other surfaces are not associated with transmission of infections to patients or 
health-care workers. Therefore, extraordinary attempts to disinfect or sterilize these environmental surfaces are not necessary. However, 
cleaning and removal of soil should be done routinely.
Cleaning schedules and methods vary according to the area of the hospital or institution, type of surface to be cleaned, and the amount 
and type of soil present. Horizontal surfaces (e.g., bedside tables and hard-surfaced flooring) in patient-care areas are usually cleaned 
on a regular basis, when soiling or spills occur, and when a patient is discharged. Cleaning of walls, blinds, and curtains is recommended 
only if they are visibly soiled. Disinfectant fogging is an unsatisfactory method of decontaminating air and surfaces and is not 
recommended.
Disinfectant-detergent formulations registered by EPA can be used for cleaning environmental surfaces, but the actual physical removal 
of microorganisms by scrubbing is probably at least as important as any antimicrobial effect of the cleaning agent used. Therefore, cost, 
safety, and acceptability by housekeepers can be the main criteria for selecting any such registered agent. The manufacturers’ instructions 
for appropriate use should be followed.
Cleaning and Decontaminating Spills of Blood or Other Body Fluids
Chemical germicides that are approved for us« as “hospital disinfectants” and are tuberculocidal when used at recommended dilutions 
can be used to decontaminate spills of blood and other body fluids. Strategies for decontaminating spills of blood and other body fluids 
in a patient-care setting are different than for spills of cultures or other materials in clinical, public health, or research laboratories. In 
patient-care areas, visible material should first be removed and then the area should be decontaminated. With large spills of cultured 
or concentrated infectious agents in the laboratory, the contaminated area should be flooded with a liquid germicide before cleaning, then 
decontaminated with fresh germicidal chemical. In both settings, gloves should be worn during the cleaning and decontaminating 
procedures.
Laundry
Although soiled linen has been identified as a source of large numbers of certain pathogenic microorganisms, the risk of actual disease 
transmission is negligible. Rather than rigid procedures and specifications, hygienic and common-sense storage and processing of clean 
and soiled lined are recommended (2 6 ). Soiled linen should be handled as little as possible and with minimum agitation to prevent gross 
microbial contamination of the air and of persons handling the linen. All soiled linen should be bagged at the location where it was used; 
it should not be sorted or rinsed in patient-care areas. Linen soiled with blood or body fluids should be placed and transported in bags 
that prevent leakage. If hot water is used, linen should be washed with detergent in water at least 71 C (160 F) for 25 minutes. If 
low-temperature ( < 70 C [158 F]) laundry cycles are used, chemicals suitable for low-temperature washing at proper use concentration 
should be used.
Infective Waste
There is no epidemiologic evidence to suggest that most hospital waste is any more infective than residential waste. Moreover, there is 
no epidemiologic evidence that hospital waste has caused disease in the community as a result of improper disposal. Therefore, identifying 
wastes for which special precautions are indicated is largely a matter of judgment about the relative risk of disease transmission. The 
most practical approach to the management of infective waste is to identify those wastes wilh the potential for causing infection during 
handling and disposal and for which some special precautions appear prudent. Hospital wastes for which special precautions appear 
prudent include microbiology laboratory waste, pathology waste, and blood specimens or blood products. While any item that has had 
contact with blood, exudates, or secretions may be potentially infective, it is not usually considered practical or necessary to treat all such 
waste as infective (2 3 ,2 6 ) . Infective waste, in general, should either be incinerated or should be autoc laved before disposal in a sanitary 
landfill. Bulk blood, suctioned fluids, excretions, and secretions may be carefully poured down a drain connected to a sanitary sewer. 
Sanitary sewers may also be used to dispose of other infectious wastes capable of being ground and flushed into the sewer.
Implementation of Recommended Precautions
Employers of health-care workers should ensure that policies exist for
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1. Initial orientation and continuing education and training of all health-care workers—including students and trainees —on the 
epidemiology, modes or transmission, and prevention of HIV and other blood-borne infections and the need for routine use of 
universal Mood and body-fluid precautions for aU patients.
2. Provision of equipment and supplies necessary to minimize the risk of infection with HIV and other blood-bome pathogens.
3. Monitoring adherence to recommended protective measures. When monitoring reveals a failure to follow recommended precautions, 
counseling, education, and/or re-training should be provided, and, if necessary, appropriate disciplinary action should be considered.
Professional associations and labor organizations, through continuing education efforts, should emphasize the need for health-care workers 
to follow recommended precautions.
Serologic Testing for HIV Infection
Background
A person is identified as infected with HIV when a sequence of tests, starting with repeated enzyme immunoassays (EIA) and including 
a Western blot or similar, more specific assay, are repeatedly reactive. Persons infected with HIV usually develop antibody against the 
virus within 6-12 weeks after infection.
The sensitivity of the currently licensed EIA tests is at least 99% when they are performed under optimal laboratory conditions on serum 
specimens from persons infected for > 12 weeks. Optimal laboratory conditions indude the use of reliable reagents, provision of 
continuing education of personnel, quality control of procedures, and participation in performance-evaluation programs. Given this 
performance, the probability of a false-negative test is remote except during the first several weeks after infection, before detectable 
antibody is present. The proportion of infected persons with a false-negative test attributed to absence of antibody in the early stages 
of Infection is dependent on both the incidence and prevalence of HTV infection in a population (Table 1).
Table I. Estimated awtiaal number of patients Infected with HIV 
















5.0% 1.0% 550 17-18
5.0% 0 3 % 525 11-12
1.0% 0 .2 % 110 3-4
1.0% 0.1% 105 2-3
0.1% 0.02% 11 0-1
0.1% 0.01% 11 0-1
•The estimates are based on the following assumptions: 1) the sensitivity of the screening test is 99% (i.e., 99% erf HIV-infected persons 
with antibody will be detected); 2) persons infected with HIV will not develop detectable antibody (seroconvert) until 6 weeks (1.5 
months) after infection; 3) new infections occur at an equal rate throughout the year; 4) calculations of the number erf HIV-infected 
persons in the patient population are based on the mid-year prevalence, which is the beginning prevalence plus half the annual incidence 
of infections.
Hie specificity of the currently licensed EIA tests is approximately 99% when repeatedly reactive tests are considered. Repeat testing 
of initially reactive specimens by EIA is required to reduce the likelihood of laboratory error. To increase further the specificity erf 
serologic tests, laboratories must use a supplemental test, most often the Western blot, to validate repeatedly reactive EIA results. Under 
optimal laboratory conditions, the sensitivity of the Western blot test is comparable to or greater than that of a repeatedly reactive EIA, 
and the Western Mot is highly specific when strict criteria are used to interpret the test results. The testing sequence of a repeatedly 
reactive EIA and a positive Western Mot test is highly predictive of HIV infection, even in a population with a low prevalence of infection 
(Table 2). If the Western blot test result is «determinant, the testing is considered equivocal for HIV infection. When this occurs, the 
Western Mot test should be repeated on the same serum sample, and, if still indeterminant, the testing sequence should be repeated on
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a sample collected 3-6 months later. Use of other supplemental tests may aid in interpreting of results on samples that are persistently 
indeterminant by Western blot.





Repeatedly reactive 0.2% 28.41%
enzyme immunoassay (EIA)t 2.0% 80.16%
20.0% 98.02%
Repeatedly reactive EIA 0.2% 99.75%
followed by positive 2.0% 99.97%
Western blot (WB)t 20.0% 99.99%
'Proportion of persons with positive test results who are actually infected with HIV. 
tAssumes EIA sensitivity of 99.0% and specificity of 99>5%.
(Assumes WB sensitivity of 99.0% and specificity of 99.9%.
Testing of Patients
Previous CDC recommendations have emphasized the value of HIV serologic testing of patients for 1) management of parenteral or 
mucous-membmie exposures of health-care workers, 2) patient diagnosis and management, and 3) counseling and serologic testing to 
prevent and control HTV transmission in the community. In addition, more recent recommendations have stated that hospitals, in 
conjunction with state and local health departments, should periodically determine the prevalence of HIV infection among patients from 
age groups at highest risk of infection (52).
Adherence to universal blood and body-fluid precautions recommended for the care of all patients will minimize the risk of transmission 
of HIV and other blood-borne pathogens from patients to health-care workers. The utility of routine HIV serologic testing of patients 
as an adjunct to universal precautions is unknown. Results of such testing may not be available in emergency or outpatient settings. In 
addition, some recently infected patients will not have detectable antibody to HIV (Table 1).
Personnel in some hospitals have advocated serologic testing of patients in settings in which exposure of health-care workers to large 
amounts of patients’ Mood may be anticipated. Specific patients for whom serologic testing has been advocated include those undergoing 
major operative procedures and those undergoing treatment in critical-care units, especially If they have conditions involving uncontrolled 
bleeding. Decisions regarding the need to establish testing programs for patients should be made by physicians or individual institutions. 
In addition, when deemed appropriate, testing of individual patients may be performed on agreement between the patient and the 
physician providing care.
In addition to the universal precautions recommended for all patients, certain additional precautions for the care of HIV-infected patients 
undergoing major surgical operations have been proposed by personnel in some hospitals. For example, surgical procedures on an HIV- 
infected patient might be altered so that hand-to-hand passing of sharp instruments would be eliminated; stapling instruments rather than 
hand-suturing equipment might be used to perform tissue approximation; electrocautery devices rather than scalpels might be used as 
cutting instruments; and, even though uncomfortable, gowns that totally prevent seepage of blood onto the skin of members of the 
operative team might be worn. While such modifications might further minimize the risk of HIV infection for members of the operative 
team, some of these techniques could result in prolongation of operative time and could potentially have an adverse effect on the patient.
Testing programs, if developed, should include the following principles:
•  Obtaining consent for testing.
•  Informing patients of test results, and providing counseling for seropositive patients by property trained persons.
•  Assuring that confidentiality safeguards are in place to limit knowledge of test results to those directly involved In the care 
of infected patients or as required by law.
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•  Assuring that identification of infected patients will not result in denial of needed care or provision of suboptimal care.
•  Evaluating prespectively 1) the efficacy of the program in reducing the incidence of parenteral, mucous-membrane, or 
significant cutaneous exposures of health-care workers to the blood or other body fluids of HIV-infected patients and 2) 
the effect of modified procedures on patients.
Testing of Health-Care Workers
Although transmission of HIV from infected health-care workers to patients has not been reported, transmission during invasive 
procedures remains a possibility. Transmission of hepatitis B (HBV)—a blood-borne agent with a considerably greater potential for 
nosocomial spreadnfrom health-care workers to patients has been documented. Such transmission has occurred in situations (e.g., oral 
and gynecologic surgery) in which health-care workers, when tested, had very high concentrations of HBV in their blood (at least 100 
million infectious virus particles per milliliter, a concentration much higher than occurs with HIV infection), and the health-care workers 
sustained a puncture wound while performing invasive procedures or bad exudative or weeping lesions or microlacerations that allowed 
virus to contaminate instruments or open wounds of patients (3 3 ,3 4 ).
The hepatitis B experience indicates that only those health-care workers who perform certain types of invasive procedures have 
transmitted HBV to patients. Adherence to recommendations in this document will minimize the risk of transmission of HIV and other 
blood-borne pathogens from health-care workers to patients during invasive procedures. Since transmission of HIV from infected health­
care workers performing invasive procedures to their patients has not been reported and would be expected to occur only very rarely, 
if at all, the utility of routine resting of such health-care workers to prevent transmission of HIV cannot be assessed. If consideration 
is given to developing a serologic testing program for health-care workers who perform invasive procedures, the frequency of testing, as 
well as the issues of consent, confidentiality, and consequences of test results—as previously outlined for testing programs for 
patients —must be addressed.
Management of Infected Health-Care Workers
Health-care workers with impaired immune systems resulting from HIV infection or other causes are at increased risk of acquiring or 
experiencing serious complications of infectious disease. Of particular concern is the risk of severe infection following exposure to 
patients with infectious diseases that are easily transmitted if appropriate precautions are not taken (e.g., measles, varicella). Any health­
care worker with an impaired immune system should be counseled about the potential risk associated with taking care of patients with 
any transmissible infection and should continue to follow existing recommendations for infection control to minimize risk of exposure 
to other infectious agents (7 ,3 5 ) . Recommendations of the Immunization Practices Advisory Committee (ACIP) and institutional policies 
concerning requirements for vaccinating health-care workers with live-viros vaccines (e.g., measles, rubella) should also be considered.
The question of whether workers infected with HIV—especially those who perform invasive procedures—can adequately and safely be 
allowed to perform patient-care duties or whether their work assignments should be changed must be determined on an individual basis. 
These decisions should be made by the health-care worker’s personal pbysician(s) in conjunction with the medical directors and personnel 
health service staff of the employing Institution or hospital.
Management of Exposures
If a health-care worker has a parenteral (e.g., needlestiek or cut) or a mucous-membrane (e.g., splash to the eye or mouth) exposure to 
blood or other body fluids or has a cutaneous exposure involving large amounts of blood or prolonged contact with blood—especially 
when the exposed skin is chapped, abraded, or afflicted with dermatitis—the source patient should be informed of the incident and tested 
for serologic evidence of HIV infection after consent is obtained. Policies should be developed for testing source patients in situations 
in which consent cannot be obtained (e.g., an unconscious patient).
If the source patient has AIDS, is positive for HTV antibody, or refuses the test, the health-care worker should be counseled regarding 
the risk of infection and evaluated clinically and serologically for evidence of HTV infection as soon as possible after the exposure. The 
health-care worker should be advised to report and seek medical evaluation for any acute febrile illness that occurs within 12 weeks after 
the exposure. Such an illness — particularly one characterized by fever, rash, or Jymphadenopathy — may be indicative of recent HIV 
infection. Seronegative health-care workers should be retested 6 weeks post-exposure and on a periodic basis thereafter (e.g., 12 weeks 
and 6 months after exposure) to determine whether transmission has occurred. During this follow-up period — especially the first 6-12 
weeks after exposure, when most infected persons are expected to seroconvert—exposed health-care workers should follow U.S. Public 
Health Service (PHS) recommendations for preventing transmission of HTV (3 6 ,3 7 ).
No further follow-up of a health-care worker exposed to infection as described above is necessary if the source patient is seronegative 
unless the source patient is at high risk of HIV infection. In the latter case, a subsequent specimen (e.g., 12 weeks following exposure) 
may be obtained from the health-care worker for antibody testing. If the source patient cannot be identified, decisions regarding
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appropriate follow-up should be individualized. Serologic testing should be available to all health-care workers who are concerned that 
they may have been infected with HIV.
If a patient has a parenteral or mucous-membrane exposure to blood or other body fluid of a health-care worker, the patient should be 
informed of the incident, and the same procedure outlined above for management of exposures should be followed for both the source 
health care worker and the exposed patient.
R e fe r e n c e s
1. Centers for Disease Control. Acquired immunodeficiency syndrome (AIDS): Precautions for clinical and laboratory staffs. MMWR 
1982; 31:577-80.
2. Centers for Disease Control. Acquired immunodeficiency syndrome (AIDS): Precautions for health-care workers and allied 
professionals. MMWR 1983; 32:450-1.
3. Centers for Disease Control. Recommendations for preventing transmission of infection with human T-lymphotropic virus type 
DI/!ymphadenopatby-associated virus in the workplace. MMWR 1985; 34:681-6, 691-5.
4. Centers for Disease Control. Recommendations for preventing transmission of infection with human T-lymphotropic vims type 
III/lymph adenopathy-associated virus during invasive procedures. MMWR 1986; 35:221-3.
5. Centers for Disease Control. Recommendations for preventing possible transmission of human T-lymphotropic virus type 
III/lymphadenopathy-assodated virus from tears. MMWR 1985; 34:533-4.
6. Centers for Disease Control. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic 
virus type lU/lymphadenopathy-associated vims infection. MMWR 1986; 35:376-8, 383.
7. Gamer JS, Simmons BP. Guideline for isolation precautions in hospitals. Infect Control 1983; 4 (suppl):245-325.
8. Centers for Disease Control. Recommended infection control practices for dentistry. MMWR 1986; 35:237-42.
9. McCray E, The Cooperative Needlestick Surveillance Group. Occupational risk of the acquired immunodeficiency syndrome among 
health care workers. N Engl J Med 1986; 314:1127-32.
10. Henderson DK, Saah AJ, Zak BJ, et al. Risk of nosocomial infection with human T-cell lymphotropic virus type 
IU/lymphadenopathy-associated vims in a large cohort of intensively exposed health care workers. Ann Intern Med 1986;104:644-7.
11. Gerberding JL, Bryant-LeBlanc CE, Nelson K, et al. Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and 
hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis 1987; 156:1-8.
12. McEvoy M, Porter K, Mortimer P, Simmons N, Shanson D. Prospective study of clinical, laboratory, and ancillary staff with 
accidental exposures to blood or body fluids from patients infected with HIV. Br Med J 1987; 294:1595-7.
13. Anonymous. Needlestick transmission of HTLV-III from a patient infected in Africa. Lancet 1984; 2:1376-7.
14. Oskenhendler E, Harzic M, Le Roux JM, Rabian C, Clauvel JP. HIV infection with seroconversion after a superficial needlestick 
injury to the finger [Letter]. N Engl J Med 1986; 315:582.
15. Neisson-Vernant C, Arfi S, Mathez D, Leibowitch J, Monplaisir N. Needlestick HIV seroconversion in a nurse [Letter]. Lancet 1986; 
2:814.
16. Grint P, McEvoy M. Two associated cases of the acquired immune deficiency syndrome (AIDS). PHLS Commun Dis Rep 1985; 
42:4.
17. Centers for Disease Control. Apparent transmission of human T-lymphotropic vims type III/lymphadenopa thy-associated virus from 
a child to a mother providing health care. MMWR 1986; 35:76-9.
18. Centers for Disease Control. Update: Human immunodeficiency virus infections in bealth-care workers exposed to blood of infected 
patients. MMWR 1987; 36:285-9.
Guide tines for Prevention of Transmission of HIV and HBV to Health-Care and Public-Safety Workers 46
19. Kline RS, Phelan J, Friedland OH, et al. Low occupational risk for HIV infection for dental professionals [Abstract]. In: Abstracts 
from the III International Conference on AIDS, 1-5 June 1985. Washington, DC: 155.
20. Baker JL, Kden GD, Sivertson KT, Quinn TC. Unsuspected human immunodeficiency virus in critically ill emergency patients. 
JAMA 1987; 257:2609-11.
21. Favero MS. Dialysis-associated diseases and their control. In: Bennett JV, Brachman PS, eds. Hospital infections. Boston: Little, 
Brown and Company, 1965:267-84.
22. Richardson JH, Barkley WE, eds. Biosafety in microbiological and biomedical laboratories, 1984. Washington, DC: US Department 
of Health and Human Services, Public Health Service, HHS publication no. (CDC) 84-8395.
23. Centers for Disease Control. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: Agent summary statement. 
MMWR 1986; 35:540-2, 547-9.
24. Environmental Protection Agency. EPA guide for infectious waste management. Washington, DC: U.S. Environmental Protection 
Agency, May 1986 (publication no. EPA/530-SW-86-014).
25. Favero MS. Sterilization, disinfection, and antisepsis in the hospital. In: Manual of clinical microbiology. 4th ed. Washington, DO 
American Society for Microbiology, 1985; 129-37.
26. Garner JS, Favero MS. Guideline for handwashing and hospital environmental control, 1985. Atlanta: Public Health Service, Centers 
for Disease Control, 1985. HHS publication no. 99-1117.
27. Spire B, Montaenier L, Barri-Sinoussi F, Chermann JC. Inactivation of lymphadenopathy associated virus by chemical disinfectants. 
Lancet 1984; 2:899-901.
28. Martin LS, McDougal JS, Loskoski SL. Disinfection and inactivation of the human T lymphotropic virus type QI/lymphadenopathy- 
associated virus. J Infect Dis 1985; 152:400-3.
29. McDougal JS, Martin LS, Cort SP, et al. Thermal inactivation of the acquired immunodeficiency syndrome virus - 
m/lymphadenopathy-assodated virus, with special reference to antihemophilic factor. J Clin Invest 1985; 76:875-7.
30. Spire B, Barrt-Sinoussi F, Dormont D, Montagnier L, Chermann JC. Inactivation of lymphadenopalhy-associated virus by heat, 
gamma rays, and ultraviolet light. Lancet 1985; 1:188-9.
31. Resnik L, Veren K, Salahuddin SZ, Tondreau S, Markham FD. Stability and inactivation of HTLV-II1 /LAV under clinical and 
laboratory environments. JAMA 1986; 255:1887-91.
32. Centers for Disease Control. Public Health Service (PHS) guidelines for counseling and antibody testing to prevent HIV infection 
and AIDS. MMWR 1987; 36:509-515.
33. Kane MA, Lettau LA. Transmission of HBV from dental personnel to patients. J Am Doit Assoc 1985; 110:634-6.
34. Lettau LA, Smith JD, Williams D, et al. Transmission of hepatitis B virus with resultant restriction of surgical practice. JAMA 1986; 
255:934-7.
35. Williams WW. Guideline for infection control in hospital personnel Infect Control 1983; 4{suppl):326-49.
36. Centers for Disease Control Prevention of acquired immune deficiency syndrome (AIDS): Report of inter-agency recommendations. 
MMWR 1963; 32:101-3.
37. Centers for Disease Control Provisional Public Health Service inter-agency recommendations for screening donated Wood and 
plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR 1985; 34:1-5.
Section 8: OVERHEADS

AIDS = Acquired immunodeficiency Syndrome 
AIDS is caused by HIV = Human immunodeficiency Virus
Outcome of infection with the virus varies:
. Some have no symptoms.
. Some have less severe symptoms than those with AIDS.
• AIDS results from destruction of the immune system which 
allows diseases to threaten life or health.
How widespread is HIV infection?
80,000 cases of AIDS in the U.S. (January 1989)
Over half of these have died.
Estimate: 1.5 million Americans are infected.
Infected people represent all ages, races, men and 
women, and all lifestyles.
You cannot "catch" HIV:
. through the air (like a cold or flu)
• through casual, everyday contact (sharing bathrooms, 
kitchens, etc.)
. through nonsexual social situations
. through insects or mosquitoes
. through urine, feces, nasal secretions, sputum, vomitus, 
saliva, sweat or tears from an infected person
What personal behaviors/practices put you at risk?
. sexual contact with an infected person 
. sharing infected needles
• infected women to her child at birth
Blood supply is screened so that risk of infection from 
transfusion is extremely small.
How can you prevent HIV transmission in your personal life? 
Refrain from:
. anal sex
. vaginal or oral sex with someone who uses IV drugs 
or engages in anal sex
. sex with someone you do not know well
• sex with someone who has multiple sex partners
. sex without a condom with an infected person
. sharing IV drug needles
Occupationally Acquired HIV Infection and AIDS
There are a small number of health care workers who have 
become infected through work-related duties.
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Protect yourself from HIV on the job by avoiding contact with blood and 
potentially infectious body fluids that can transmit the virus.
Blood is the single most important source of HIV 
in the occupational setting.
Protect yourself from fluids that are contained in the spine, 
chest cavity and abdomen, and in the womb surrounding an 
unborn child because the risk for these fluids is unknown.
The risk of HIV infection through contact with feces, nasal 
secretions, saliva, sputum, sweat, tears, urine and vomitus 
is extremely low or nonexistent.
8
Workers can come Into contact with blood or potentially infectious 
body fluids through:
. Needlestick
. Broken or nonintact skin4*
• Mucous membranes of the eye, nose, and mouth
*Nonintact skin = chapped, abraded, weeping, or 
having rashes or eruptions.
Risk of HIV infection through
Needlestick: 0.5% following needlestick contaminated 
with blood from a known infected person.
Chapped/broken skin or mucous membranes: less, 
but not definitively known
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Antibodies to HIV in an infected person’s blood 
can be detected by a test.
Persons usually develop antibodies 
within 6 to 12 weeks after becoming infected.
How can you protect yourself from HIV?
• Use protective procedures and equipment that 
we are going to describe.
. There is no vaccine at the present time.
What is hepatitis B?
Caused by hepatitis B virus (HBV)
Is a disease that damages the liver, causing symptoms 
that range from mild or inapparent to severe or fatal.
25% of infected individuals develop acute hepatitis.
6% to 10% become HBV carriers. Carriers can develop 
liver disease and are infectious to others.
In 1987, new cases of HBV infection in U.S. = 300,000
12,000 health care workers become infected through 
occupational exposure each year.
500-600 infected health-care workers are hospitalized 
each year.
200-300 infected health-care workers die each year with 
associated diseases.
What personal behaviors put you at risk for HBV infection?
.  S e x u a l  c o n t a c t  w i t h  a n  i n f e c t e d  p e r s o n .
.  S h a r i n g  d r u g  n e e d l e s  a n d  s y r i n g e s  w i t h  i n f e c t e d  
p e r s o n .
.  S i n c e  b l o o d  s u p p l y  i s  s c r e e n e d  f o r  H B V ,  t h e  c h a n c e  o f  
b e i n g  i n f e c t e d  t h r o u g h  t r a n s f u s i o n  i s  e x t r e m e l y  s m a l l .
What occupational exposures put a worker at risk for HBV? 
C o n t a c t  w i t h  b l o o d  o r  p o t e n t i a l l y  i n f e c t i o u s  b o d y  f l u i d s  t h r o u g h
.  N e e d l e s t i c k
t  B r o k e n  o r  n o n i n t a c t  s k i n  
.  M u c o u s  m e m b r a n e s  o f  e y e s ,  n o s e  a n d  m o u t h
S a l i v a  i n j e c t e d  t h r o u g h  a  h u m a n  b i t e  c a n  a l s o  
t r a n s m i t  H B V .
• •
T h e  s a m e  p r o t e c t i v e  e q u i p m e n t  a n d  p r o c e d u r e s  
t h a t  w i l l  b e  d i s c u s s e d  f o r  H I V  w i l l  p r o t e c t  t h e  
w o r k e r  a g a i n s t  H B V .
B l o o d  t e s t s  a r e  a v a i l a b l e  t o  d e t e c t  a n t i b o d i e s  
f o r  H B V  i n  a n  i n f e c t e d  p e r s o n .
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Vaccines provide protection against HBV Infection 
(90% protection for 7 or more years).
Vaccines are 70% to 88% effective when given within 1 week of exposure.
HBIG (hepatitis B immune globulin) provide some temporary protection
after exposure.
How are HBV and HIV similar? Different?
H B V  H I V
M o d e  o f  t r a n s m i s s i o n :
B l o o d  y e s  y e s
S e m e n  y e s  y e s
V a g i n a l  s e c r e t i o n s  y e s  y e s
S a l i v a  ( f r o m  a  b i t e )  y e s  n o
T a r g e t  i n  t h e  b o d y  l i v e r  i m m u n e
s y s t e m
R i s k  o f  i n f e c t i o n
a f t e r  n e e d l e s t i c k  6 %  t o  3 0 %  0 . 5 %
t o  i n f e c t e d  b l o o d
H i g h  n u m b e r  o f  v i r u s e s
i n  b l o o d  y e s  n o
V a c c i n e  a v a i l a b l e  y e s  n o
PROTECTIVE EQUIPMENT
G l o v e s
.  d i s p o s a b l e  p r o t e c t s  a g a i n s t  b l o o d  a n d  f l u i d s
« h e a v y  p r o t e c t s  a g a i n s t  s h a r p  o b j e c t s
.  c h a n g e  i f  t o r n  o r  s o i l e d
.  c h a n g e  b e t w e e n  h a n d l i n g  o f  d i f f e r e n t  p e o p l e
M a s k s ,  E y e w e a r ,  G o w n s
.  n o t  n e e d e d  u n l e s s  b l o o d  o r  p o t e n t i a l l y  i n f e c t i o u s  f l u i d s  
a r e  p r e s e n t
.  m a s k s  a n d  e y e w e a r  a r e  w o r n  t o g e t h e r  i f  y o u  a n t i c i p a t e  
s p l a s h e s
•  g o w n s  o r  a p r o n  a r e  w o r n  t o  a v o i d  s o a k i n g  o f  c l o t h e s
N o  r e p o r t e d  c a s e s  o f  H B V  o r  H I V  t r a n s m i s s i o n  
f r o m  m o u t h - t o - m o u t h  r e s u s c i t a t i o n .
B e c a u s e  o t h e r  d i s e a s e s  c a n  b e  t r a n s m i t t e d  t h i s  w a y ,  
u s e  p r o t e c t i v e  d e v i c e s :
.  m e c h a n i c a l  r e s p i r a t o r y  d e v i c e s
.  p o c k e t  m o u t h - t o - m o u t h  r e s u s c i t a t i o n  m a s k s
How can you protect yourself against HIV and HBV?
.  I f  y o u  p e r f o r m  t a s k s  t h a t  p u t  y o u  i n  c o n t a c t  w i t h  b l o o d ,  
o t h e r  p o t e n t i a l l y  i n f e c t i o u s  b o d y  f l u i d s ,  y o u  s h o u l d  b e  
v a c c i n a t e d  a g a i n s t  H B V .
.  W e a r  d i s p o s a b l e  g l o v e s  i f  b l o o d  o r  p o s s i b l y  i n f e c t i o u s  
b o d y  f l u i d s  a r e  p r e s e n t .
.  P u t  o n  p r o t e c t i v e  e q u i p m e n t  i f  t h e  c h a n c e  o f  e x p o s u r e  
t o  b l o o d  o r  p o s s i b l y  i n f e c t i o u s  b o d y  f l u i d s  i s  h i g h .
•  C a r r y  p e r s o n a l  p r o t e c t i v e  e q u i p m e n t  o n  e m e r g e n c y  
r e s p o n s e  v e h i c l e s .
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H I V  c a n n o t  l i v e  i n  a  d r y  e n v i r o n m e n t  f o r  m o r e  t h a n  a  f e w  h o u r s .
H B V  c a n  l i v e  i n  a  d r y  e n v i r o n m e n t  f o r  a t  l e a s t  7  d a y s .
O n c e  t h e  v i r u s  i s  d e a d —i t ’ s  d e a d .  Y o u  c a n n o t  " r e a c t i v a t e "  i t  b y  
a d d i n g  w a t e r .
Needles and sharps disposal
« N e e d l e s  s h o u l d  n o t  b e  r e c a p p e d  o r  m a n i p u l a t e d  b y  
h a n d .
.  D i s p o s a b l e  b l a d e s  a n d  o t h e r  s h a r p s  s h o u l d  b e  p l a c e d  
i n  a  p u n c t u r e - r e s i s t a n t  c o n t a i n e r .
•  P u n c t u r e - r e s i s t a n t  c o n t a i n e r s  s h o u l d  g o  t o  t h e  s i t e  
o f  v i c t i m  a s s i s t a n c e .
.  R e u s a b l e  n e e d l e s  s h o u l d  b e  p l a c e d  i n  p u n c t u r e -  
r e s i s t a n t  c o n t a i n e r s  f o r  t r a n s p o r t  t o  r e p r o c e s s i n g  
a r e a .
Handwashing
U s e  a  u t i l i t y  o r  r e s t r o o m  s i n k  f o r  h a n d w a s h i n g -  
n o t  t h e  f o o d  p r e p a r a t i o n  a r e a .
W a s h  w i t h  s o a p  a n d  w a t e r .
W a t e r l e s s  a n t i s e p t i c  h a n d  c l e a n s e r  s h o u l d  b e  
a v a i l a b l e  o n  r e s p o n s e  v e h i c l e s .
C a r e f u l l y  r e a d  l a b e l s  a n d  p a c k a g e  i n s e r t s  w i t h  g e r m i c i d a l  p r o d u c t s .
S te r i l i z a t io n :  u s e  f o r  i n s t r u m e n t s  t h a t  p e n e t r a t e  t h e  s k in .
• M e th o d s :  s t e a m  u n d e r  p r e s s u r e  ( a u to c la v e )
g a s
d r y  h e a t
im m e r s io n  in  E P A -a p p ro v e d  c h e m ic a l  f o r  lo n g  p e r io d  
H ig h - le v e l  d i s in f e c ta n t :  f o r  i n s t r u m e n t s  t h a t  c o m e  in to  c o n ta c t  w i th  m u c o u s  m e m b r a n e s .
• M e th o d s :  h o t  w a te r  p a s t e u r i z a t i o n
e x p o s u r e  to  s a m e  c h e m ic a l  a s  a b o v e , b u t  f o r  
s h o r t e r  p e r io d
I n te r m e d ia te - le v e l  d i s in f e c ta n t :  f o r  s u r f a c e s  t h a t  c o m e  in to  c o n ta c t  w i th  i n t a c t  s k in .
• M e th o d s :  u s e  o f  c h e m ic a l  g e rm ic id e s  t h a t  a r e  tu b e r c u lo c id a l
b le a c h  (1:100 d i lu t io n )
L o w -lev e l d i s in f e c t io n :  r e m o v a l  o f  s o i l in g  w ith  n o  v is ib le  b lo o d
• M e th o d :  " h o s p i ta l  d is in f e c ta n t s "
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Cleaning and decontaminating spills of blood:
.  P u t  o n  g l o v e s  a n d  c l e a n  w i t h  d i s p o s a b l e  t o w e l s .  P l a c e  
s o i l e d  t o w e l s  i n  p l a s t i c  b a g .
.  W e a r  e y e  a n d  f a c e  p r o t e c t i o n  i f  t h e r e  i s  s p l a s h i n g .
.  W e a r  s h o e  c o v e r s  i f  a m o u n t  o f  b l o o d  i s  g r e a t .
•  D e c o n t a m i n a t e  w i t h  g e r m i c i d e  o r  b l e a c h .  W i p e  a r e a  w i t h  
c l e a n  t o w e l s  a n d  a i r  d r y .
.  R e m o v e  c o n t a m i n a t e d  i t e m s ,  s h o e  c o v e r i n g s ,  e t c .  a n d  
p l a c e  i n  p l a s t i c  b a g  f o r  d i s p o s a l .  R e m o v e  g l o v e s  l a s t .
.  W a s h  h a n d s  a f t e r  r e m o v i n g  g l o v e s .
Laundry
H a n d l e  s o i l e d  i t e m s  a s  l i t t l e  a s  p o s s i b l e .
B a g  s o i l e d  l i n e n  w h e r e  i t  w a s  u s e d  a n d  p l a c e  i n  
b a g s  t h a t  p r e v e n t  l e a k a g e .
W a s h  l i n e n s  i n  n o r m a l  l a u n d r y  c y c l e s  a c c o r d i n g  
t o  r e c o m m e n d a t i o n s  o f  m a c h i n e  a n d  d e t e r g e n t  
m a n u f a c t u r e r s .
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Decontaminating and laundering of protective clothing
.  T r a n s p o r t  c l o t h i n g  i n  b a g s  o r  c o n t a i n e r s  t h a t  p r e v e n t  
l e a k a g e .
•  W e a r  g l o v e s  w h e n  b a g g i n g  a n d  p l a c i n g  i n  w a s h e r .
.  U n i f o r m s  s h o u l d  b e  w a s h e d  a n d  d r i e d  a c c o r d i n g  t o  
m a n u f a c t u r e r ’s  r e c o m m e n d a t i o n s .










A n  e x p o s u r e  i s  c o n t a c t  w i t h  b l o o d  o r  f l u i d s  t h a t  h a v e  
t h e  p o t e n t i a l  t o  b e  i n f e c t i o u s  t h r o u g h  a  n e e d l e s t i c k ,  
t h r o u g h  b r o k e n  o r  n o n i n t a c t  s k i n ,  o r  t h r o u g h  t h e  
m u c o u s  m e m b r a n e s  o f  t h e  n o s e ,  m o u t h ,  o r  e y e s .
W o r k e r s  w h o  a r e  e x p o s e d  s h o u l d :
.  W a s h  t h e  a f f e c t e d  a r e a .
•  R e p o r t  t h e  i n c i d e n t  a n d  b e  e x a m i n e d  b y  t h e  
p r o p e r  m e d i c a l  a u t h o r i t y  f o r :
A s s e s s m e n t
C o u n s e l i n g

